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SUMMARY   
With the emerging threat from biotoxins, we study the fate of three biological warfare 
agents namely ricin, staphylococcal enterotoxin B (SEB) and T-2 mycotoxin in an indoor 
office environment. In this research study, we will look into the stability profile of each 
toxin with a suitable analytical technique over a period of 7 days. Based on the principle 
of amine specific isobaric tagging (i.e. iTRAQ reagents) as well as the use of nano-flow 
liquid chromatography-mass spectrometry, we describe here a new quantitative strategy 
that looks into the stability profiles of staphylococcal enterotoxin B (SEB) and ricin over 
170 hours on carpet and parquet. This is the first paper that looks into the quantitative 
work of SEB and ricin using iTRAQ reagents. Using the MS/MS signature ions from the 
amine-derivated peptides and comparison with standard, we have shown that the study of 
SEB and ricin with absolute quantitation is feasible by amine isobaric tagging and 
analysis with nano-flow liquid chromatography-mass spectrometry (nanoLC-MS).   
This quantitative methodology based on iTRAQ labeling/nanoLC-MS showed that the 
stability of ricin on carpet had dropped drastically to half of the spiked amount by the 8th 
hour and had leveled down to ~20% by the end of the 7th day, leaving an amount of 15.5 
ug/cm2 ricin.  As for ricin on parquet, it was much stable than on carpet with ~70% 
remaining at the end of the 7th day. SEB was very stable on parquet with no observable 
degradation for up to 7 days but degraded gradually on carpet with ~25% (19.5 ug/cm2) 
remaining on the 7th day in an indoor office environment. SEB on parquet (~100% 
remaining) was more stable compared to ricin on parquet (~70% remaining). Both 
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protein toxins were more stable on parquet than carpet with ~20% to 25% toxin 
remaining on carpet.   
The stability profile of T-2 toxin on carpet and parquet was studied using liquid 
chromatography-mass spectrometry (LC-MS) based on selected ion monitoring. The 
stability profile of T-2 toxin was showed to be twice as stable on carpet as compared to 
parquet under indoor conditions up to 7 days. On the 7th day, there was 0.20 mg/25 cm2 
(i.e. 20%) remaining on parquet. As for carpet, T-2 toxin was more stable and persistent 
with 0.34 mg/25 cm2 (i.e. 34%) remaining. In contrast to SEB and ricin, T-2 toxin was 
more stable on carpet than on parquet. Parquet is an interesting indoor substrate giving 
extreme opposite toxin stability results for the proteinaceous toxins (i.e. SEB and ricin) 
and non-proteinaceous toxin (i.e. T-2 toxin) studied thus far. T-2 toxin degraded rapidly 
on parquet whereas SEB and ricin were extremely stable on parquet. This implied that 
non-protein toxin as well as protein toxins behave differently on different matrices and 
degrade to different extents.          
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CHAPTER 1  INTRODUCTION  
1.1  BIOLOGICAL WARFARE AGENTS  
1.1.1 Its definition, classification and threats 
Biological warfare agents (BWA) are agents that can achieve their deliberate intention by 
causing infectivity of diseases or intoxication through the release of microorganisms, 
viruses and toxins of biological origin, resulting in death, illness and incapacitation of 
human beings, animals or plants1. The pathogenicity caused by some of the BWA could 
be due to its own generated toxic substances. Such BWAs are known as toxins.  Toxins 
are toxic chemical compounds produced naturally by animals, plants and microorganisms 
or by chemical synthesis. They could be either proteinaceous or non-proteinaceous 
toxins.  The main characteristic difference between living organisms and toxins is that the 
former are alive and can reproduce and multiply in the target host whereas the latter are 
non-living chemical compounds from biological sources2. These two classes of BWA not 
only differ in their nature but also on their stability, toxicity, lethality, infected time and 
route of disease transmission. Unlike living organisms, toxins only have effects on the 
population that has direct exposure to them and will not transmit among human beings. 
The dissemination of the living organisms is much limited due to its stability3. As for 
toxins, they are mostly stable leading to simple dissemination system.    
Toxins do not achieve their effects through infectivity, but rather due to toxicity. This is 
similar to the definition of chemical warfare agents (CWA), even though they are 
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biological warfare agents. Thus, toxins are known as mid-spectrum agents since they fall 
between the two different classes of warfare agents. The two main differences between 
toxins and CWA are that toxins are non-volatile and non-dermal active except for 
trichothecene mycotoxins4. Bio-toxins are believed to be the new emerging threat5 to 
humans and their impact on population and casualties may be even more severe than 
classical CWA since bio-toxins are more lethal per kilogram than many CWA. The North 
Atlantic Treaty Organization (NATO) recognized the difficulty of identifying a wide 
diversity of mid-spectrum agents due to limitations in BWA detection, which also have 
diverse potencies and thus, listed out the criteria for identification of both proteinaceous 
and non-proteinaceous toxins6.   
Recent attempts to deploy anthrax spores and botulinum toxin aerosol in Tokyo by 
Japanese sect Aum Shinrikyo, followed by the 9/11 terrorist attack and mails containing 
anthrax spores in US had raised the alarm on the possibility of bioweapons. BWA pose a 
wide spectrum of threat from insignificant to massive casualties and death. The level of 
threat would depend on the nature of BWA used, its stability in environment, its 
dissemination system, its population’s preparedness and its agencies’ countermeasure. 
However, BWA do not need to be highly potent in order to be an effective weapon. For 
the horror, panic and confusion caused by BWA, it would have fulfilled its intended 
motive of psychological warfare, apart from physical injury or illness caused7. Thus, it is 
important to have the agencies and people well-educated and prepared for the possibility 
of bioterrorism.   
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1.1.2 Its potential use  
The various inherent advantages of BWA are stated as follows: availability, ease of low 
cost production, high lethality and capability to incapacitate population, appropriate 
aerosol particle size which poses as the most fatal route, ease of dissemination and 
stability after production. At this moment of time, it is extremely difficult to detect the 
use of toxins as BWA immediately due to the current limitation in detection. This makes 
bio-toxins the most potential weapon to be used in the next era. A merging list from the 
Centers for Disease Control and Prevention (CDC), the North Atlantic Treaty 
Organization (NATO), the Defense Threat Reduction Agency (DTRA) and other entities8 
had also shown us the emerging threat from BWA. Thus, there is an urgent need to 
develop a rapid detection and quantitation method for BWA in order to counteract with 
proper medical treatment or decontamination to reduce the mortality rate.   
1.2  RICIN  
1.2.1 Its structure, properties & mechanism of action 
Ricin is a class of proteinaceous toxin, which is also a mid-spectrum agent that can be 
deployed in biological warfare, other than its great promise as immunotoxins9 for cancer 
therapy. Ricin toxin is found in the seeds of castor bean, Ricinis communis. It is one of 
the most toxic and easily obtainable plant toxins. Among the mid-spectrum agents, ricin 
takes a unique position, because it is the only protein listed under the Chemical Weapons 
Convention (CWC). Even though its lethal toxicity is about 10,000 fold less than 
botulinum toxin, ricin still has its potential for weaponization due to its worldwide 
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availability in bulk quantities as a by-product from castor oil production, its extreme heat 
stability and its ease of extraction.  Before the 1990s, ricin intoxication was uncommon 
and thus, not much effort had been made to produce vaccination. However, with the 
increased possibility of using toxins for bioterrorist attack, it cannot be neglected. Effort 
was made by Olson et al10 where they used protein engineering to produce an immune 
serum for ricin which was still under development.      
Figure 1: Structure of Ricin.  
Source from Swissprot account number P02879 & RCSB protein data bank, account number 2AAI.  
It is drawn using Rasmol version 2.6.  
Ricin is an approximately 66 kDa globular protein consisting of two moieties, the A-
chain (approximately 32 kDa) and the B-chain (approximately 34 kDa), connected by a 
disulfide bond as shown in Figure 1. The two chains must be associated for toxicity 
where one group of di-chain ribosome-inactivating proteins is specific for the 
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depurination of a single adenosine in ribosomal ribonucleic acid (RNA). Basically, it is 
the A-chain which acts as N-glycosidase that is responsible for its toxicity effect causing 
inhibition of protein biosynthesis.  
The B-chain has lectin properties that bind to complex galactosides of cell-surface 
carbohydrates where this binding of B-chain to glycoside residues on glycoproteins and 
glycolipids would promote onset of the endocytotic uptake of the protein. Thus, it 
facilitates the internalization of the toxin by transporting A-chain into the cytosol within a 
few hours. The enzymatically active A-chain acts as a ribosome-inactivating protein by 
removing an adenine residue from an exposed loop of 28S ribosomal RNA once it enters 
into the cytoplasm of a eukaryotic cell. This causes the failure of elongation factor-2 to 
bind and thus, these truncated ribosomes can no longer support protein synthesis11, 12 as 
the A-chain molecule inactivates ribosomes faster than the cell can make new ones.   
The route of ricin poisoning could be through inhalation, intravenous injection, 
intraperitoneal injection, subcutaneous injection or ingestion but inhalation route is 
presumed to be the likeliest threat in battlefield. The toxicity of ricin depends on the route 
of poisoning, with the LD50 for mice being between 3 to 5 ug/kg for 60 hours exposure 
through inhalation.  A longer exposure time of 90 hours would be required for mortality, 
following intravenous injection of 5 ug/kg, whereas 20 mg/kg would be required by 
ingestion. The high amount required for toxicity through injection reflects the poor 
absorption of ricin via the gastrointestinal tract. It has also been shown that there was no 
toxicity associated with dermal administration of ricin. The clinical symptoms of ricin 
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poisoning vary depending on the size of dose and the route of poisoning. In animal 
studies13, poisoning through inhalation would generally produce physical symptoms such 
as sudden respiratory difficulties, eye irritation and chest tightness, and in more severe 
case, asthma lasting for several hours. During the first 8 hours of exposure, there would 
not be any damage to the lungs. By the 12th hour of exposure, increased inflammatory 
cell counts and total protein were observed, indicating inflammation. By the 30th hour of 
exposure, alveolar flooding followed by arterial hypoxemia and acidosis would be 
observed. Death usually occurs within 36 to 48 hours but it will depend on the size of 
dose being exposed. As the action of ricin is rapid, once inhaled, it is irreversible and post 
treatment would be difficult.  For ingestion intoxication, there would be symptoms of 
nausea, vomiting, and abdominal pain, followed by bloody diarrhea and in severe 
instances, liver necrosis, rental failure, circulation collapse, coma or even death may 
occur. Ingestion poisoning should show all the gastrointestinal symptoms. For injection, 
there would be immediate localized muscle pain and regional lymph node necrosis.   
As ricin has several different oligosaccharide chains linked to four glycosylation sites, it 
could exist in several forms by the differences in carbohydrate composition, which makes 
the analysis even more challenging. For environmental monitoring in bioterrorism attack 
as well as for medical treatment purpose, there is a need for a rapid and sensitive 
detection and quantitation method on trace amount of ricin in different matrices.     
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1.2.2 Review of analytical methods for Ricin detection  
One of the earliest detection methods for low concentration ricin was radioimmunoassay 
(RIA) 14, 15 which used radioactive 125I-labeled ricin. It could be used to quantify as low 
as 100 pg of ricin. Even though it had good sensitivity, its major drawbacks were long 
incubation time, difficulties in handling and disposing of radioisotopes. These limitations 
had made it less preferred compared to enzyme-linked immunosorbent assay (ELISA). 
ELISA involved shorter assay time compared to RIA. The principle of ELISA is based on 
antibody-antigen interaction. It can be in direct, competitive or sandwich format.  
Sandwich ELISA16 using rabbit anti-ricin antibody was done, giving a detection limit of 
40 ng/ml for ricin. This development of ricin assay had been made based on the usage of 
affinity-purified rabbit antiserum and avidin/biotin immuno-peroxidase complex.   
Enhanced colorimetric and chemiluminescence ELISA17, in which an affinity-purified 
goat polyclonal antibody was utilized to form a sandwich assay with the same antibody 
(biotinylated), were explored. The addition of avidin-linked alkaline phosphatase (AP) 
allowed colorimetric measurement at optical density of 405 nm. The enhanced 
colorimetric assay was made with increased biotinylated antibody content and a reduction 
in dilution ratio of avidin-linked AP, giving a detection of 100 pg/ml for ricin in buffer, 
human urine and serum. This sandwich assay could be configured to 
chemiluminescence’s detection with quantitative range of 0.1-1 ng/ml and was subjected 
to greater variations compared to colorimetric assay. Further development on 
colorimetric detection was investigated. Monoclonal antibodies (MAb) was used in a 
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sandwich format with affinity purified anti-ricin B chain MAb that extracted ricin and 
anti-ricin A chain MAb that conjugated with peroxidase18 to give a colorimetric detection 
at optical density of 450 nm. This allowed a detection of 5 ng/ml ricin in buffer, urine and 
human serum.  
The main disadvantages of classical ELISA are its long incubation time and lengthened 
assay time due to several washing steps involved and also limited throughput. For an 
inexpensive monitoring and rapid detection of BWA, both colorimetric and 
chemiluminescence ELISA would not have met these requirements. With a change in the 
detection module to a laser-induced fluorescence, a fluorescence-based fiber optic 
immunoassay19 was reported giving a detection limit of 100 pg/ml in buffer solution 
within a much reduced assay time of 20 minutes. This fluorescence-based assay involved 
the use of evanescent wave for detection and the enhanced sensitivity attributed to the 
avidin-biotin principle that improved the antibody binding activity. Other form of 
conjugation in immunoassay was explored with reduced assay time. The use of colloidal 
gold particles20 as a detection reagent was used in comparison to the conventional 
conjugation. This allowed detection to be done in less than 10 minutes and yet gave 
sensitivity close to classical ELISA. The detection limit was 50 ng/ml ricin but this could 
be stretched down to even lower limit of 100 pg/ml with just the use of silver 
enhancement. The advantages of these gold particles are their superior mobility, less 
aggregation and commercial availability. Through coupling polyclonal antibodies with 
carboxylated latex particles21, it allowed a sensitized latex agglutination test, which gave 
a sensitivity of 2.8 ng/0.5 ml of latex particles. 
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Simultaneous detection of toxins is desirable as it is not longer sufficient to have just a 
fluorescence-based immunoassay for detection of a single analyte since in a bioterrorist 
attack, we would have no idea what BWA has been released. A planar array 
immunosensor22, equipped with a charge-coupled device (CCD) was reported to 
simultaneously analyze three toxins, namely ricin, SEB and Yersinia pestis. It was a 
simple and disposable sensing array coated with different antibodies detected through 
CCD. This planar array platform was able to give a detection limit of 25 ng/ml ricin, 5 
ng/ml SEB and 15 ng/ml Y. pestis. With this detection platform, it allowed multiple 
analytes’ detection, low quantity sample requirement and simultaneous analysis inclusive 
of both positive and negative controls. This array technology was extended further to 
analyze simultaneously six toxins23 namely, ricin, SEB, cholera toxin, botulinum toxoids, 
trinitrotoluene and mycotoxin fumonisin.   
From a normal sized spot on the array surface to a micrometer-sized spot, a microarray 
was designed. A flow-based microarray platform24 was developed based on this 
microsized array where the surface was fitted to a flow module with six channels. This 
flow module containing the analytes’ solution would flow through the microarray of 
fluorescence-coated antibodies and could detect low concentration of ricin rapidly in 15 
minutes. Simultaneous detection of both proteins and bacteria was possible giving a 
detection limit of 10 ng/ml for ricin, 4 ng/ml for SEB, 8 ng/ml for cholera toxin and 
6.2x104 cfu/ml for Bacillus globligi. The major advantage of microarray immunoassay 
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would probably be its massive number of spots on a single array surface, thus allowing 
several analytes to be run in parallel.  
Even though fluorescence-labeled immunotechnology could give multiplexed analysis, 
organic fluorophores still subjected to complications such as occurrence of multiple 
spectral characteristics that made data analysis more challenging. By replacing such 
fluorophores with luminescent semiconductor nanocrystals (quantum dots)25, it was 
reported to perform multiplexed fluoroimmunoassay on ricin, cholera toxin, shiga-like 
toxin and SEB with a good detection limit of 30 ng/ml and 3 ng/ml for ricin and SEB 
respectively.  Quantum dots are inorganic fluorophores that are robust and span the 
visible spectrum. It allows particles of different sizes to be excited simultaneously at a 
single wavelength and yet emits multiple wavelengths. The results obtained using 
quantum dots were reproducible, which organic fluorophores could not. But cross 
reactivity may still occur within any immunoassay.   
Antibodies have been the crucial part of the immunoassay technology. But due to its 
sensitivity to high temperature, it could be denatured easily and thus, its storage life is 
short. This problem could be resolved by a change of receptor to either aptamer chips26 or 
glycosphinogolipids (GSLs) 27. Aptamers are functional binding species from selected 
combinatorial oligonucleotide libraries, which can be chemically synthesized. The 
adoption of aptamer receptor into a microarray platform had various advantages like high 
stability of chip leading to long storage and ease of transportation, and could be 
regenerated without any loss of activity. But its sensitivity was only 320 ng/ml. As for 
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GSLs, it has strong interaction with protein toxins and its usage as recognition molecules 
surpasses the antibody technology since they are stable at room temperature, ease of 
orientation by hydrophobic and hydrophilic interaction and more binding sites available. 
This study was done using quartz crystal microbalance (QCM) sensor which gave a 
detection limit of 5 ug/ml compared to 25 ug/ml of antibody.  On comparison, it showed 
that with a change of antibody to GSLs, it gave a better sensitivity but this detection limit 
was not low enough. This could be improved by a change in the detection module.   
Using the principle of microchip, a three-dimensional hydrogel containing various 
immobilized proteins/antibodies on a microchip known as protein gel-based microchip28 
was manufactured. This gel-based microchip used in conjunction with various 
immunoassays was done. The detection of analyte was through fluorescence, chemi-
luminescence equipped with CCD or mass spectrometry (MS).  The highest sensitivity of 
0.1 ng/ml for ricin and 1ng/ml for SEB was achieved by sandwich immunoassay format 
done individually. However when studied in parallel analysis, its sensitivity was dropped 
to 0.7 ng/ml of ricin. This gel-based microchip has various advantages such as good 
stability up to six months due to its hydrophilic condition, ease of production, and 
covalent immobilization of proteins within the structure, highly porous for ease of 
interaction and no cross reaction due to proper selection of the antibody pairs.  However, 
it required several hours for analysis. It was mentioned in this study that the approach of 
MS is promising since it was a one- step procedure which requires no labeling of 
antibodies.   
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Development on the solid-phase surface of immunoassay technology was made by a 
replacement of the conventional microplate with magnetic microspheres29 or gold-coated 
magnetoelastic sensor surface30, 31.  In immunomagnetic microsphere surface, it involved 
two-phase chemiluminescence based techniques, fluorogenic-chemiluminescence (FCL) 
and electro-chemiluminescence (ECL) using magnetic microspheres giving detection of 
1000 pg/ml ricin and 0.5 pg/ml ricin respectively. These ECL and FCL detectors could 
identify multiple BWA like SEB, Botulinum A, Bacillus anthracis, Bacillus subtilis and 
Escherichia coli with high sensitivity. Advantages of microsphere are large surface area 
for capturing antibodies which enhances sensitivity, higher reaction rates which lead to 
reduction in analysis time and easy detection using simple magnetic field. This technique 
allowed a direct separation of target analyte from a complex mixture.   
Both FCL and ECL have similar formats except that FCL uses alkaline phosphatase as 
label and detects through measurement of fluorescence whereas ECL uses ruthenium-
tribipyridal as label and detects through photo emission. For magnetoelastic sensor, the 
detection technology is a sandwich complex of anti-ricinus communis agglutinin 
antibody on the sensor surface and uses biocatalytic precipitation to cause a change in 
mass. This in turn, causes a shift in the resonance frequency which allowed quantitation 
of ricin at 5 ng/ml. This magnetoelastic sensor has sensitivity comparable to ELISA but it 
allows cheaper, disposable and relatively faster analysis.   
Most detection techniques for ricin have been focusing on bioassay principle. From 
changes of various formats, labels, detection modules and receptors, the goal for 
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detection of ricin is clear. They aim at rapid detection with high sensitivity and ease of 
performance with multiplexed analysis in a single run. But for typical bioassays 
techniques, even though they are not ricin specific, it can also cause cell death and 
possibility of cross-reactivity. Only a few papers on chemical analysis have been 
published. They are believed to have higher specificity. Chemical analysis like Fourier 
transform near-infrared reflectance spectrometry32 based on multivariate technique can 
give a fast and accurate quantification on ricin. Though it is a non-destructive method 
giving both structural and physical properties of the analyte, its low sensitivity of 1.5 
mg/500 mg of wheat flour is the biggest drawback.   
There have been reports of ricin analysis through the use of capillary electrophoresis 
(CE) detecting 10 mg/ml ricin by UV detector33. The attraction of CE lies in its ability to 
do both separation and purification of complex mixtures rapidly. Incorporating this into 
immunoassay where it combines the separation power of CE and the specificity of 
antibodies for detection results in a capability known as capillary electrophoresis-based 
immunoassay (CEIA)34. CEIA is much simpler than classical model which allows more 
flexibility such as custom making of analyte assay. It requires less sample and reagents’ 
volume and yet allows simultaneous multiplexed detection and ease of result 
interpretation. This CE technology was improvised into a hand-held device35 based on 
two microchip separations, namely gel (CGE) and zone electrophoresis (CZE). Using a 
microfluidic principle on chip, it allows detection of fluorescence-labeled toxin by a 
miniaturized laser-induced fluorescence detection module. This system was a small 
instrument for ease of logistic but its sensitivity was not optimized giving 25 nm for CZE 
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and 5 nm for CGE.  Other than being miniatured, it also requires relatively less sample or 
solvent and at a lower cost.  
Other than immunoassay, CE can be coupled to mass spectrometry (MS) 36, 37 giving a 
powerful analytical tool which can analyze, characterize and differentiate between 
various forms of ricin toxins. It provides a more precise and efficient analysis of ricin. 
Most proteinaceous toxins are not amenable to gas chromatography mass spectrometry 
analysis (GC-MS) and thus, liquid chromatography (LC) based methods are used.  Mass 
spectrometry has emerged to be a useful tool for analysis of high molecular weight 
protein. During the past two decades, mass spectrometry has become established as the 
primary method for protein identification from complex mixtures of biological origin. 
This is largely attributed to the rapid instrumental advances and growth in genomic 
databases.   
Mass spectrometers (MS) employed in proteomic analysis used are either matrix-assisted 
laser desorption/ionization (MALDI) or electrospray ionization (ESI). With this 
combination of soft ionization methods, it provides a rapid and sensitive tool for 
determination of accurate molecular weight and also the possibility of amino acid 
sequencing for identification. However, ESI has been the standard ionization method38 
for LC-MS and LC-MS/MS. ESI is usually employed for single and triple quadrupoles 
and quadrupole ion traps that typically give modest resolution. The combination of a 
quadrupole mass selector and quadrupole collision cell with orthogonal acceleration TOF 
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(Qq TOF) gives high resolution (~10,000) and perhaps 5ppm mass accuracy39. Qq TOF 
has been widely used in protein/peptide analysis40, 41, 42, 43.   
Multi-dimensional (MD) LC coupled with MS is possible by having C18 desalt column 
or cation exchange (SCX) column in the first dimension and separation of protein/ 
peptides through C18 column in the second dimension, followed by MS analysis. On-line 
separation and purification made through MDLC coupled to ESI-MS44, 45 allow us to 
identify and quantify the protein/peptides. Characterization of ricin46, 47, 48 had been done 
using MS but no detection limit was reported.  With the advancement of MS/MS, the 
power of MS could be used in different approach like the use of label such as isotope-
coded affinity tag (ICAT) 49, 50, 51 for relative quantitation or iTRAQ reagents 52, 53 for 
absolute quantitation. In Table 1, we had summarized the various methods and lowest 
level of detection (LOD) for ricin.  Despite the fact that we do not have any reported 
LOD for LC-MS, we do see MS technology as a potential for ricin detection and 
quantitation given their advantages in sensitivity, speed and multi-agents detection. With 
the labeling technology, it also allows accurate quantitation.         
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Table 1: summarized methods and LODs for Ricin  
Ricin Methodologies Lowest level of detection  




5-40 ng/ml (colorimetric)16,18 
100 pg/ml(enhanced colorimetric)17 
0.1-1 ng/ml(chemiluminescence)17 
50 ng/ml (colloidal gold particles)20 
100 pg/ml(gold particles with silver enhancement)20  
3 Fluorescence-based fiber 










10 ng/ml (flow-based platform)24  
6 Aptamer microarray 320 ng/ml26  
7 GSLs with QCM 5 ug/ml27  
8 Protein gel-based 
microchip immunoassay 
0.7 ng/ml28 
9 Magnetic microsphere 
with (a) ECL or (b) FCL 
(a) 0.5 pg/ml29 
(b) 1000 pg/ml29  
10 gold-coated 
magnetoelastic sensor 
5 ng/ml in aqueous media30,31 
11 Fourier transform near-
infrared reflectance 
spectrometry 
1.5 mg/500 mg of wheat flour32 
12 Capillary electrophoresis 
with (a) UV or (b) MS 
(a)10 mg/ml33 
(b)characterization done but no limit of detection 
reported34  
13 CZE, CGE 25 nm, 5 nm35  
14 LC-MS Not reported  
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1.3 STAPHYLOCOCCAL ENTEROTOXIN B (SEB)  
1.3.1 Its structure, properties & mechanism of action 
Staphylococcal enterotoxin B (SEB) is one of the seven enterotoxins produced by strains 
of Staphylococcus aureus. Depending on the phase of cell growth cycle, pH and the 
glucose content, it would produce a variety of different staphylococcal toxins such as 
type A, B, C1, C2, C3, D and E. Their classification is based on their sequence 
homology. SEB belongs to a group of proteins with molecular weight ranging from 23 to 
29 kDa. It is stable to heat, proteolytic digestion and pH change (pH 4 to 10) and also 
water-soluble.   As a pyrogenic toxin, it is capable of incapacitating a person for up to 
two weeks with a dosage as low as 0.0004 ug/kg. It may even serve as a better 
incapacitant than many CWA incapacitants since its effect would be longer2. They are 
low volatile compounds and are extremely potent gastrointestinal toxins. Its structure is 
shown in Figure 2.  
Figure 2: Structure of SEB.  
Source from Swissprot account number P01552 & protein data bank account number 3SEB.  
It was drawn using Rasmol version 2.6. 
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Due to its inherent stability, high morbidity rate, high intoxication effect and ease of 
dissemination, it is an attractive choice of biological aerosol weapon as considered by 
NATO54.  It is classified as a B-list agent in CDC. A significantly lower quantity is 
required to produce the same effect as synthetic chemical agents. The mechanism of 
action is thought to be the activation of the immune system receptors by SEB where it 
causes a strong binding with the T-cells and class II molecules that would mimic the CD4 
binding leading to production of large quantity of T-cells independent of antigen 
recognition. This could result in a massive release of cytokines such as interferon-
gamma, interleukin-6 and tumor necrosis factor-alpha or histamine and leukotriene from 
mast cells55. The clinical symptoms for inhalation are fever, myalgia, dyspnoea and chest 
pain. As for ingestion, the usual gastrointestinal signs would be observed. With enough 
rest and water, it would promote recovery.  
Increased awareness of its usage as BWA had raised attention from both the physicians as 
well as various agencies to combat any bioterrorist attack.  For a fast response from them, 
we need an adequate and efficient detection technique, which we are now looking into 
with our research work.  
1.3.2 Review of analytical methods for SEB detection  
In the early days, there were three immunological assay formats that had been used for 
SEB detection, namely immunodiffusion assays, radioimmunoassay (RIA) and enzyme-
linked immunosorbent assays (ELISA). However due to its low sensitivity of 0.1 ug/ml 
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and long analysis time, immunodiffusion assay was not preferred. Though competitive 
RIA was more sensitive in detecting as low as 1 ng/ml and could be used for quantitative 
measurement, its limitations had been on the handling and disposal of radioactive 
compounds and also the low binding of the radioactive labeled toxin. Thus, ELISA has 
been the option for SEB detection. From classical ELISA, it transformed into a double-
antibody sandwich system and detected through colorimetric54 measurement. This 
sandwich system allowed relative quantitation from both culture media and food extract 
as well as from human urine.  
A comparison study was done between monoclonal and polyclonal antibody system56. It 
showed that monoclonal antibody (Mab) system was more favored than polyclonal 
system. Advantages of Mab were that it provided unlimited supply of high grade reagents 
and adoption of cross-reactive MAbs. Despite the various improvements made in the 
technology of sandwich ELISA, its performance still depends heavily on the affinity and 
specificity of the selected antibody. Not only that, ELISA is time consuming for any 
analysis due to its long incubation and assay time. Reduction of analysis time was 
explored and a rapid and sensitive sandwich ELISA based on a highly avid anti-SEB 
antibody (polyclonal) 57 was developed. The avid anti-SEB antibody (polyclonal) served 
as the capture antibody and biotinylated antibody conjugate. By using glutaraldehyde 
fixation method, it concentrated the capture antibody as well as added the discrimination 
function of positive and negative controls. With addition of 1% polyethylene glycol, its 
detection sensitivity improved to 0.5 ng/ml and it could be done in 45 minutes.  
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A proposal of changing the antibody receptor to glycosphingolipid digalactosylceramide 
(diGalCer) 58 in sandwich ELISA would be able to prevent cross reactivity, which was 
unavoidable in classical ELISA. diGalCer was found in human kidney and proximal 
tubular cells which binded specifically to SEB. Since this receptor controlled the 
metabolic action of SEB, it could be formulated into a receptor-based immunoassay and 
would be of wide application due to its long shelf life. This analysis was fast, simple and 
sensitive to 1 ng/ml of SEB. It was comparable to existing methods in terms of sensitivity 
but most importantly, it was SEB specific and the results could be read with naked eye. 
Another approach towards the improvement of immunoassay had been the use of 
bidiffractive grating59. Detection was made through change in the refractive index and it 
was much faster than classical ELISA allowing multiplexed detection with lowest 
detection at 1 ng/ml.   
With fluorescence labeling of antibody, known as fluorescence based immunoassay60, the 
time of analysis would be faster by four times and yet would give sensitivity comparable 
to classical ELISA. . Other than introducing fluorophores into the antibody, we could also 
use an active electronic microchip to develop a microelectrophoresis assay61. This assay 
could be coupled with other analytical techniques such as CE and MS, hence improving 
the purity of sample for easier identification, as well as sensitivity. Its principle involved 
a combination of electrophoresis and immunoassay platform. The active electronic 
microchip consisted of a planar array of microelectrodes where the charged molecules 
transported to and from sites on the chip called microlocations. Multiplex detection was 
accomplished by having multiple individual assay sites present in a single microchip. The 
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charged molecules did not affect the solution on other parts of the array and also with the 
generation of an electric field, it increased the binding and improved the selectivity.  
Cross reactivity in classical ELISA could be resolved.    
Based on the fluorescence technology, an array-based biosensor was developed that 
consisted of two recognition elements, which allowed simultaneous detection and 
quantification of multiple analytes that ranged from 4 to 20 ng/ml.  The immobilized 
capture antibodies served as the first recognition element, followed by the recognition of 
the bounded analyte by fluorescent tracer antibodies.  This array sensor utilized the 
evanescent wave where it excited the fluorescent immunocomplexes and quantified 
through CCD. Evanescent excitations were only sensitive to surface coated with 
fluorophores and thus it allowed real-time monitoring. The development of array 
biosensors started off with three bacterial samples and four toxin samples detection62 
followed by a nine-analyte detection63 in automated format. This was done in 15-20 
minutes. Other than its high speed, good sensitivity and multiplexed detection, this 
biosensor could be miniaturized for the ease of transport.   
A novel fluidics cube was used in the development of a portable array biosensor64. This 
fluidics cube was constructed using poly (methyl methacrylate) where it contained six 
reservoirs for samples and six reservoirs for fluorescence tracer antibodies. One end was 
connected to a pump and the other end consisted of inlets connected to the sample and 
tracer. Once the air valve was relieved, the sample or tracers were loaded onto the 
waveguide surface and detected by CCD.  
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From the existing ELISA assays, it could be converted to a time-resolved fluorometry 
assay65 through the use of lanthanide chelate labels, which have a unique fluorescence 
property. This assay had a sensitivity of 10 pg for SEB in human serum, urine, sewage 
water or dirt. There were other possible ways of coupling such as coupling to a silicon-
based light-addressable potentiometric sensor (LAPS) 66. Despite the fact that it gave a 
good sensitivity ranging from 3 to 310 pg/ml, the analysis would require an hour and the 
sensitivity was volume dependent.   
To meet the demands of high sample throughput as well as high sensitivity, various 
developments had been made on the immunoassay such as immunomagnetic separation 
(IMS) with different detection modes. In IMS, magnetic beads coated with antibodies 
were used as the target antigen capturing probe. One mode of detection was through the 
use of a microplate fluorometer (FM) 67 in which the magnetic beads-coated antibody 
captured the target analyte for analysis. IMS in a microplate platform allowed efficient 
targets capture and served as a concentration step to give an enhanced sensitivity of 0.1 
ng/ml. The advantages of this IMS-FM system are rapid analysis, direct analysis on crude 
sample, semiautomatic reduction of exposure of BWA to personnel, labor-saving and 
reduction of any non-specific false interference. IMS could be coupled to other detection 
modules such as flow cytometer 68, 69, allowing detection of 100 pg SEB in culture 
supernatant of methicillin-resistant S. aureus using Alex fluor 647 labeled antibodies, in 
less than 45 minutes. By coupling with electrochemiluminescence (ECL) 70, it provided 
detection by increasing its sensitivity through high luminescent signal to noise ratios that 
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was initiated in a controlled fashion by a voltage potential at the site of immune complex 
formation. This was accomplished by a heavy metal called chelate ruthenium (II) tris-
bipyridal that conjugated to a detector antibody giving a high sensitivity of 1 pg/ml in 
serum, urine, tissue or buffer and was reproducible. This IMS-ECL assay was rapid (30 
minutes), sensitive, reproducible and robust.  
There are various forms of immunosensors immobilized on different platforms for 
examples on optical fiber71, piezoelectric crystal72, 73 and gold surface plasmon resonance 
(SPR) 74, 75, 76, 77. The fiber optic biosensor was based on the sandwich immunoassay and 
quantified through optoelectronics, where a diode laser was utilized to excite the 
polystyrene optical probe. The emitted fluorescence would produce a signal, which is 
proportional to the amount of target antibody giving a detection limit of 5 ng/ml. The 
disadvantage of such system was the failure to give a full coating of sample and 
antibodies on the probes. Further research is needed to rectify this issue. In piezoelectric 
crystal immunosensor, it used piezoelectric crystal as the sensor. The disadvantage was 
the variation in the coating on the gold electrode of the crystal that would affect the 
signaling. The advantages are no labeling required and direct quantitation but the biggest 
drawback is its sensitivity that ranged from 0.1 ug/ml to 2.5 ug/ml.   
In SPR sensor, the recognition antibodies were immobilized on the gold SPR by 
adsorption and were quantified through increase in refractive index.  There are two 
classes of SPR sensors which are based on wavelength or angle interrogation. 
Wavelength interrogation implies using a fixed angle of incidence and monitors the 
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spectral variation. As for angle interrogation, it implies using fixed wavelength and traces 
the angle of reflectance. SPR sensors offer more advantages compared to the other 
detection methods. They allow continuous real-time monitoring of experiment, ease of 
removal of target analyte by low pH wash, require no consumption of reagents for direct 
detection, are small and compact in size for field trial and are extremely sensitive in sub-
nanomolar level. With amplification, it would be in femtomolar level. A reported 
miniaturized wavelength based SPR sensor gave a sensitivity of 5 ng/ml for direct 
detection and 0.5 ng/ml with amplification in less than 10 minutes. More improvements 
were made such as having a dual channel SPR where the reference channel would 
compensate for the bulk refractive index, non-specific binding and temperature 
fluctuations.   
All these developments had increased the potential of SPR sensors in biological and 
chemical agents monitoring. A recent finding for both BWA and CWA monitoring had 
been on the use of magnetoelastic sensor78 where it used magnetoelastic material being 
immobilized onto antibodies. It was based on the change in sensor resonance frequency, 
which was caused by the mass change of the sensor when there was association between 
the analyte to the receptor immobilized on the surface of the ribbon-like magnetoelastic 
sensor. Both biocatalytic precipitation and biotin-avidin interaction had amplified the 
mass change and thus, enhanced the sensitivity to 0.5 ng/ml for an hour of incubation. 
The SEB sensitivity was comparable to optical and piezoelectric mass sensing except that 
for this magnetoelastic material, it had a very low cost and could be developed to have 
disposable properties. Majority of the determination methods for SEB had been based on 
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immunological technology. However, these methods are always dependent on the toxin 
amounts or concentration that could influence the sensitivity and specificity.   
Alternative methods were explored and a sensitive and specific PCR-ELISA79, 80 system 
was developed for simultaneous detection of enterotoxins giving a detection of 1 pg. This 
assay utilized the internal biotin-labeled oligonucleotides as the immobilization capture 
probes for capturing amplified toxin sequence and quantified using enzymatic 
amplification of colorimeter. The optimization of the PCR-ELISA was through the 
adjustment of probe concentration and hybridization time. There was no cross-reactivity 
and the SEB PCR-ELISA was more specific and sensitive than ELISA except that it was 
more time consuming.   
We observe the same trend for development of immunoassay technology on both 
proteinaceous toxins, which are the tremendous efforts made to improve sensitivity, 
speed, multiplexed detection and portability of immunoassay method. However, the 
enormous development in analytical chemistry had opened the door to structure 
identification and confirmation of analyte with the use of mass spectrometry (MS) due to 
its molecular mass, specificity, sensitivity and ability to provide structural detail. Thus, 
there was increased interest in biological based chemical instrumental 81, 82, 83 analyses 
where it used a biomolecular recognition element like antibodies or SPR chip in 
conjugation with MS. This is not only specific and selective on the target analyte, it also 
allows identification with high mass resolution. MALDI-TOF and ESI-TOF MS are the 
two main areas which researchers are showed interest. It allowed analysis to be 
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completed in less than 1 hour and gave a detection limit of 1ng/ml. This could be 
adjusted to below 1 ng/ml by using a larger sample volume and a slower flow rate. The 
trend of analytical approach started in the early 1980s where there were reports on using 
high-performance liquid chromatography (HPLC) 84, 85 to separate and purify SEB. LC 
was then used in line with electrospray mass spectrometry 86, 87 known as LC-ESI MS. A 
comparison between micro-LC-ESI MS and normal mode LC-ESI MS was made and it 
had shown that with a smaller internal diameter, it allowed the sensitivity to increase by 
30-40 folds. The determination of SEB was down to the level of 0.1-1 ng/ml. The 
combination of LC-ESI MS/MS allows accurate determination by the molecular mass 
and also by the amino acid sequencing after enzymatic digestion. In Table 2, we had 
summarized the lowest detection limit for various SEB methodologies. It showed that 
LC-MS’s detection limit was comparable to ELISA. With these positive data, we do see 
that MS usage could be further extended for our SEB detection and quantitation study.           
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Table 2: summarized methods and LODs for SEB  
SEB methodologies Lowest level of 
detection 
1 Immunodiffusion assay 0.1 ug/ml54,56  
2 Radioimmunoassay 1 ng/ml54,56  






5 ELISA-bidiffractive grating 1 ng/ml59  
6 Fluorescence assay based lanthamide chelate 
label 
10 pg/ml65 
7 ELISA-LAPS 3-310 pg/ml66  
8 Immunomagnetic separation 




9 Fiber optic-sandwich immuno assay 5 ng/ml71  
10 Piezoelectric crystal immunosensor 0.1 ug/ml-2.5 ug/ml72,73  
11 Surface plasmon resonance 0.5 ng/ml-5 ng/ml74-77  
12 Magnetoelastic sensor 0.5 ng/ml78  
13 ELISA-PCR 1 pg79,80  
14 LC-MS 0.1 ng/ml-1 ng/ml86,87  
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1.4 Trichothecene mycotoxins (T-2 toxin)  
1.4.1    Its structure, its properties & mechanism of action 
Trichothecenes are a family of closely related sesquiterpenoids. Most of them have a 
double bond at position C-9, 10, a 12-13-epoxide ring, and a variable number of hydroxyl 
and acetoxy groups. In Figure 3 is the structure of T-2 toxin. This group of mycotoxin is 
mainly produced by various species of Fusarium fungi. They are non-volatile with a low 
molecular weight. They are relatively insoluble in water but soluble in organic solvents 
like acetone, ethanol, chloroform, methanol and ethyl acetate. They are ringed non-
protein compounds.    
Figure 3: Structure of T-2 toxin.  
Source from Journal of Chromatography A, 989 (2003), 257-264  
Trichothecenes are subdivided into four different groups. Type B-trichothecenes differ 
from type A by the presence of -unsaturated carbonyl groups. Type C are 
characterized by an additional epoxide and type D are macrocyclic trichothecenes. 
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Trichothecene mycotoxins can be disseminated in the form of dusts, droplets, aerosols, or 
smoke from aircraft, rockets, missiles, and artillery, mines or portable sprayers. Because 
of its anti-personnel properties, ease of large-scale production and apparent proven 
delivery by various aerial dispersal systems, the trichothecene mycotoxins (especially T-2 
toxin) have excellent potential for weaponization. T-2 toxin is heat stable and not easily 
decontaminated by autoclaving. However, by using 5% solution of sodium hypochlorite, 
it could be effectively decontaminated.   
T-2 mycotoxin is a type A trichothecence with a molecular weight of 466 Da. It acts 
primarily by inhibiting protein synthesis through binding to the ribosomal RNA, which 
results in disruption of cell membranes. It also inhibits either the initiation or the 
elongation process of translation, by interfering with peptidyl transferase activity, and can 
inhibit electron transport activity. T-2 toxin is about 400 times more potent than mustard 
during dermal exposure. The clinical symptoms2, 88 are dose dependent, but include skin 
irritation and burning sensations within hours following high dermal exposure. High 
inhalation exposure causes vomiting, dizziness, rapid heartbeat and chest pain within an 
hour. Once the eyes are exposed to T-2 toxin, the response ranges from tearing to 
irreversible cornea damage, depending on the dosage. As for oral ingestion, sore throat, 
bleeding gums, abdominal pain and bloody vomit may occur that can lead to death. 
However, the major toxic effect from T-2 toxin as an incapacitant arises from dermal 
exposure. Treatment such as washing in soap and water within 3 hours effectively 
removes the toxin from the skin, following which calamine lotion is applied. An effective 
analytical method for rapid detection of T-2 toxin is essential.  
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1.4.2 Review of analytical methods for T-2 toxin detection  
The classification of trichothecene analysis can be divided into two categories89, namely 
the screening techniques such as thin layer chromatography (TLC) and ELISA or 
analytical techniques such as gas chromatography (GC) and high performance liquid 
chromatography (HPLC). The first method developed for the determination of T-2 toxin 
was based on thin layer chromatography (TLC) 90, 91, 92. Basically, TLC operated in an 
offline mode and was suitable for crude sample analysis. Its advantages are adjustable 
detection limit simply by the use of larger sample volume and capability to detect as low 
as 0.005 ug/kg by using fluorescence or absorbance densitometer. Although TLC was a 
simple, robust and inexpensive technique, it lacked in separating power and was also 
unable to discriminate any possible co-extracted interference from the toxins of interest93. 
TLC is useful only as a screening test due to its high variance.   
Different immunochemicals methods especially enzyme-linked immunosorbent assay 
(ELISA) systems94 had also been established for T-2 toxin. For ELISA using either 
monoclonal or polyclonal antibodies, it was less precise than TLC.  However, ELISA 
method gave a higher recovery, allowed more rapid analysis and was less laborious to 
handle compared to TLC. Improvement was made in ELISA by the use of labeled 
sandwich immunoassay95 with fluorogenic-chemiluminescence (FCL) and electro-
chemiluminescence (ECL) detection.  The former assay reaction was determined by 
measuring the fluoroscence and the latter was assessed through photon emission. Even 
with this increased sensitivity, ELISA method has not been validated at sufficiently low 
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levels and also it is time-consuming since incubation period is required.  The invention of 
membrane based immuno-filtration96 assay for detection of T-2 toxin would speed up the 
analysis time taken. It uses a competitive format, which involves three layers. The first 
layer was a membrane layer that consisted of 36 antibody spots, the second layer was an 
absorbent layer and the third layer was polyethylene card. This setup allowed 
simultaneous analysis of different analytes and also an on-site detection by densitometer. 
It gave a detection of 12.5 and 25 ug/kg in wheat and poultry feed respectively in 40 
minutes. With monoclonal immunoassay97, it was able to achieve a low detection limit of 
30 ng/g T-2 toxin, which was comparable to GC analysis. But the advancement on T-2 
toxin detection was still on the use of GC analysis where the majority of the published 
papers for T-2 toxin had been on GC instrumentation.   
There were two review papers 98, 99 that focused on the chemical instrumental methods 
for T-2 toxin. The most frequently used method was GC analysis and had been 
established on flame ionisation detection (FID) 100 giving a limit of quantification of 75 
ug/kg, electron capture detection (ECD)101, 102 about 40 ug/kg and mass spectrometry 
(MS) 103, 104, 105, 106, 107, 108 approximately 5 ng/g. GC-MS is the method that is most widely 
employed today since it allows simultaneous analysis of several trichothecences, 
capability to identify them based on their spectrum and high sensitivity in ng/g.. However 
almost all GC methods required derivatisation of hydroxyl groups forming trimethylsilyl 
(TMS), trifluoroacetyl (TFA), pentafluoropropionyl (PFP) or hepta-fluorobutyryl (HFB) 
derivatives in order to attain the volatility and sensitivity required for detection. And the 
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required derivatisation reagent was dependent on type of trichothecene involved and also 
what detection method was employed.    
The problem with derivatized trichothecenes was that only the MS spectra of the 
common trichothecenes were published, although special libraries had been established. 
GC-MS could have incomplete derivatisation reaction and removal of water prior to 
derivatisation was essential. Although GC-ECD had less daily variation, the matrix effect 
and the problem of derivatisation were similar to GC-MS. For identification of samples, 
GC-MS was run in scan modes as for quantitative purpose, the GC had to be run in 
selected ion monitoring (SIM) mode. Some non-derivatised GC methods109 had been 
explored by using on-column injection technique in conjunction with GC-MS. This was 
able to give a quantitative detection limit of 0.1-0.5 ug/g but the problem was that due to 
repeated injections, there could be contaminations from the non-volatile samples on top 
of the column. Alternative form without any chemical derivatisation was by using solid 
phase microextraction (SPME) coupled with GC-FID110 giving detection at 10 ng/ml. 
This SPME principle works on a principle of aqueous and liquid phases coated on the 
fiber. Once immersed in sample, the sample would be absorbed and when this fiber was 
exposed in GC, it desorbed and analysis was done.   
Although GC-MS has an important role in the confirmatory determination, scientists have 
diverted their attention to the use of HPLC since it is less hassle to handle and no 
derivatisation is required. High performance liquid chromatography (HPLC) had been 
used by coupling with various detectors such as LC-refractive index (LC-RI) 111, 112 and 
  
33
UV 113, 114 for T-2 toxin study. But LC-UV detection was not suitable for T-2 toxin 
detection, as it did not contain a carbonyl function at C8 conjugation with a double bond 
in C9-10 so it was not for UV absorption115. Alternatively, fluorescent labeling reagents 
could be added to T-2 toxin where it could be determined through HPLC-fluorescence 
(F) 116 detection giving a low detection limit of 0.005 ug/ml. Immunoaffinity column was 
used to extract T-2 toxin, followed by pre-column derivatisation with 1-Anthroylnitrile 
and then detection through HPLC-F.   
The trend of HPLC is moving towards MS117, 118, 119, 120, 121 both on qualitative and 
quantitative works. In HPLC-MS analysis, no derivatization is required and this reduces 
the sample preparation time substantially. Problems arise from GC methods such as 
inability to obtain straight calibration curves, memory effects and matrix interferences are 
being resolved. With the use of selected ion monitoring (SIM) mode for HPLC, it is a 
quick and sensitive method as the background noise is reduced. Given the MS spectrum 
from LC-MS, it could confirm the analyte of interest. Based on a recent paper of HPLC-
ESI-MS on T-2 toxin, it was able to give a detection limit of 5 ng/g122. This detection 
limit was comparable to GC-MS. Thus, given the various advantages of LC-MS such as 
no derivatisation required, good sensitivity, confirmatory identification and quantitation, 
there seem to be no reasons why it should not be in demand for future works.  Other 
techniques being used for T-2 determination was supercritical fluid chromatography 
(SFC). But this technique of SFC was suitable only to compounds with low volatility and 
high polarity.  Again LC-MS/MS compare to all other methods has shown to be superior 
due its rapid analysis time, high specificity giving structural confirmation as well as good 
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sensitivity and no derivatisation. In Table 3, we summarized the lowest level of detection 
for T-2 methodologies where LC-MS showed comparable LOD as to the common GC 
methods. Thus, in our study, we used LC-MS for relative quantitation of T-2 toxin for our 
time profile study.  
Table 3: summarized methods and LODs for T-2 toxin   
T-2 methodologies Lowest level of detection 
1 TLC 0.005 ug/kg90-92 
2 ELISA 12.5-25 ug/kg96 
3 Monoclonal immunoassay 30 ng/g97 
4 GC-FID 75 ug/kg100 
5 GC-ECD 40 ug/kg-200 ug/kg101,102 
6 GC-MS ~5 ng/g103-108 
7 Non-derivated GC-MS (on-column injection 
technique) 
0.1-0.5 ug/g109 
8 SPME GC-FID 10 mg/ml110 
9 HPLC-fluorescence detection 0.005 ug/g116 




1.5 AIMS & OBJECTIVES  
In this project, the stability profiles on carpet and parquet surfaces of three potential 
BWA, ricin, staphylococcal enterotoxin B (SEB) and trichothecene mycotoxin (T-2 
toxin),  have been investigated over 7 days under indoor office conditions of air 
temperature 22.5-25.50C and relative humidity <70%. This condition is referenced to 
National Environment Agency’s acceptable indoor air quality. A suitable analysis method 
has been developed and tested for each toxin.   
For SEB and ricin, the feasibility of using amine specific isobaric tagging as well as the 
use of nano-flow liquid chromatography-mass spectrometry would be determined since 
this amine labeling has not yet been reported before for both toxins. This amine derived 
peptides will then be analyzed by nano-flow LC-MS/MS. For T-2 toxin, we have chosen 
HPLC-ESI-MS system since no derivatization is required as compared to GC methods 
and much less cumbersome in sample preparation.                  
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CHAPTER 2   MATERIALS AND METHODS  
2.1 SUPPLY OF T-2 TOXIN, SEB AND RICIN   
T-2 toxin from Fusarium SP (product number T4887-5 mg) was purchased from Sigma-
Aldrich. SEB (Cat.number BT202, 10 mg) was purchased from Toxin Technology, Inc. 
Ricin was extracted and purified in-house at DSO National Laboratories.    
2.2 CHEMICALS AND MATERIALS   
Acetonitrile and water used were HPLC grade from TEDIA company, Inc. 50% Formic 
acid/50% water was from Fluka, HPLC grade.  iTRAQ reagents kit was from Applied 
Biosystem. Trypsin enzyme was from Sigma-Aldrich. The concentrating tubes were 
Millipore Amicon Ultra-15 with molecular cutoff of 5 kDa and 10 kDa.   
2.3 USAGE OF AMINE SPECIFIC ISOBARIC TAGGING, ITRAQTM 
REAGENTS52, 53 IN OUR STUDY  
Based on our literature search on the detection methods as well as the detection limits for 
both ricin and SEB, we see a potential use of LC-MS/MS as well as stable isotope 
labeling technology for our toxin analysis. In our study, we used iTRAQ reagents as label 
on the peptides of the extracted samples for quantitation purpose. With the rapid 
evolution of stable isotope tagging reagents being made available like iTRAQ, ICAT and 
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SILAC, they provide additional advantages such as elimination of sample to sample 
recovery difference and also allow multiple samples detection. The isotope tagging 
methodology that we used in this research study was iTRAQTM reagents (from the 
Applied Biosystems Inc, CA). This novel multiplexed set of four unique isobaric tagging 
reagents was recently introduced in mid-2004 for quantitative protein analysis. iTRAQ 
reagents are amine-specific labeling reagents that allows multiplexed relative and 
absolute protein quantitation via MS/MS, other than identification of protein.   
With a single multiplex kit, one can perform any combination of experiments based on 
the nature of the desired project. It can be used for a minimum of two set of experiments 
or up to a maximum of four set of experiments in a single analysis run. This is highly 
economical since running multiple samples in a single experiment can significantly 
reduce operating costs as well as making it less laborious. Yet, precision and accuracy are 
not compromised since all the processes are performed in parallel workflows as in Figure 
4. Our sample preparation is in order of the schematic diagram shown in Figure 4. Extract 
1, 2 and 3 represent the sample extracts from the matrices. Standard represents the control 
which has the identical amount of spiked toxin.   
iTRAQ reagents consist of a reporter and a balancer group as shown in Figure 5. The 
iTRAQ methodology works on the isobaric mass labels of 114, 115, 116 and 117 being 
tagged onto the N termini and lysine side chains of peptides in a digest mixture.    
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Figure 4: Our modified iTRAQ protocol     
    
       
Labeling     
Combine    
Analysis      
The reporter group provides quantitation by producing MS/MS signature ions at m/z 114, 
115, 116 and 117, following collision-induced dissociation. The individual ratio of the 
Extract 1 Extract 2 Extract 3 
Standard 









Millipore Amicon Centrifuge tubes 
10ml extracted toxin 
concentrates down to 
200ul with Amicon tubes 
Reduce, Alkylate 
and Digest with 
Trysin enzyme 
Sample mixture 
Online desalting, followed by nanoLC/MS/MS
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identified peptides from the signature ion peak areas using ProQuant software (from 
Applied Biosystems) would allow identification and quantification of sample even if the 
amine derivatized peptides are isobaric and chromatographically indistinguishable. 
Absolute quantitation of targeted proteins can be achieved by using internal standard as 
one of the mass labels.    
       Isobaric Tag 
     Total Mass=145      
Reporter Group Balance Group Amine Specific 
Mass=114-117 Mass=31-28  Peptide Reactive  
Group  
Figure 5: iTRAQ reagent’s structure  
(Source from Applied Biosystem’s iTRAQ reagents chemistry reference)  
With the use of iTRAQ reagents, the MS/MS spectra obtained allows enhanced 
sensitivity and increased confidence as well as the peptide coverage. The multiplex 
tagging techniques makes analysis of up to four different biological samples 
simultaneously possible and also remove any quantitative variation that occurs between 
sample to sample. Thus, our research study would discuss the feasibility of using iTRAQ 
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reagents and chemical instrumentation of nano-flow LC-MS/MS for quantitative study of 
BWA, SEB and ricin.  
2.4  METHOD FOR RICIN  
2.4.1 Nano-flow LC-MS/MS system for ricin and SEB  
For both ricin and SEB study, we used the same nano-flow LC-MS/MS system. Nano-
flow liquid chromatography was from Agilent 1100 series and QSTAR XL MS/MS 
system was from Applied Biosystem as shown in Figure 6. The nanoLC column was self 
packed by using LUNA 3 m C18 (2) 100 angstrom packing material into New 
Objective’s PicoFrit self /p column of OD 360 m, ID 75 m with tip of 15 m. The 
desalt column used was Zorbax 300SB C18, 5 m, 5 x 0.3 mm.   
Figure 6: Agilent nano-flow LC-Qstar XL MS/MS system 
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2.4.2 Mass Spectrometry for toxins  
In our study, we used two kinds of mass spectrometers. In nano-flow LC MS/MS system 
(i.e. ricin and SEB studies), it involved nano-flow LC-nanosprayESI-QTOF mass 
spectrometer and in LC-MS system (i.e. T-2 toxin study), it involved LC-ESI-ion trap 
mass spectrometer. Despite that both are LC-MS methods, their representative data were 
different. Here, we took a selected mass spectrum from the ricin’s experiment as the 
representative set to show how we obtain our final data in terms of the ratio of 
extract:control using the ProQuant software for identification and quantitation. The first 
data obtained from iTRAQ labeled sample injection was a total ion chromatography 
(TIC) as shown in Window A of Figure 8. This TIC was then sent to mass spectrometer 
to obtain the TOF-MS scan in Window B, which was a scan of all the mass range of the 
peptides found in TIC. From TOF-MS, the two most intense peaks would undergo TOF-
MS/MS to obtain the product ion as shown in Window C and D of Figure 8.  
In Window A, the TIC showed various small peaks. At each peak, it contained many 
peptides. This chromatogram obtained was different from the usual LC-MS spectrum as 
in T-2 toxin study using LC-MS, where one peak represented the identity of T-2 toxin. In 
normal LC-MS, each peak must have a good resolution touching the baseline in order to 
have a good quantitation (i.e. area under the curve) of T-2 toxin as shown in Figure 7. But 
for our iTRAQ labeled extracts, our focus would be on the 114, 115, 116 and 117 mass 
label peaks showed in MS/MS spectra in Window C and D. Basically, in TIC, it was a 
one dimensional LC separation for the peptides to undergo separation using the gradient 
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elution but it would not have a single peak representing one peptide as there were 
multiple peptides that could elute at the same time. Instead, a TOF-MS was obtained 
based on the TIC, followed by TOF-MS/MS for us to identify the iTRAQ labeled peaks 
at 114, 115, 116 and 117 of each identified peptides.   
Figure 7: Normal LC-MS chromatogram of T-2 toxin using LC-MS  
      















Single peak of T-2 toxin with 
good baseline  
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Figure 8: The data representative of the iTRAQ labeled extracts using nano-flow LC-
MS/MS 
Using Mascot search as shown in Figure 9, the acquired MS/MS spectra in Window C 
and D was sent for identification. The database used was MSDB where it contained 
1019653 sequences and 321672149 residues. The enzyme selection was trypsin with no 
fixed modification but with variable modification set to MMTS, iTRAQ_Lys(K), 
iTRAQ_Tyr(Y) and N-term_iTRAQ. The peptide tolerance was set at +0.2 Da, MS/MS 
tolerance at +0.5 Da and peptides charge between +2 and +3. This search would take into 
consideration of iTRAQ being labeled onto peptides. The mascot result showed in Table 







showed a hit list of peptides belonging to ricin. We made comparison with the results 
obtained from ProQUANT 1.0 software at a particular product ion of 520.8. ProQUANT 
search would be used for identification and quantitation for the rest of this study and thus 
the confidence level and accuracy of its function must be tested. By clicking at the 
mascot result of 520.8 in Table 4, it showed that both b and y ions had good hit in Figure 
10 and Table 5.    
Figure 9: Mascot search screen 
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Table 4: Mascot Results of ricin extracted from parquet at 170hours  
Significant hits:  
RLCSD           ricin D precursor - castor bean 
Q41174          Proricin A chain (EC 3.2.2.22) (rRNA N-glycosidase) (Fragment).- Ricinus communis (Castor 
bean). 
1BR5A           ricin (EC 3.2.2.22) - castor bean 
AAB22584        S40368 NID:  - Ricinus communis    
1. RLCSD            Mass: 64050   Total score: 782  Peptides matched:34  
   ricin D precursor - castor bean 
Check to include this hit in error tolerant search or archive report   
Query   Observed   Mr(expt)   Mr(calc)   Delta  Miss Score  Rank   Peptide 
159     450.24     898.46     898.50    -0.04    0    22     1    WMFK + iTRAQ_Lys (K); N-term_iTRAQ 
234     520.80    1039.59    1039.63    -0.04    0    46     1    VGLPINQR + N-term_iTRAQ 
235     520.80    1039.59    1039.63    -0.03    0   (12)    1    VGLPINQR + N-term_iTRAQ 
237     520.81    1039.60    1039.63    -0.03    0   (28)    1    VGLPINQR + N-term_iTRAQ 
282     406.89    1217.65    1217.70    -0.05    0   (22)    1    HEIPVLPNR + N-term_iTRAQ 
283     406.89    1217.66    1217.70    -0.04    0    35     1    HEIPVLPNR + N-term_iTRAQ 
284     406.89    1217.66    1217.70    -0.04    0   (19)    1    HEIPVLPNR + N-term_iTRAQ 
285     406.90    1217.67    1217.70    -0.03    0   (26)    1    HEIPVLPNR + N-term_iTRAQ 
305     683.32    1364.63    1364.66    -0.04    0    25     1    ILSCGPASSGQR + MMTS (C); N-term_iTRAQ    
306     683.32    1364.63    1364.66    -0.03    0   (13)    3    ILSCGPASSGQR + MMTS (C); N-term_iTRAQ 
321     487.57    1459.68    1459.74    -0.06    0    28     1    FQYIEGEMR + iTRAQ_Tyr (Y); N-term_iTRAQ 
322     487.57    1459.70    1459.74    -0.04    0   (22)    1    FQYIEGEMR + iTRAQ_Tyr (Y); N-term_iTRAQ 
Product ion 520.8 
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348     814.38    1626.74    1626.79    -0.06    0    77     1    SFIICIQMISEAAR + MMTS (C) 
359     591.29    1770.84    1770.89    -0.05    0   (77)    1    SFIICIQMISEAAR + MMTS (C); N-term_iTRAQ 
360     591.29    1770.85    1770.89    -0.04    0   (34)    1    SFIICIQMISEAAR + MMTS (C); N-term_iTRAQ 
367     936.94    1871.87    1871.95    -0.08    0   123     1    SAPDPSVITLENSWGR + N-term_iTRAQ 
368     624.97    1871.88    1871.95    -0.07    0   (57)    1    SAPDPSVITLENSWGR + N-term_iTRAQ 
369     624.97    1871.90    1871.95    -0.05    0   (56)    1    SAPDPSVITLENSWGR + N-term_iTRAQ 
370     624.97    1871.90    1871.95    -0.05    0   (66)    1    SAPDPSVITLENSWGR + N-term_iTRAQ 
376     669.35    2005.02    2005.10    -0.08    0    86     1    NDGTILNLYSGLVLDVR + N-term_iTRAQ 
377     669.36    2005.05    2005.10    -0.05    0   (17)    1    NDGTILNLYSGLVLDVR + N-term_iTRAQ 
378     669.37    2005.08    2005.10    -0.02    0   (27)    1    NDGTILNLYSGLVLDVR + N-term_iTRAQ 
391     786.08    2355.23    2355.34    -0.11    0    79     1    FSVYDVSILIPIIALMVYR + N-term_iTRAQ 
394     801.74    2402.19    2402.27    -0.08    0   (85)    1    LSTAIQESNQGAFASPIQLQR + N-term_iTRAQ 
395     801.74    2402.19    2402.27    -0.08    0   (69)    1    LSTAIQESNQGAFASPIQLQR + N-term_iTRAQ 
396     801.74    2402.19    2402.27    -0.07    0   (62)    1    LSTAIQESNQGAFASPIQLQR + N-term_iTRAQ 
397     801.74    2402.19    2402.27    -0.07    0    89     1    LSTAIQESNQGAFASPIQLQR + N-term_iTRAQ 
398     807.76    2420.25    2420.34    -0.09    0   (47)    1    QIILYPLHGDPNQIWLPLF + N-term_iTRAQ 
399     807.76    2420.27    2420.34    -0.07    0   (44)    1    QIILYPLHGDPNQIWLPLF + N-term_iTRAQ 
400     807.76    2420.27    2420.34    -0.07    0    59     1    QIILYPLHGDPNQIWLPLF + N-term_iTRAQ 
401     817.06    2448.14    2448.23    -0.09    1   (31)    1    YTFAFGGNYDRLEQLAGNLR + N-term_iTRAQ 
402     817.06    2448.15    2448.23    -0.08    1    52     1    YTFAFGGNYDRLEQLAGNLR + N-term_iTRAQ 
404     855.79    2564.34    2564.44    -0.10    0   (50)    1    QIILYPLHGDPNQIWLPLF + iTRAQ_Tyr (Y); N-term_iTRAQ 
405     914.81    2741.40    2741.48    -0.09    1    71     1    WMFKNDGTILNLYSGLVLDVR + iTRAQ_Lys (K); N-term_iTRAQ
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Figure 10: Mass ranges for b and y ions based on Mascot search of product ion, 520.8   
  
Table 5: Showed good hit for b and y ions based on Mascot search of product ion, 520.8   
# b b++ b* b*++ Seq. y y++ y* y*++ #
1 244.18 122.59 V  8
2 301.20 151.10 G 797.46 399.24 780.44 390.72 7
3 414.28 207.65 L 740.44 370.72 723.42 362.21 6
4 511.34 256.17 P 627.36 314.18 610.33 305.67 5
5 624.42 312.71 I 530.31 265.66 513.28 257.14 4
6 738.46 369.74 721.44 361.22 N 417.22 209.11 400.19 200.60 3
7 866.52 433.77 849.50 425.25 Q 303.18 152.09 286.15 143.58 2
8 R 175.12 88.06 158.09 79.55 1
       
Red implied that all the peptides found 
from extract met the same peptides’ list 
as b and y ions of ricin. 
  
48
ProQUANT 1.0 software was set with confidence setting at 90, tolerance setting for 
peptide identification at 0.3 Da for MS and 0.6 Da for MS/MS, and charge ranging from 
+2 to +4. The ProQUANT search screen was shown in Figure 11. The same data in 
Figure 8 was sent to ProQUANT search and the result identified ricin with 99 confidence, 
37 peptides and a good hit of b and y ions as well for the product ion 520.8 of sequence 
VGLPINQR in Figure 12 and Table 6. This showed that the identification made through 
using ProQUANT software gave the same level of accuracy and confidence as to Mascot. 
ProQUANT software was used for the rest of the experiment for both the identification 
and quantitation purpose. The identification was based on the matched amino sequences 
and the quantitation was based on the area under the curve of the iTRAQ labeled peptide 
peaks as shown in Figure 13.  
ProQUANT data analysis sequence  
1. Send same MS/MS data to ProQuant – click process data 
Figure 11: ProQUANT software 
screen for iTRAQ reagents 
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2.  Results from ProQUANT software   
It identified Ricin under the column name with 99 confidence and 37 peptides. This 
identification was based on the matched amino sequences. The average ratio of 
extract:control was shown as Avg 115:114 or Avg 116:114 or Avg 117:114. This was 
used for quantitation of the remaining toxin from the matrices. Using the same sequence 
of VGLPINQR from the product ion 520.8, it showed an equivalent good hit of b and y 
ions comparable to Mascot search.  
Figure 12: Results from ProQUANT search  
Identity Confidence No. of peptides Average ratio of extract:sample





Table 6: Hit list of b and y ions using ProQUANT on product ion, 520.8  
                
Yellow highlighted implied that all the 
peptides found from extract met the same 
peptides’ list as b and y ions of ricin. 
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Based on the MS/MS spectra of the product ion 520.8, we zoomed into the mass range of 
114 – 117 where our iTRAQ labeled peptides were quantified based on the area under the 
peak of 114, 115, 116 and 117 generated by statistic of ProQUANT 1.0 software.    
Figure 13: Area under the peak of 114,115,116,117 label of product ion, 520.8  
  
All the quantitation data reported here would be based on the average ratio of 
115/116/117:114 (i.e. extract:control). The identification would be based on the 
matched amino sequences. Only ProQuant software has the capability to quantify the 
iTRAQ mass labels. For Mascot, it could only be used for identification purpose but 
not quantifying the iTRAQ mass labels.   
2.4.3 Nano LC-MS/MS conditions  
Separation was done using binary mobile phase gradient elution at 150 nl/min after 
injection of 1 ul sample. Triplicate wash in water was set before injection and blank run 
of water were done in between samples to prevent any carry-over of sample from the 
previous run. Agilent 1100 LC isocratic pump was set at 60ul/min using 5% acetonitrile 
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and 95% water. Agilent 1100 LC nanopump was at 150 nl/min using gradient elution of 
eluent A and B from 60% A to 10% A where A was 0.1% formic acid in 95% water and 
5% acetonitrile and B was 0.1% formic acid in 100% acetonitrile. For the first 8 minutes, 
it was set at column 1 mode for desalting purpose, after which it was switched to column 
2 mode to elute out the relevant peptides. All MS/MS data was acquired using 
information dependent acquisition in Analyst QS 1.1 with oMALDI source support and 
BioanalystTM extension software from Applied Biosystem in 65 minutes.  
The switching criteria were ions greater than 300 m/z, smaller than 1500 m/z with charge 
state from 2 to 3 that exceed 30 counts. In Experiment 1, positive TOF MS scan type was 
chosen and accumulation time was 1 second between TOF masses of 300 to 1500. In 
experiment 2 and 3, positive product  ion scan type was used with accumulation time of 4 
seconds between TOF masses of 100 to 2000. Nitrogen gas was used as curtain gas at 25 
and collision gas at 4. Ionspray voltage was set at 2200V, declustering potential at 50, 
focusing potential at 190, declustering potential 2 at 15, automated collision energy, ion 
release delay at 6.0 and ion release width at 5.0.  The voltage used will be 2200V or 
2500V depending on the batch of column used with access default set at 2500V for both 
TOF-MS and TOF-MS/MS.   
2.4.4 Preparation of labeled peptides  
The sample preparation was modified from Applied Biosystem’s iTRAQ protocol to 
prevent precipitation of toxin. 20 ul of dissolution buffer and 1 ul of denaturant were 
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added to 100 ug of toxin, vortexed and spin down at 2000 g.  2 ul of reducing reagent was 
then added, vortexed and spin down. This mixture was incubated at 50oC for 60 minutes. 
Droplets of toxin would form on the inner cap of the eppendorf tube and thus, required to 
spin down before addition of 1 ul of cysteine blocking reagent. This was then allowed to 
incubate at room temperature for 10 minutes. Trypsin concentration of 0.2 mg/ml was 
prepared using HPLC grade water. 5 ug of trypsin solution was added to 100 ug of toxin 
giving a trypsin digestion ratio of 1:20. This was incubated at 37oC for 16 hours. Once 
the digestion was done, 25 ug of sample was withdrawn and labeled with 20 ul of iTRAQ 
reagent. An incubation time of one hour was required after addition of iTRAQ reagents 
for the labeling reaction to take place.  If there are more than two samples, each sample is 
labeled with a different mass label and after one-hour incubation, samples are to be mix 
into a single vial.   
2.4.5  Verification of iTRAQ tagging on Ricin (1:1 ratio)  
Two identical concentration of Ricin (100 ug) was trypsin digested based on the iTRAQ 
protocol as in section 2.4.4.  Identical amount of digested ricin (i.e. 50 ug) was withdrawn 
and labeled with 30 ul of 114 and 117 respectively. This is to verify that both the 
theoretical and experimental results gave 1:1 ratio.  Since no paper has reported the use of 
iTRAQ reagents on ricin analysis, this is the first paper that verifies the possibility of 
iTRAQ labeled ricin peptides.    
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2.4.6 Lowest level of detection of iTRAQ labeled Ricin   
A range of 1, 5, 10 and 40 ug of digested Ricin was labeled according to the respective 
amount of required iTRAQ label based on the protocol that for 100 ug of digested 
sample, 70 ul of iTRAQ label was required. Based on Table 7, the respective amount of 
iTRAQ reagents were added to digested ricin. These labeled samples were run using 
nano-flow LC-QSTAR and the acquired data was analyzed by Mascot search. Those that 
identified with at least three peptides hit would be significant.  
Table 7: Volume of iTRAQ reagents to be utilized 





2.4.7 Concentration factor of Millipore Amicon Ultra-15, 10 kDa molecular cut-off 
centrifuge tube   
90 ug of Ricin was spiked into 10 ml HPLC grade water and concentrated down by 
Millipore Amicon Ultra-15 10 kDa centrifuge tube by spinning down at 25oC, 4100 rpm 
for 30 minutes. The retentate volume was trypsin digested as in section 2.4.4 and labeled 
with 70 ul of iTRAQ mass label of 115, 116 or 117. Another set of control having 
identical concentration without going through Millipore Amicon Ultra-15 10 kDa 
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centrifuge tube was also trypsin digested and labeled as 114. Triplicate was done and the 
inverse of the average ratio of 115/116/117:114 would be the concentration factor.  
2.4.8 Recovery efficiency of Ricin extract from matrices using Millipore Amicon 
Ultra-15, 10 kDa at 0hour  
As solvent was required for extraction, it would need a concentrating step in order to 
concentrate down the diluted extract after 100 ug of ricin was extracted from the 
matrices. 10 ml of 100% HPLC grade water was used as the extraction solvent for carpet, 
followed by vortexing for 3 minutes before transferring to Millipore Amicon Ultra-15 10 
kDa centrifuge tube for concentrating. It was centrifuged at 25oC at 4100 rpm for 30 
minutes. The retentate volume was trypsin digested and iTRAQ labeled with comparison 
to a control. The control had identical concentration as the retentate except that it did not 
go through the concentrating step. The acquired MS data was then analyzed using 
ProQUANT 1.0 software. For parquet extraction, 10ml of 100% HPLC grade water was 
used as extraction solvent and vortexed for 1 minute before centrifuged with Millipore 
Amicon Ultra-15, 10 kDa centrifuge tube. The inverse of the average ratio of 
extract:control would be the recovery efficiency factor.  
2.4.9 Stability profile experiment of Ricin on carpet and parquet   
100 ug of Ricin was spiked onto 1.2 cm x 1.2 cm carpet. Triplicate carpets were done for 
each time intervals at time 0, 2, 8, 24, 48, 72 and 170 hours. At each timing, 10 ml of 
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100% HPLC grade water was added and vortexed at 3 minutes for carpet. For parquet, 
triplicates were done on 1.2 cm x 1.2 cm parquet with lacquer painted surface at 0, 2, 24, 
48, 72 and 170 hours. 10 ml of 100% HPLC grade water was used and vortexed for 1 
minute. The extract was then added to Millipore Amicon Ultra-15ml centrifuge tube with 
10kDa molecular weight cut-off. It was then centrifuged at 25oC for 4100 rpm and 30 
minutes. The retentate volume was digested by trypsin enzyme followed by iTRAQ 
labeling protocol in section 2.4.4. 25 ug of the digested ricin was then withdrawn and 
labeled with 20 ul of iTRAQ reagents. The control was labeled as 114 and the triplicates 
were labeled as 115, 116 and 117. The acquired MS/MS data was sent to ProQUANT 1.0 
for data analysis.  
2.5  METHOD FOR SEB  
2.5.1 Verification of iTRAQ tagging on SEB (1:1 ratio)  
Both the nano-flow LCMS condition and data analysis remained the same for SEB except 
that the gradient elution for composition A started from 70% to 10% and the voltage 
applied was 1800V or 2200V with access default of 2350V set for TOF-MS and 2400V 
for TOF-MS/MS. As for the preparation of iTRAQ labeled peptides of the SEB extracts, 
they were incubated at 50oC for 50 minutes instead of 60 minutes to prevent occurrence 
of precipitation. 20 ug of SEB was labeled with 20 ul of iTRAQ reagents in the actual 
stability experiment.  
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Since no paper has reported the use of iTRAQ reagents on SEB, this is also the first paper 
that verifies the possibility of iTRAQ labeling on digested SEB. Two identical 
concentration of SEB (100 ug) was trypsin digested based on the iTRAQ protocol in 
section 2.4.4 and identical amount of 50 ug was labeled with 30 ul of 115 and 117 
respectively. This is to verify that for both theoretical and experimental results, we would 
get 1:1 ratio.   
2.5.2 Lowest level of detection of iTRAQ labeled SEB   
For the lowest detectable amount of iTRAQ labeled digested SEB, the same protocol in 
section 2.4.6 was carried out except that the toxin used was SEB.   
2.5.3 Concentration factor of Millipore Amicon ultra-15, 5 kDa centrifuge tube 
and Reproducibility of the nano-flow LC-QSTAR  
100 ug of SEB was spiked into 10 ml HPLC grade water and concentrated down by 
Millipore Amicon Ultra-15 5 kDa centrifuge tube spinning at 25oC at 4100 rpm for 45 
minutes.  The retentate volume was trypsin digested and iTRAQ labeled with 70 ul 
reagents. Another set of control having same concentration was also digested and labeled 
as 114 except that it did not go through concentrating step. The sample was injected 
thrice into nano-flow LC-QSTAR to validate the reproducibility of the instrument and 
also to determine the concentration factor for this concentrating step. The inverse of the 
average ratio would be the concentration factor. 
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2.5.4 Recovery efficiency of SEB extract from matrices using Millipore Amicon 
Ultra-15, 5 kDa at 0hour  
10 ml of 20% acetronitrile-80% water was used as the extraction solvent for carpet, 
followed by vortexing for 3 minutes before transferring to Millipore Amicon Ultra-15 5 
kDa centrifuge tube for concentrating down the diluted extract. It was centrifuged at 25oC 
at 4100 rpm for 45 minutes. The retentate volume was trypsin digested and iTRAQ 
labeled and compared to a control of identical concentration. The MS data was then 
analyzed using ProQUANT 1.0. A comparison of SEB recovery between 5 kDa and 10 
kDa Millipore Amicon Ultra-15 centrifuge tube based on SEB extract from carpet was 
done to see which molecular cut-off would be good for SEB.  
For parquet extraction, 10 ml of 100% HPLC grade water was used as extraction solvent 
and vortexed for 1 minute before centrifuged with Millipore Amicon Ultra-15, 5 kDa 
centrifuge tube. The recovery efficiency would be the inverse of average ratio of 
extract:control.   
2.5.5 Stability profile experiment of SEB on carpet and parquet  
100 ug of SEB was spiked onto 1.2 cm x 1.2 cm carpet. Triplicate carpets were done for 
each time intervals of 0, 2, 27, 50, 74 and 170 hours. At each timing, 10 ml of 20% 
acetronitrile-80% water was added and vortexed for 3 minutes for carpet. For parquet, 
triplicates were done on 1.2 cm x 1.2 cm parquet with lacquer painted surface using 10 
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ml of 100% HPLC grade water and vortexing for 1 minute. The extract was then added to 
Millipore Amicon Ultra-15 ml centrifuge tube with 5 kDa cut-off molecular weight. It 
was centrifuged at 25oC for 4100 rpm and 45 minutes. The proteolysis digestion and 
iTRAQ labeling followed exactly the same as section 2.4.9 except that 20 ug of digested 
SEB was labeled with iTRAQ reagents.  Exact data analysis was done too.   
2.6 METHOD FOR T-2 MYCOTOXIN  
2.6.1 HPLC-ESI-MS system  
In our study, the analysis was done by using Finnigan LCQ system fitted with 
electrospray source. LC separation was done by using Phenomenex Luna 150 x 2 mm 5 
m C18(2) series number 148734-2 with attached guard column of Phenomenex C18 
(ODS Octadecyl) 4 mm L x 2 mm ID at gradient elution of 80% acetonitrile, 10% 
[1methanol:1 MilliQ water] and 10% [0.1% acetic acid in MilliQ water] for 20 minutes. 
The mass spectrometer was set at selected ion monitoring mode at 467 [466+H], 484 
[466+H2O] and 489 [466+Na].  
2.6.2 Sample Preparation  
5 mg of T-2 toxin in a standard vial was diluted with 5 ml of 30% acetonitrile/70% 
MilliQ water to prepare 1mg/ml of spiking vial.  
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2.6.3 Reproducibility, Linearity, Lowest level of detection (LOD) &  quantitation 
(LOQ)  
To check the reproducibility of the system, a standard vial of 25 ppm T-2 toxin in 84% 
acetonitrile/16% MilliQ water was prepared and injected eight times into the LCQ. Area 
under the peak was quantified for each injection.  
To check the linearity of T-2 toxin, three different concentrations of 2.5 ppm, 10 ppm and 
25 ppm in 84% acetonitrile/16% MilliQ water were prepared and rub using LCQ. A 
linearity graph was plotted based on the peak area versus the various concentrations.   
Two low T-2 toxin concentrations of 0.05 ppm and 0.1 ppm standard were prepared to 
the check the LOD and LOQ.  
2.6.4 Filter factor prior to LC  
A 25 ppm T-2 toxin standard prepared in 84% acetonitrile/16% MilliQ water with an 
internal standard of 100 ppm of benzophenone was done to compare with another exact 
set but filtered through a 0.45um nylon filter. The reciprocal of the area differences 
would be the filter factor.    
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2.6.5 Recovery efficiency of T-2 toxin from Carpet and Parquet  
Carpet and parquet were cut into dimension of 5 cm x 5 cm. Each matrix was placed into 
a LOCK & LOCK container of 180 ml. Duplicate set of three different T-2 toxin 
concentrations of 1 mg/ml, 0.4 mg/ml and 0.1 mg/ml were spiked onto the centre of the 
matrix and 40ml of 84% acetonitrile/16% MilliQ water was added instantly. It was 
vortexed for 3 minutes before 1 ml of the sample was withdrawn. 100 ppm benzophenone 
was added as internal standard for parquet.  For carpet, benzophenone was not used as 
there was an interference peak from the carpet extract that co-eluted at the same time. 
The sample was then filtered through a 0.45 um filter prior to LC run. Standard vials of 
2.5 ppm, 10 ppm and 25 ppm T-2 toxin in 84% acetonitrile/16% MilliQ water with and 
without internal standards were run concurrently to determine the consistency of 
extraction recovery. The average of the three concentrations was taken as the extraction 
recovery and the reciprocal of the average was taken as the extraction factor.   
2.6.6 Stability profiles of T-2 toxin on Carpet and Parquet  
Eight vials of 1 mg/ml of T-2 toxin (i.e. in 1 ml of 30% acetonitrile/70% MilliQ water) 
were spiked onto eight matrices and at time 0, 4, 8, 12, 26, 48, 74 and 170 hours. 40 ml of 
extraction solvent (i.e. 84% acetonitrile/16%MilliQ water) was added. At each time 
interval, it was vortexed for 3 minutes and 1 ml of sample was withdrawn and filtered 
through 0.45 um filter. For the purpose of consistency of experiments, the matrices were 
not spiked with internal standard. Samples were then run using LCQ. Triplicate set was 
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done for each matrix and experiments were carried out in an enclosed chamber of 
monitored temperature 22.5-25.50C and relative humidity <70%. On each day, a one-
point external calibration of 25 ppm T-2 standard in 84% acetonitrile/16%MilliQ water 
was done. The recovery percentage at each time interval was calculated based on the 
absolute area of the peak. The amount of T-2 toxin present was quantified based on the 
extraction efficiency factor and filter factor. The stability profile for carpet and parquet 
was presented in graphs.                 
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CHAPTER 3  RESULTS AND OBSERVATIONS  
3.1 Ricin  
3.1.1 Verification of 1:1 ratio of Ricin  
Ricin was identified by analyzing the iTRAQ labeled peptides data via ProQUANT 
software. It identified Ricin with confidence of 99, 91 peptides and average 117:114= 
0.9836. Thus, it verified that theoretical iTRAQ labeling on ricin could give an 
approximately 1:1 ratio experimentally. This is the first reported paper that used iTRAQ 
reagents on ricin for quantitation purpose. We had showed the MS/MS spectra of 117:114 
peak areas at product ion 820.3 in Figure 14 where the peak area under 114 and 117 were 
similar.   
Figure 14: The MS/MS spectrum of the 117 and 114 peak areas for Ricin 
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3.1.2 Lowest level of detection of iTRAQ labeled Ricin  
As explained in section 2.4.5, the mascot identification is only significant when the 
peptide hit is at least 3 peptides. In Table 8, it showed that the lowest amount of ricin 
required to be effectively labeled in order to be used for quantitation purpose must be at 
least 5 ug where Mascot search identified 4 peptides with a score of 133.  
        Table 8: Lowest level of detection of iTRAQ labeled Ricin 
Amount/ug score No. of peptides Coverage
1 No ricin detected
5 133 4 8%
10 127 11 14%
40 209 24 16%
3.1.3 Concentration factor of Millipore Amicon Ultra-15 10 kDa  
A comparison of ricin extract with and without passing through the concentrating step of 
Millipore Amicon Ultra-15 10 kDa centrifuge tube was done. This allowed us to 
determine any loss of sample during concentrating step. The results in Table 9 showed 
that the recovery of ricin from Millipore Amicon Ultra-15 10 kDa centrifuge tube gave an 
approximate 100% recovery with CV% of 1.94%. Thus, this gave us a concentration 
factor of approximately 1.   
  
65
         Table 9: Concentration factor for Ricin using 10 kDa Millipore Amicon Ultra-15  
extract1 extract2 extract3 average SD CV% 
10 kDa centrifuge 
tube 1.03 1.05 1.01 1.03  0.020  1.94 
Extract 1, 2 and 3 represented the average ratio of 115/116/117:114, SD represented the standard deviation and CV% represented the 
correlation variation.   
3.1.4 Recovery efficiency of Ricin extract from Carpet and Parquet  
Based on the usage of Millipore Amicon Ultra-15 10 kDa centrifuge tube on ricin 
extracted out from carpet, the retentate volume was trypsin digested and labeled with 
iTRAQ mass label of 115, 116 and 117. These iTRAQ labeled extracts were mixed with 
a control (i.e. 114) without concentrating step. The extraction efficiency of ricin from 
carpet at time 0 was 100% recovery with CV% of 2.50% as shown in Table 10. As for 
ricin recovery from parquet, the recovery was also 100% with CV% of 7.88%. These 
results observed had revealed that the extraction efficiency based on the selected 
extraction solvent and developed methodology was good.   
Table 10: Recovery efficiency of Ricin from carpet and parquet  
Extract 1 Extract 2 Extract 3 Average SD CV% 
Carpet 0.98 1.01 1.03 1.01 0.025 2.50 
Parquet 0.94 1.10 1.04 1.03 0.081 7.88 
Extract 1, 2 and 3 represented the average ratio of 115/116/117:114, SD represented the standard deviation and CV% represented the 
correlation variation.    
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3.1.5 Stability profile of Ricin on Carpet   
The stability profile for ricin spiked on carpet was shown in Table 11. Triplicate set was 
done at each time interval and by taking the average and the SD, a graph of ricin recovery 
from carpet versus time profile up to 170 hours was plotted in Figure 15. Its extraction 
efficiency for ricin from carpet at the point of experiment was averaged out to be 95% 
with correlation variation of 2.85%. Thus, the recovery factor was 1/0.95=1.06. The 
stability profile of ricin on carpet was observed to drop drastically to half of the spiked 
amount after 8 hours of residence, followed by gradual drop leaving an amount of 22.3 
ug/1.44 cm2 (15.5 ug/cm2) ricin on the carpet at the end of 7th day, taking into 
consideration the recovery factor and the concentration factor. We also extracted out the 
MS/MS spectra of a particular product ion of 579 as example where we took a look at the 
changes of the 114, 115, 116 and 117 peak areas as shown in Figure 16. The intensity of 
the peak areas had showed a rapid drop over the first 24 hours and from 48 hours 
onwards, it seemed to level down to a consistent recovery of ~20 % remaining until the 
end of the 170th hour. As in this study, we focused on the quantitation study of the ricin 
from carpet, all other acquired data like the matched sequences used for identification 
purpose were filed in chapter 6 under appendix A.  
Table 11: Ricin’s stability on Carpet over 7 days 
Hours extract1 extract2 extract3 average SD CV%
0 0.98 0.93 0.93 0.95 0.03 2.85
2 0.83 0.97 0.95 0.92 0.07 8.12
8 0.53 0.40 0.44 0.46 0.07 15.02
24 0.30 0.23 0.36 0.30 0.06 21.03
48 0.21 0.20 0.32 0.25 0.07 27.60
72 0.24 0.20 0.26 0.24 0.03 12.95
170 0.28 0.18 0.17 0.21 0.06 28.58
Extract1, 2 and 3 were expressed in average ratio against SEB standard (115/116/117:114), SD = standard deviation and CV%= correlation variation.  
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Figure 15: Stability profile of Ricin on carpet over 7 days  



























    
Figure 16: MS/MS spectra of the product ion, 579 over 170 hours for Ricin on carpet  
Ricin on carpet at time 0 hour Ricin on carpet at time 2 hours 
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Ricin on carpet at time 8 hours 
 
Ricin on carpet at time 48 hours 
Ricin on carpet at time 170 hours 
Ricin on carpet at time 24 hours 
Ricin on carpet at time 72 hours 
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3.1.6 Stability profile of Ricin on Parquet  
The stability profile for ricin spiked on parquet was shown in Table 12. A graph of ricin 
recovery from parquet versus the time profile up to 170 hours was plotted in Figure 17. 
Its extraction efficiency for ricin from parquet was approximated to be 100% with 
correlation variation of 7.87%. Thus, the recovery factor was 1. As compared to ricin on 
carpet, the stability on parquet was observed to be much more persistent on matrix and 
only dropped by approximately 30% by the end of 170th hour. This good stability of ricin 
on parquet was also observed on SEB on parquet but SEB seemed to be much stable than 
ricin on parquet with almost 100% remaining on parquet.   
An extraction of a product ion, 450 was done from time 0 to 170 hours to see the trend in 
the peak areas of 114, 115, 116 and 117 in Figure 18. The trend of the peak area change 
followed Figure 17 except for the last time interval at 170th hour. The reason was that the 
ratio of 115/116/117:114 was an average of all identified product ions and at this 
particular product ion, the ratio at this product ion was slightly lower. However, once it 
was averaged against the rest of the product ions, it should be the reported average ratio 
as in Table 12. The matched sequences for identification at each time interval was filed 
under chapter 6, appendix B since our focus here was on the average ratio of 
115/116/117:114.    
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Table 12: Ricin’s stability on Parquet over 7 days 
hours extract1 extract2 extract3 average SD CV%
0 0.94 1.10 1.04 1.03 0.081 7.87
2 0.80 0.93 0.71 0.81 0.111 13.60
24 0.74 0.78 0.96 0.83 0.117 14.18
48 0.85 0.71 0.84 0.80 0.078 9.76
72 0.78 0.85 0.80 0.81 0.036 4.45
170 0.70 0.75 0.69 0.71 0.032 4.51
Extract1, 2 and 3 were expressed in average ratio against SEB standard (115/116/117:114), SD = standard deviation and CV%= 
correlation variation.    
Figure 17: Stability profile of Ricin on parquet over 7 days 






























Figure 18: MS/MS spectra of the product ion, 450 over 170 hours for ricin on parquet 
Ricin on parquet at time 0 hour 
Ricin on parquet at time 24 hours 
Ricin on parquet at time 72 hours 
Ricin on parquet at time 2 hours 
Ricin on parquet at time 48 hours 
Ricin on parquet at time 170 hours 
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3.2 SEB  
3.2.1 Verification of 1:1 ratio of SEB  
SEB was identified by using iTRAQ labeled SEB peptides analyzed via ProQUANT 
software. It identified SEB with confidence of 99, 156 peptides and average 117:115= 
0.9664. This showed that the theoretical labeling of 1:1 ratio gave a true labeling of 1:1 
ratio experimentally. This was also the first reported paper on SEB using iTRAQ reagent 
for quantitation purpose. We showed a MS/MS spectrum of a product ion, 674.1 in 
Figure 19, where it showed similar peak areas under the 115 and 117 peaks.   
Figure 19: The MS/MS spectrum of the 117 and 115 peak areas for SEB 
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3.2.2 Lowest level of detection of iTRAQ labeled SEB  
The results in Table 13 showed that the lowest amount of SEB required to be effectively 
labeled for quantitative work must be at least 1 ug using Mascot search since the lowest 
number of peptides hit for a protein identification to be significant was 3. At 1 ug of SEB, 
it gave identification of 3 peptides with score of 63.  
    Table 13: Lowest level of detection of iTRAQ labeled SEB 
Amount/ug score No. of peptides Coverage
1 63 3 9%
5 132 18 26%
10 143 21 26%
40 233 29 31%
3.2.3 Concentration factor of Millipore Amicon Ultra-15 5 kDa and 
Reproducibility of the nanoLC-QSTAR  
The results in Table 14 showed that it was reproducible with an average of 96.2% and 
correlation variation of 0.165% from the same vial of sample. This was extremely precise 
and accurate as CV% was much less than 10%, giving us a concentration factor of 1.04 
by taking the inverse of the average ratio (i.e. 1/0.962).    
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Table 14: Concentration factor for SEB 
Sample # 1 2 3 
No. of peptides 171 174 210
Ave 116:114 0.964 0.962 0.961
Standard Deviation 0.0015 CV% 0.165
3.2.4 Recovery efficiency of SEB extract from Carpet and Parquet  
Using 5 kDa and 10 kDa Millipore Amicon Ultra-15 centrifuge tube for concentrating 
SEB extract from carpet, the concentrated volume was then proteolysis digested and 
iTRAQ labeled. Using 5 kDa centrifuge tube, it allowed 95% recovery with CV% of 
5.17%. With 10 kDa centrifuge tube, it obtained a lower recovery of SEB of 71% with 
CV% of 13.6%. All these results were shown in Table 15. They were made with 
comparison to control of the same concentration without passing through the Millipore 
Amicon Ultra-15 centrifuge tube. Thus, we concluded that the use of 5 kDa Millipore 
Amicon Ultra-15 centrifuge tube for concentrating SEB extract from carpet would give a 
better recovery of approximately 100%. Since in the case of carpet, 5 kDa Millipore 
Amicon Ultra-15 centrifuge tube was selected due to better efficiency. The same 5 kDa 
Millipore Amicon Ultra-15 centrifuge tube was applied to parquet extract, which gave a 
recovery of 74.0% with CV% of 5.74%.     
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Table 15: Recovery efficiency of SEB from carpet and parquet 
Carpet Extract 1 Extract 2 Extract 3 Average SD CV% 
5 kDa 0.93 0.92 1.01 0.95 0.049 5.17 
10 kDa 0.82 0.67 0.64 0.71 0.096 13.6 
Parquet       
5 kDa 0.70 0.73 0.78 0.74 0.042 5.74 
Extract1, 2 and 3 were expressed in average ratio against SEB standard (116/117/118:114), SD = standard deviation and CV%= 
correlation variation.   
3.2.5 Stability profile of SEB on Carpet   
The stability profile for SEB spiked on carpet was shown in Table 16. A graph of 
recovery versus the time profile up to 170 hours was plotted in Figure 20. The recovery 
of 1 implies 100% recovery of SEB extraction from carpet. At time 0 hour, the extraction 
efficiency for SEB was averaged out to be 95.3% with correlation variation of 5.17%. 
Thus, the recovery factor was 1/0.953=1.05.  Taking into consideration the recovery 
factor as well as the concentration factor, by the end of the 7th day it still contained 28.1 
ug/1.44 cm2 = 19.5 ug/cm2 which was much higher than the LD50. The stability of SEB 
on carpet dropped by half at 50th hour of its spiked amount and gradually dropped over 
the remaining days. It settled to a remaining recovery of ~20% by the 72nd hour and this 
was maintained until 170 hours. We extracted out the MS/MS spectrum of a product ion 
575 from time 0 to 170 hours to illustrate the changes of the peak areas of 114, 115, 116 
and 117 in Figure 21. It showed that the stability of SEB on carpet was better than ricin 
on carpet as ricin amount dropped by half on the 8th hour onwards but for SEB, it only 
started to drop by half from 50th hour onwards. But the amount remaining for both toxins 
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on carpet was approximately 20%. The matched sequences used for identification 
purpose was filed under chapter 6, appendix C.  
Table 16: SEB’s  stability on Carpet over 7 days 
Hours extract1 extract2 extract3 average SD CV%
0 0.93 0.92 1.01 0.953 0.049 5.17
2 0.80 0.98 0.65 0.810 0.165 20.40
27 0.52 0.53 0.65 0.567 0.072 12.77
50 0.56 0.53 0.45 0.513 0.057 11.08
74 0.17 0.16 0.30 0.210 0.078 37.19
170 0.16 0.37 0.24 0.257 0.106 41.29
Extract1, 2 and 3 were expressed in average ratio against SEB standard (115/116/117:114), SD = standard deviation and CV%= 
correlation variation.     
Figure 20: Stability profile of SEB on carpet over 7 days 





























Figure 21: MS/MS spectra of the product ion, 575 over 170 hours for SEB on carpet
SEB on carpet at time 0 hour 
SEB on carpet at time 27 hours 
SEB on carpet at time 74 hours 
SEB on carpet at time 2 hours 
SEB on carpet at time 50 hours 
SEB on carpet at time 170 hours 
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3.2.6 Stability profile of SEB on Parquet  
The stability profile for SEB spiked on parquet was shown in Table 17. A graph of SEB 
recovery versus the time profile up to 170 hours was plotted in Figure 22. Its extraction 
efficiency for SEB from parquet was averaged out to be 74% with correlation variation of 
5.74%. Thus recovery factor was 1/0.74 = 1.35. SEB on parquet had showed to be much 
persistent and its degradation rate was almost zero even at the end of the 7th day. It 
implied that SEB was extremely stable on parquet. By the end of the 7th day, the actual 
amount of SEB left on parquet after multiplied by the recovery factor and concentration 
factor remained approximately the same as the spiked amount. We extracted out the 
product ion of 575 to take a look at the trend of the changes in peak areas of 114, 115, 
116 and 117 in Figure 23. The intensity of the four peaks was showed to be persistent 
over 170 hours. On comparison to carpet, SEB seemed to be less stable on carpet.   
It was noted that for most timings in parquet, the CV% were less than 10% with only one 
exception at 27 hours. But for carpet, the CV% deviated much more after time 0 and this 
could be due to the nature of the surface where the parquet had smooth surface but carpet 
was hollow/uneven surface allowing “interaction” of toxin with carpet or the toxin 
absorbed into the carpet at different extent and therefore the amount of extract differed 
more between each matrix at the same time interval.  This CV% for carpet after time 0 
were not due to the extraction technique as we already verified that at time 0, the 
extraction efficiency was 95.6% with good CV% of less than 10%. It was most likely due 
to the different “interaction” or absorption rate. This same trend of CV% was observed 
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for ricin as well. The matched sequence for identification purpose was filed under chapter 
6, appendix D.   
Table 17:  SEB’s stability on Parquet over 7 days 
Hours extract1 extract2 extract3 average SD CV%
0 0.70 0.73 0.78 0.74 0.042 5.74
2 0.77 0.74 0.79 0.77 0.026 3.45
27 0.80 0.84 0.52 0.72 0.174 24.09
50 0.77 0.84 0.77 0.79 0.042 5.34
74 0.71 0.61 0.69 0.67 0.052 7.79
170 0.73 0.67 0.79 0.73 0.058 8.00
      
Extract1, 2 and 3 were expressed in ratio against SEB standard, SD = standard deviation and CV%= correlation variation.     
Figure 22: Stability profile of SEB on parquet over 7 days 

































Figure 23: MS/MS spectra of the product ion, 575 over 170 hours for SEB on parquet 
SEB on parquet at time 0 hour 
SEB on parquet at time 27 hours 
SEB on parquet at time 74 hours 
SEB on parquet at time 2 hours 
SEB on parquet at time 50 hours 
SEB on parquet at time 170 hours 
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3.3       T-2 MYCOTOXIN   
3.3.1 Reproducibility   
LC-MS was used to quantify the amount of T-2 toxin extracted from matrices.  The 
reproducibility of the quantitation was assessed to ensure the stability of the LC system 
and validity of the T-2 toxin analysis results.  In Table 18, it showed that the LC-MS had 
a good reproducibility of T-2 toxin giving a CV% of 5.03 for the eight repeated injections 
from the same vial of sample.   
Table 18: Reproducibility of the LC-MS system 
Sample# 1 2 3 4 5 6 7 8 
Retention 
time[min]
2.98 2.83 2.97 2.83 2.96 2.83 2.99 2.68 
Peak area 2.12E9 2.18E9 2.12E9 2.32E9 2.21E9 2.30E9 1.99E9 2.10E9 
Average    = 2.17E9 
Standard deviation   = 1.09E8 
Correlation variation % =  5.03  
3.3.2 Linearity  
The linearity for the T-2 toxin standard calibration was done to show that the peak area of 
the T-2 toxin correlates to the amount of T-2 toxin present. Table 19 showed the 
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concentration of toxin versa area count. The plot gave a R2 of 0.9948 as shown in Figure 
24. As such, a single point external calibration will be done each day of the experiment.  
Table 19: Linearity of area count versus concentration of T-2 toxin 
T-2 
Concentration
2.5 ppm 10 ppm 25 ppm 
Retention 
time[min] 
2.85 2.69 2.67 
Peak Area 9.39E7 2.74E8 5.47E8 
Figure 24: Linearity of area count versus concentration of T-2 toxin 
Absolute area vs conc of T2[ppm]















3.3.3 Lowest level of detection (LOD) & quantitation (LOQ)  
Both LOD and LOQ were analyzed to determine the sensitivity of the instrument. LOD 
was determined to be 0.05 ppm. LOQ was determined to be 0.1 ppm.  
3.3.4 Filter factor prior to LC  
Since the sample had to be filtered through a nylon filter before LC run, the loss of 
sample through this filtering step was determined. The recovery from nylon filter was 
derived by taking the average relative area (RA) of T-2 toxin through nylon filter divided 
by the average RA of T-2 toxin standard. This gave a recovery of 85% (i.e. 
19.96/23.58*100%) and thus, the filter factor which was the inverse of recovery, gave 
1.18 as shown in Table 20. 
    Table 20: Determination of filter factor 
T-2 standard Extract1 Extract2 Extract3 Average RA 
RT(T2) 2.54 3.01 2.63 
A(T2) 3.29E8 3.93E8 5.34E8 
RT(Ben) 3.38 3.84 3.52 
A(Ben) 1.25E7 1.59E7 2.71E7 
RA 26.32 24.72 19.70 
23.58 
T-2 thru’ Nylon filter Extract1 Extract2 Average RA 
RT(T2) 2.84 2.85 
A(T2) 3.89E8 5.07E8 
RT(Ben) 3.68 3.84 
A(Ben) 2.09E7 2.38E7 
RA 18.61 21.30  
19.96 
Where RT= retention time[min], A=peak area, Ben=Benzophenone internal standard, RA=relative area of T-2/Ben 
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3.3.5 Recovery efficiency of T-2 toxin from carpet  
In Figure 25, it showed the extraction efficiency of T-2 toxin from carpet. With 2.5 ppm 
of T-2 toxin spiked on the carpet, the average recovery from it was 60.8%. When the 
spiking concentration was increased to 10 ppm and 25 ppm, its average recovery was 
73.5% and 63% respectively. The spiked amount was 1000 ppm T-2 toxin on matrices 
and thus after adding 40 ml of extraction solvent, its concentration would be diluted to 25 
ppm and thus, the calibration standard should be established below 25ppm. We needed to 
show that the calibration standard was linear for us to do relative quantitation based on 
peak area count of standard T-2 toxin. It had showed that the recovery of T-2 toxin from 
carpet was reasonably consistent over three different concentrations with a mean of 
65.8% and standard deviation of 15.1% in Table 21. The carpet extraction factor was then 
derived to be 1.5 (i.e. 1/0.658).  
Figure 25: Extraction efficiency of T-2 toxin from carpet  
Extraction efficiency% of T2 from Carpet vs standard T2 concentration [ppm]




























Table 21: T-2 toxin recovery from carpet 
Spiked concentration 2.5ppm T-2 10ppm T-2 25ppm T-2 
Ave. recovery% 60.8 73.5 63.0 
Mean     = 65.8% 
Average standard deviation = 15.1% 
Carpet extraction factor = 1.5 
Refer to appendix (E) for raw data.  
3.3.6 Recovery efficiency of T-2 toxin from parquet  
Different matrices would give different extraction efficiency and thus, we needed to 
repeat the same procedure as in section 3.3.5 to determine the extraction efficiency factor 
of T-2 toxin from parquet.  Figure 26 showed that the extraction efficiency of T-2 toxin 
from parquet was reasonably consistent over three different concentrations with a mean 
of 97.3% and standard deviation of 18.0% in Table 22. By taking the inverse of the mean 
recovery, the parquet extraction factor was derived to be 1.03 (i.e. 1/0.973).        
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Figure 26: Extraction Efficiency of T-2 toxin from Parquet  
Extraction efficiency% of T2 from parquet vs concn[ppm]
























Table 22: T-2 toxin recovery from parquet  
Spiked concentration 2.5ppm T-2 10ppm T-2 25ppm T-2 
Ave. recovery% 101.1 99.9 90.7 
Mean     = 97.3% 
Average standard deviation = 18.0% 
Parquet extraction factor = 1.03 
Refer to appendix (F) for raw data.    
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3.3.7 Stability profiles of T-2 toxin on Carpet and Parquet determined by  
HPLC-MS system  
In Figure 27, T-2 toxin was observed to be more persistent on carpet showing an 
appreciable degradation only after 26th hour dropping to half of the spiked amount.  It 
leveled off with an average recovery of 33.55% (taking into consideration the filter factor 
and extraction factor) by the end of the 7th day. Exact amount of T-2 toxin remaining 
from the spiked amount of 1mg was 1 x 0.34 = 0.34 mg/25 cm2.  
On comparison to parquet as shown in Figure 28, we could clearly see that the decay 
profile of T-2 toxin on parquet started almost instantaneously and by the 4th hour, it 
degraded to 50% of the initial spiked amount and leveled off from 12th hour onwards 
giving an average recovery of 19.50% (taking into consideration the filter factor and 
extraction factor). Exact amount of T-2 toxin remaining from the spiked amount of 1mg 
was 1 x 0.20 = 0.20 mg/25 cm2.   
We observed that T-2 toxin was not as stable on parquet compared to on carpet. The rate 
of degradation of T-2 toxin on parquet was much faster than carpet and the remaining 
amount at the end of 7th day was also lower. However, the stability of T-2 toxin on both 
matrices would come to a stable point where the recovery was consistent for the 
remaining 3 days.    
  
88
Figure 27: Stability profile of T-2 toxin from Carpet using LC-MS 




















Figure 28: Stability profile of T-2 toxin from Parquet using LC-MS  















Refer to appendix G and H for raw data of the stability profiles.  
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CHAPTER 4 DISCUSSION AND CONCLUSIONS   
4.1 Stability profile of Ricin up to 170 hours on Carpet and Parquet  
The stability of the toxin refers to the toxin being able to maintain its original form on the 
matrices. The recovery of the toxin refers to the toxin being able to extract out from the 
matrices. However, if the toxin was able to be recovered from the matrices and identified 
by its molecular mass as the respective toxin, it implied that this recovered amount of 
toxin was the toxin that stayed in its original form since its molecular mass was a unique 
characteristic of each toxin. Thus, the recovered toxin refers to the toxin that is stable in 
its original form on the matrices. This definition was applied to the three toxins used in 
this study.  
The stability profile of ricin over 0, 2, 27, 50, 74 and 170 hours in an indoor office 
environment of 22.5-25.50C and relative humidity <70%, was studied by labeling 
digested sample extract with an amine isobaric tag (i.e. iTRAQ reagent) and analyzed 
using nano-flow liquid chromatography mass spectrometry (nano-flow LC-MS/MS). For 
carpet, an additional time interval at 8th hour was done as the drop between 2nd hour and 
27th hour was too huge to see the trend. The verification of the feasibility of iTRAQ 
reagent labeling on ricin and SEB for quantitation work analyzed using nano-flow LC-
MS/MS was done. It gave an approximately 1:1 ratio reading for two samples of identical 
concentration. This implied that iTRAQ labeling could give an accurate representation of 
the exact experimental amount and this labeling technique was applicable to ricin and 
SEB’s quantitative work using nano-flow LC-MS/MS. 
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As the extraction was done using 10 ml of solvent, a concentration step was required 
before trypsin digestion. For ricin, a higher molecular weight cutoff Millipore Amicon 
centrifuge tube of 10 kDa was used for concentrating diluted toxin extract of 10 ml to 
approximately 200 ul since it had a much larger molecular weight of ~66 kDa. This 
concentrating step gave a concentration factor of 1 since with or without passing through 
the 10 kDa molecular cutoff centrifuge tube, it still quantified the same amount. Thus, 
there was no loss of sample during the concentrating step. The extraction solvent used 
was solely HPLC grade water as any content of organic solvents would result in less 
peptides detection. With carpet, it was required to vortex for 3 minutes after addition of 
10 ml of HPLC grade water.  This allowed an extraction efficiency of ricin from carpet to 
be 95% with CV% of 2.85%. Thus, the extraction efficiency factor was 1/0.95 = 1.06.  As 
for parquet, it was vortexed for 1 minute and it gave an almost 100% recovery with CV% 
of 7.88%. This gave an extraction efficiency factor of 1 for parquet. With these two 
extraction factors determined for carpet and parquet, the exact amount of ricin remaining 
on the matrix can be determined by average iTRAQ ratio X 100ug spiked toxin X 
concentration factor X extraction factor.  
After verification of these concentration and extraction factors, we did a stability time 
profile of ricin up to 7 days for carpet and parquet. The stability of ricin on carpet 
dropped drastically within 24 hours by 70% and gradually leveled off until the 7th day, 
with 15 ug/cm2 remaining (~20% remaining). But for ricin on parquet, it showed more 
stability with only a slight drop from 2 hours onwards to ~80% remaining. By the end of 
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7th day, there was ~70% of the spiked amount remaining. Ricin showed two different 
trends for two different matrices implying that the stability of the same toxin could 
behave differently with different matrices under the same condition. Thus, the stability of 
ricin was matrix-dependent.  The CV% was observed to be larger on carpet compared to 
on parquet. This is probably due to the nature of the surface that the toxin resided on. 
Carpet was “hollow” and absorptive compared to a smooth parquet surface and thus 
carpet would allow more “interaction” or absorption of toxin as the time of residence 
lengthened.  This larger CV% was not due to the extraction technique as at time 0 hour, it 
had been verified that the CV% was less than 10% for both matrices.   
4.2 Stability profile of SEB up to 170 hours on Carpet and Parquet  
The same time intervals were used for SEB up to 170 hours in an indoor office 
environment. Based on iTRAQ labeling on digested SEB extracts, the concentration 
factor using Millipore Amicon ultra-15 5 kDa centrifuge tube for diluted extract sample 
of SEB gave a better reproducible recovery of 96.2% compared to 10 kDa centrifuge 
tube. Thus, the 5 kDa Millipore Amicon Ultra-15 centrifuge tube was used as the 
concentrating step for SEB. The concentration factor derived was 1.04 (i.e. 1/0.962). The 
extraction solvent used for carpet was 20%acetronitrile-80%water and for parquet was 
100% HPLC grade water. The extraction efficiency factors for SEB from carpet and 
parquet were determined to be 95.3% and 74.0% respectively, giving extraction 
efficiency factors of 1.05 (i.e. 1/0.953) and 1.35 (i.e. 1/0.74).   
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SEB was found to be much more stable on parquet than carpet under indoor office 
environment of 22.5-25.50C and relative humidity <70% over 7 days.  The SEB stability 
profile on carpet matrices showed a much more gradual degradation over time compared 
to ricin on carpet where the stability of ricin on carpet dropped to half by the 8th hour as 
compared to 27th hour for SEB on carpet. There was a significant amount of 19.5 ug/cm2 
SEB remaining at the end of 7th day on carpet using iTRAQ-nano-flow LC-MS/MS 
methodology. This was approximately 30% of the spiked amount remaining. For both 
toxins on carpet, the amount remaining was much higher than the LD50. As for parquet, 
SEB showed almost no degradation in the stability profile. These stability profile 
experiments showed that the stability and fate of toxins were dependent on the nature of 
the toxins themselves as well as the matrices that these toxins were exposed to. On the 
whole, for proteinaceous toxins (SEB and ricin), they showed similar trends for both 
matrices except that SEB on parquet had been observed to be slightly more stable (i.e. 
~100% remaining) compared to ricin on parquet (~70% remaining).   
4.3  Advantages of our iTRAQ-nano-flow LC-MS/MS method compared to the 
commonly used ELISA method  
With this new quantitative methodology of iTRAQ-nano-flow LC-MS/MS, it gave 
numerous advantages compared to the classical immunoassay method like ELISA, which 
had been the most commonly used method. In a single run based on iTRAQ labeled 
peptides obtained from the extract, it not only gave online identification of the toxin, it 
also allowed multiple samples detection as well as both relative and absolute 
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quantification in just 65 minutes. As mass spectrometry was involved, it allowed us to 
obtain unique characteristics of a substance, namely its molecular mass and structure. The 
same instrument can be used for CWA, BWA and mid-spectrum agents since each agent 
has its own unique molecular mass.   
Using the MS/MS signature ions from the amine-derivated peptides (i.e. 114, 115, 116 
and 117 peaks) of our extracts and compared with standard, the stability profile studies of 
SEB and ricin were feasible with quantitation since the triplicate was mixed in the same 
vial as the control. This new quantitative technique allowed identification of toxin based 
on the matched amino acid sequences obtained simultaneously as the quantitative ratio of 
iTRAQ labeled peptides using ProQUANT 1.0 software. It had the basic function as to 
ELISA for identification purpose but the time spent and the sample preparation required 
were much faster and easier by using iTRAQ-nano-flow LC-MS/MS. No isolation and 
purification were required before the analysis since it could be done online with our 1-
dimensional LC. Our 1-dimensional LC consisted of a desalt column and a separation 
column for desalting and purifying samples. When comparison was made with a standard 
peptide, absolute quantitative work was possible. This could not be achieved by ELISA 
since it only allows relative quantitation.   
However, in terms of the detection level, it was limited by the lowest detectable amount 
of iTRAQ labeled peptides. For iTRAQ labeled ricin to be detectable, it must be at least 5 
ug and for SEB, it must be at least 1 ug. However, if we look in terms of a real 
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bioterrorist attack, this amount would be justifiable since the terrorists would release 
ample amount.   
4.4  Stability profile of T-2 toxin up to 170 hours on Carpet and Parquet  
The stability profile of T-2 toxin on carpet and parquet were studied using Liquid 
Chromatography-Mass Spectrometry (LC-MS). In our research study, we used Finngan 
LCQ. We had determined that the LOD for our LC-MS analysis on T-2 toxin was 0.05 
ng/ul, which was comparable to GC methods. The filter factor was determined to be 1.18 
since filtration was required before running the samples in LC. The extraction efficiency 
factors for parquet and carpet were derived at time 0 where they were 1.03 and 1.50 
respectively. Benzophenone was used as internal standard for parquet but not carpet. No 
internal standard was used for carpet. We could not find a suitable internal standard as the 
elution time was near to the solvent elution time. However, as shown in Table 20, the 
deviation was less than 20%. We concluded that for carpet, we could do without internal 
standard since the purpose of internal standard was to eliminate any variation that arose 
and our experimental variation was within our criteria.   
The stability profile of T-2 toxin was showed to be twice as stable on carpet compared to 
parquet under indoor conditions up to 7 days. On parquet under indoor conditions, the 
stability of T-2 toxin dropped by ~ 80% in 7 days. As for carpet, T-2 toxin was more 




Ave. amount of T-2 
left after 7 days 
0.34 mg/25cm2  0.20 mg/25cm2  
For T-2 toxin, greater stability was observed on carpet compared to parquet where the 
stability on carpet dropped to half after 24 hours compared to after 4 hours on parquet. 
Contrary to T-2 toxin, the two proteinaceous toxins were extremely stable on parquet but 
degraded gradually on carpet. Parquet is an interesting indoor substrate that could 
‘naturally’ degrade T-2 toxin to large extent (80% in 7 days) whereas SEB deposited on 
parquet would remain extremely stable and persistent. For ricin on parquet, the stability 
was good with ~70% remaining. Proteinaceous toxins (ricin and SEB) showed a 
completely opposite stability trend compared to non-proteinaceous toxin (T-2 toxin) on 
parquet. As for carpet, the percentage remaining at the end of 7th day for T-2 toxin was 
slightly more than the proteinaceous toxins.   
4.5  Conclusions  
In this research study, we had showed the feasibility of using amine isobaric labeling (i.e. 
iTRAQ reagents) on ricin and SEB and analysis by using nano-flow LC-MS/MS. This 
was the first study that showed the possibility of using iTRAQ reagents for both 
quantitative and identification studies on ricin and SEB using nano-flow LC-MS/MS. 
Two extraction factors were determined for carpet and parquet respectively and also the 
concentration factor for each toxin. The exact amount of ricin/SEB remaining on the 
matrix was calculated by taking the average iTRAQ ratio X 100ug spiked toxin X 
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concentration factor X extraction factor. We had determined the stability profiles for 
three BWA toxins namely ricin, SEB and T-2 toxin in an indoor office environment. The 
stability of ricin on carpet dropped drastically within 24 hours to ~30% remaining and 
gradually leveled off until the 7th day, with 15ug/cm2 remaining (~20% remaining). But 
for ricin on parquet, it showed better stability with ~70% remaining at the end of 7th day.   
SEB was also found to be more stable on parquet (~100% remaining) compared to carpet 
(~25% remaining).  However, the stability profile of SEB on carpet matrices showed a 
more gradual drop over time compared to ricin on carpet where the stability of ricin on 
carpet dropped to half by the 8th hour as compared to after 27th hour for SEB on carpet. 
However, by the end of the 7th day, both toxins on carpet had leveled off to ~21-25%. 
These were significant amounts of toxins remaining at the end of 7th day which were 
more than the LD50 which we had noted to be alarming. As for T-2 toxin, greater stability 
was observed on carpet compared to parquet where slightly higher amount of ~35% 
remained on carpet compared to ~ 20% on parquet. On the carpet matrix, it was noted 
that the remaining percentage of the three toxins on carpet at the end of 7th day was 
similar except that ricin’s stability dropped at a faster rate compared to SEB and T-2 
toxin. But on parquet, T-2 showed a completely opposite stability trend compared to ricin 
and SEB.  
SEB was a more persistent toxin with greater environmental stability on parquet, 
followed by ricin and T-2 toxin. This new quantitative technique of iTRAQ-nano-
flowLC-MS/MS allowed identification of ricin/SEB based on the matched amino acid 
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sequences obtained simultaneously with the quantitative ratio of iTRAQ labeled peptides 
using ProQUANT 1.0 software. It had the basic function as to ELISA for identification 
purpose. But it had the additional capability of obtaining absolute quantitation, which 
ELISA could not achieve. With this novel quantitative technique made available by 
iTRAQ-nano-flow LC-MS/MS, the response time for the appropriate countermeasure 
would be shortened since it gave identity, absolute quantity and number of different 
toxins being engaged but in a more rapid time frame with higher sensitivity in a single 
run.  As for T-2 toxin, with our LC-ESI-ion trap MS, we were able to achieve the 
comparable LOD as common GC methods. This implied that LC-MS would be the next 
most potential method since it does not require derivatisation and is less laborious.    
The low yield of toxins was not due to unsuitable extraction method. Each extraction 
method had been verified to give a good recovery of toxin with low CV% for triplicate 
set as shown in Table 10, 15, 21 and 22. The three toxins selected are rather stable as 
reviewed in Introduction but given an indoor office environment exposure for 7 days, 
they would probably be degraded over time. The loss of ricin and SEB would probably be 
due to bacterial degradation. And the loss of T-2 toxin would probably be due to fungal 
degradation. We could not answer whether there was any irreversible reaction with the 
matrices as in this study, we were only looking at the stability of toxin that still stayed in 
its original form on the matrices. If the toxin did have reaction with the matrices, it 
showed that this toxin was unstable on the matrices in addition to degradation factor.   
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With this iTRAQ technique, the peptides that were found in the control would be 
compared to the peptides that were found in the extract. We would get a comparison of 
the peptides that were present in both the control and extract by an average ratio reading 
of 115/116/117:114 (i.e. extract: control) through ProQUANT 1.0 software. As we were 
only interested in the “stable” toxin that stayed in its original form, the average ratio 
would give us the “stable” toxin amount and identification but not the degraded toxin. As 
for T-2 toxin, we utilized the selected ion monitoring mode looking at the particular 
molecular masses of 467 [466+H], 484 [466+H2O] and 489 [466+Na] of T-2 toxin. Thus, 
if it degraded to other forms, we would not have observed as we did not use the scan 
mode which looked over the whole range of molecular masses. Only those T-2 toxin that 
were not degraded, would be detected by the three selected molecular masses to give a 
peak for quantitation.   
All these data that we observed would allow us to react with proper medical action as 
well as counteractive measures upon any bio-terrorist attack.         
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4.6       Future studies  
With this iTRAQ-nano-flow LC-MS/MS technology, we had achieved an understanding 
of the stability of three BWA namely ricin, SEB and T-2 toxin in an indoor office 
condition. It allowed us to deal with them in a better prospect in terms of medical or 
strategic planning. We could also do further study of these three BWA in a stimulated 
outdoor condition or even in rat blood serum for us to understand how stable these toxins 
would stay outdoor and in blood stream using this quantitative technology. One drawback 
of this iTRAQ-nano-flow LC-MS/MS technology would probably be the detection limit. 
However, we had explained in the discussion section that the possibility of bioterrorist 
attack would probably be in large quantity and thus, the detection limit of 5 ug (i.e. for 
ricin) and 1 ug (i.e. for SEB) would not be an issue.   
Nevertheless, there is another new technique called multiple reaction monitoring-initiated 
detection and sequencing and in short known as “MIDAS”.  This technique is done by 
using 4000 Q-TRAP mass spectrometer from Applied Biosystem with its third 
quadrupole configured to quadrupole mass filter and linear ion trap by a MRM trigger.  
This MIDAS technique was introduced in May 2005 by Unwin, R. D. etc al 123.  In this 
technique, the triple quadrupole mass spectrometer first functions as a mass filter to 
perform MRM analysis where it selects significant MRM product ions that transmit from 
first quadrupole to the third quadrupole.  Based on the signature peptides, it triggers a 
change of mode in the mass spectrometer to MS/MS product ion scan that allows 
generation of sequencing data and detection of peptides. MIDAS is a highly sensitive 
technique since MRM only allows ions of a specific m/z through the first quadrupole, 
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followed by fragmentation of this ion in the second quadrupole, then to the detector. 
Thus, the background noise would be extremely low giving an enhanced sensitivity and 
no stable isotope labeling would be required. This MIDAS technique would probably 
allow us to achieve a much lower detection limit, but it is still a relative quantitation 
method.  
In a scenario where absolute quantitation is crucial, iTRAQ-nano-flow LC-MS/MS 
would probably be the choice. However, in a scenario where an extremely low amount of 
sample is available, MIDAS-LC-MS/MS would probably be handy but further study on 
its feasibility with these three BWA will still need to be verified before its usage.               
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CHAPTER 6  APPENDICES   
(A) Ricin on carpet over 170 hours   
Pro Group Report: 
ricin on carpet 0hour
  
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 80 108 45.4
>95 (1.3) 2 2 201 238 100
>66 (0.47) 2 2 201 238 100
As shown: >95 
(1.30) 
2 2 201 238 100
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ -0.09 1004.48 2
1 ASDPSLK K->R SD 28.05 888.53 2
1 ASDPSLK 0.07 860.54 2
1 ASDPSLK D->E SL 14.09 874.56 2







CLTT 16.03 4990.45 5
1 DGRFHNGNAI
QLWPCJ 
D->E CJ 14.26 2157.37 4
1 DNCLTSDSNI
R 
D->E SN 14.26 1394.9 2
1 DNCLTSDSNIR 14.26 1394.9 2





VVK 14.26 1951.23 3
1 DNCLTSDSNIRETVVK 0.12 1937.09 3
1 DNTIR N(Deamida
tion) 
DN 1.07 762.48 2
1 DNTIRSNGJ -14.27 1277.45 3
1 DNTIRSNGK N(Deamida
tion) 
SN 1.05 1148.67 2
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1 DNTIRSNGK -14.05 1133.57 3
1 DNTIRSNGK 28.01 1175.63 3
1 ETVVJ -14.04 848.5 2
1 ETVVK -0.69 717.75 2
1 ETVVK 13.91 732.35 2
1 ETVVKILSCGP
ASSGQR 
V->I PASS 14.16 1889.17 4
1 ETVVKILSCGP
ASSGQR 
K->R SCG 28.12 1903.12 3
1 FQUIEGEMR F->Y / 
M(Oxidatio
n) 
IE 15.7 1475.45 3
1 FQUIEGEMR F->Y / 
M(Oxidatio
n) 
IE 15.72 1475.47 3
1 FQYIEGEMR -26.17 1289.47 3
1 FQYIEGEMR 23.29 1338.93 2
1 FQYIEGEMR -14.11 1301.52 3
1 FQYIEGEMR -26.11 1289.53 3
1 FQYIEGEMR Y->W MR 23.29 1338.92 2
1 FQYIEGEMRT
R 
M->L YI -17.78 1555 2
99 FSVYDVSILIPIIALMVYR -0.04 2355.3 3
1 GRLTTGADVR R->K TG -27.87 1160.81 2




TGA 80.19 1268.87 2
1 HEIPVLPNR 1.08 1218.78 2
1 HEIPVLPNR 1.06 1218.76 2






MFK 16.28 1927.25 3
1 ILSCGPASSGQRWMFK -13.72 1897.25 3
1 IRUNR -28.03 980.59 2
1 IRUNR -13.89 994.73 2
1 IRYNR -15.7 848.8 2
1 IRYNR -28 836.51 2










VR 1.17 1444.99 2
1 IVGRNGLCVDVR 1.17 1444.98 2
1 IVGRNGLCVDVR 1.21 1445.02 2
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1 IVGRNGLCVDVR 1.15 1444.96 2
99 LEQLAGNLR -0.03 1156.64 2
99 LEQLAGNLR -0.01 1156.66 2
99 LEQLAGNLR -0.05 1156.63 2
99 LEQLAGNLR -0.03 1156.64 2





EQ 0.95 1157.62 2
1 LEQLAGNLR 18.09 1174.76 2
1 LEQLAGNLR E->D LAG -14.13 1142.55 2
1 LEQLAGNLR E->D LAG -14.01 1142.66 2









TAIQ 0.97 2403.25 3
7 LTTGADVR D->E / V-
>I 
TT 14.01 989.57 2
1 LTTGADVR 14.01 989.57 2
1 LTTGADVR R->K TT -27.93 947.62 2




TTG 80.05 1055.61 2
1 NDGTILNLYS
GLVLDVR 
Y->H DV -25.8 1979.31 5
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.8 1989.3 2
1 NGLCVDVR 1.15 1019.68 2
1 NGLCVDVR 14.13 1032.67 2
1 NGLCVDVRDGR 1.06 1347.75 3
1 NGLCVDVRDGR 17.94 1364.62 2
99 QIILUPLHGDPNQIWLPLF -0.08 2564.37 3
99 QIILYPLHGDPNQIWLPLF -0.08 2420.27 3
1 QIILYPLHGDPNQIWLPLF -0.1 2420.24 5
1 RDNTIR -13.78 903.75 2
1 RDNTIR 1.04 918.56 2
1 RDNTIR 14.18 931.7 2
1 RNGSK 28 732.41 2
1 RNGSK R->K GS -27.74 676.66 2










ENS 79.73 2107.78 3
99 SAPDPSVITLENSWGR -0.03 1871.93 3





TL 0.97 1872.93 3
1 SNGJ 1.17 693.59 2
1 TRIR -13.79 674.66 2
1 UNRR R->K UN -27.8 867.72 2
1 UNRR 0.2 895.73 2
1 UNRR 1.08 896.6 2
1 UTFAFGGNYDR 23.3 1621.08 2
1 UTFAFGGNYDR 23.3 1621.08 2
99 VGLPINQR -0.05 1039.59 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.03 1039.6 2
99 VGLPINQR -0.03 1039.6 2
1 VGLPINQR I ->V VG -13.91 1025.72 3
98 WMFJ -0.08 898.42 2
94 WMFJ -0.02 898.48 2
1 WMFJ 0.04 898.54 2
1 WMFJ 0 898.5 2
1 WMFK 0.16 754.56 2
1 WMFK -17.74 736.66 2
1 WMFK -17.94 736.46 2
1 WMFK -0.02 754.38 2
1 YNR 1.26 596.59 1
1 YNR 23.04 618.36 2
1 YNR -27.92 567.41 1





FAF 1.24 1599.03 2
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Pro Group Report: ricin on 
carpet 2hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 2 2 173 236 100
>95 (1.3) 2 2 173 236 100
>66 (0.47) 2 2 173 236 100
As shown: >95 
(1.30) 
2 2 173 236 100
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ -0.09 1004.49 2
0 ASDPSLJ 14.09 1018.67 2
1 ASDPSLK 80.13 940.61 2
1 ASDPSLK 28.11 888.58 2
1 ASDPSLK K->R SD 28.07 888.54 2
1 ASDPSLK D->E SL 14.07 874.55 2
1 DNCLTSDSNI
R 
R->K CL -27.72 1352.93 2
1 DNTIR N(Deamida
tion) 
DN 1.07 762.49 2
1 DNTIRSNGK N(Deamida
tion) 
SN 1.03 1148.65 2
1 DNTIRSNGK -14.07 1133.54 3
1 DNTIRSNGK N(Deamida
tion) 
GK 1.13 1148.74 2




VV 79.98 942.53 2
1 ETVVJ -0.88 861.67 2
1 ETVVJ -13.78 848.77 2
1 ETVVJ -14.06 848.49 2
1 ETVVJILSCGP
ASSGQR 
L->M PASS 17.92 2037.03 3
1 ETVVK 0.25 718.68 2
1 ETVVK -0.71 717.72 2
0 ETVVK 13.93 732.36 2
1 ETVVK 80.01 798.45 2
99 FSVYDVSILIPIIALMVYR -0.04 2355.3 3





M->L WM -18.04 2037.03 3
1 IRYNR -28.02 836.48 2
1 IRYNR -28.12 836.38 2
1 IRYNR -28.08 836.42 2
1 IRYNR -28.12 836.39 2
1 IRYNR -28 836.5 2
1 IRYNR I ->V YN -13.98 850.53 2
1 IRYNR 80.1 944.61 2
1 IRYNR 80.16 944.67 2
1 IRYNR -26.02 838.48 2










VR 1.17 1444.98 2
1 IVGRNGLCVDVR 1.17 1444.98 2
99 LEQLAGNLR -0.01 1156.66 2
99 LEQLAGNLR -0.03 1156.65 2
99 LEQLAGNLR -0.03 1156.65 2
1 LEQLAGNLR 18.09 1174.77 2
76 LEQLAGNLR -0.03 1156.65 2
96 LEQLAGNLR 0.05 1156.72 2
99 LEQLAGNLR -0.03 1156.65 2
1 LTTGADVR 13.97 989.52 2
1 LTTGADVR R->K GA -27.93 947.63 2
1 LTTGADVR 80.05 1055.61 3
1 LTTGADVR 80.03 1055.59 2
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.82 1989.29 2
1 NGLCVDVR 18.11 1036.65 2
1 NGLCVDVR -27.81 990.73 2
1 NGLCVDVR N(Deamida
tion) 
DV 1.13 1019.67 2
1 NGLCVDVR N(Deamida
tion) 
DV 0.81 1019.34 2
1 NGLCVDVR 18.09 1036.63 2





NGL 1.06 1347.75 3












QIW 0.94 2565.39 4
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99 QIILUPLHGDPNQIWLPLF -0.06 2564.39 3
99 QIILYPLHGDPNQIWLPLF -0.04 2420.3 3
1 QIILYPLHGDPNQIWLPLF -0.26 2420.08 3
1 RDNTIR 14.18 931.7 2
1 RDNTIR 0.12 917.64 3
1 RNGSJ -27.75 820.76 2
5 RNGSK -27.94 676.46 2
1 RNGSK -27.76 676.65 2
29 SAPDPSVITLE
NSWGR 
E->Q PDP -1.07 1870.88 3
1 SNTDANQLWTLK 13.85 1547.65 4
1 TRIR -13.79 674.67 2
1 TRIR -14.03 674.42 2
1 TRIR -13.79 674.66 2
1 TRIR -13.87 674.58 2
1 TRIR -13.81 674.65 2
1 UNRR -27.86 867.66 2
1 UNRR -27.84 867.69 2
1 UNRR 1.06 896.59 2
1 UTFAFGGNYDR 23.28 1621.06 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.01 1039.62 2
99 VGLPINQR -0.03 1039.6 2





VG 1.15 1040.79 2
98 WMFJ -0.04 898.47 2
85 WMFJ -0.02 898.49 2
3 WMFJ 0 898.5 2
1 WMFJ 0.1 898.6 2
1 WMFJ 0 898.51 2
1 WMFJ -17.98 880.53 2
1 WMFJ -0.04 898.47 2
1 WMFK 0.14 754.55 2
1 YNR 23.04 618.36 2
1 YNR 1.08 596.41 1
1 YNRR 80.26 831.69 2
1 YNRR 1.02 752.45 2










Y->W YT 23.2 1620.99 3
Pro Group Report: Ricin on 
carpet 8hours    
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 68 108 42.4
>95 (1.3) 2 2 193 255 100
>66 (0.47) 2 2 193 255 100
As shown: >95 
(1.30) 
2 2 193 255 100
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ -0.03 1004.55 2
1 ASDPSLJ 18.09 1022.66 2
1 ASDPSLJ 14.03 1018.6 2
1 ASDPSLK 28.07 888.55 2
1 ASDPSLK 14.11 874.59 2
1 ASDPSLK D->E SL 14.05 874.52 2
1 DNCLTSDSNIR 14.2 1394.84 2
1 DNCLTSDSNI
RETVVJ 
E->Q NCLT -0.71 2080.37 3
1 DNTIR -13.71 747.71 2
1 DNTIR -13.71 747.71 2
1 DNTIRSNGJ I ->V RS -14.25 1277.46 3
1 DNTIRSNGK K->R SN 27.93 1175.55 3
1 DNTIRSNGK K->R DN 27.93 1175.54 3
1 ETVVJ -14.06 848.48 2
1 ETVVJ -13.78 848.77 2
1 ETVVJ 13.96 876.5 2
1 ETVVJ -0.9 861.65 2
0 ETVVK 0.17 718.6 2
0 ETVVK E->D VV -13.77 704.66 2
0 ETVVK 0.17 718.61 2
1 ETVVK 0.17 718.6 2
1 ETVVK V->I TV 13.89 732.33 2
1 ETVVK -0.03 718.41 2
1 ETVVK 28.25 746.68 2







SCG -13.86 1861.15 3
1 ETVVKILSCGP
ASSGQR 
Q->E GQR 1.26 1876.26 3
1 ETVVKILSCGP
ASSGQR 





TVV -14.16 1860.84 3
1 FHNGNAIQLWPCJ -22.83 1792.13 3
1 FQUIEGEMR F->Y / 
M(Oxidatio
n) 





FQ -14.31 1702.59 3
1 FQYIEGEMR -14.15 1301.49 3
1 FQYIEGEMR 15.83 1331.47 3
1 FQYIEGEMR -14.15 1301.48 3
1 FQYIEGEMR 23.23 1338.86 2
1 FQYIEGEMR -26.15 1289.48 3
1 FSVYDVSILIP
IIALMVUR 
Y->H FS -26.04 2473.4 4
1 GRLTTGADVR -28.01 1160.66 2
99 HEIPVLPNR -0.06 1217.65 3
99 HEIPVLPNR -0.06 1217.65 3
99 HEIPVLPNR -0.06 1217.64 3
1 IRYNR -28.04 836.47 2
1 IRYNR -26.04 838.46 2
99 LEQLAGNLR -0.07 1156.61 2
99 LEQLAGNLR -0.07 1156.61 2
99 LEQLAGNLR -0.05 1156.62 2
1 LEQLAGNLR 18.05 1174.72 2
1 LEQLAGNLR 18.05 1174.72 2




Q->E TAIQ 0.93 2403.2 3
1 LTTGADVR -27.93 947.62 2
1 NDGTILNLUS
GLVLDVR 
L->M DGTI 17.96 2167.17 4
0 NDGTILNLUSGLVLDVR 18.08 2167.29 4
1 NDGTILNLYSGLVLDVR 0.2 2005.3 3
43 NGLCVDVR 0.19 1018.72 2
1 NGLCVDVR -27.91 990.63 2
1 NGLCVDVR 18.07 1036.6 2
1 NGLCVDVR L->M NG 18.09 1036.63 2
1 NGLCVDVR D->E / V-
>I 
NG 13.97 1032.5 3
1 NGLCVDVR 18.09 1036.62 2
1 NGLCVDVR 14.09 1032.63 2
1 NGLCVDVR 17.89 1036.43 3
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NGS 16.23 2757.76 4
99 QIILUPLHGDPNQIWLPLF -0.14 2564.31 3
99 QIILYPLHGDPNQIWLPLF -0.14 2420.21 3
1 RDNTIR I ->V TI -13.82 903.71 2
1 RDNTIR 14.1 931.63 2
1 RDNTIR 14.16 931.68 2
1 RDNTIR I ->V TI -13.86 903.66 2
1 RNGSK -27.76 676.65 2





PDP -13.79 1858.17 3
1 SFIICIQMISE
AAR 
Q->E AAR 1.11 1726.03 3
1 SFIICIQMISE
AAR 
Q->E AAR 1.17 1726.09 3
1 TRIR -13.81 674.64 2
1 TRIR -13.81 674.64 2
1 TRIR -13.81 674.64 2
1 UNRR -27.84 867.68 2
1 UNRR -27.88 867.64 2
1 UNRR 0.16 895.68 2
1 UTFAFGGNYDR 23.2 1620.99 2
99 VGLPINQR -0.05 1039.58 2
99 VGLPINQR -0.05 1039.58 2
99 VGLPINQR -0.03 1039.6 2
3 VGLPINQR -0.05 1039.59 2
3 VGLPINQR -0.05 1039.59 2
1 VGLPINQR -14.01 1025.63 3
1 VGLPINQR 0.89 1040.52 3
0 VGLPINQR -28.05 1011.58 3
99 VGLPINQR -0.09 1039.55 2
98 WMFJ -0.08 898.42 2
21 WMFJ -17.96 880.54 2
3 WMFJ -0.04 898.46 2
0 WMFJ -18 880.5 2
1 WMFJ -17.76 880.75 2
1 WMFJ -0.04 898.47 2
1 WMFJ 0.02 898.52 2
1 WMFJ -0.02 898.48 2
1 WMFJ -0.04 898.47 2




R->K ILNL -27.78 2713.71 4
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1 WMFK -22.72 731.69 2
1 WMFK 0.12 754.53 2
1 WMFK 0.14 754.54 2
1 YNR 23.02 618.34 2
1 YTFAFGGNYDR 15.75 1469.42 3
Pro Group Report: ricin on 
carpet 24hours    
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 66 95 42.2
>95 (1.3) 1 1 66 95 42.2
>66 (0.47) 1 1 66 95 42.2
As shown: >95 
(1.30) 
1 1 66 95 42.2
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ -0.03 1004.55 2
1 ASDPSLK 14.13 874.6 2
1 ASDPSLK K->R SD 28.07 888.55 2
1 ASDPSLK 17.91 878.39 2
1 ASDPSLK D->E SL 14.07 874.55 2
1 ASDPSLK 18.17 878.65 2
1 DNCLTSDSNI
R 
D->E DN 14.24 1394.88 2
1 DNTIR -13.79 747.63 2
1 DNTIR 14.23 775.64 2
1 DNTIRSNGK K->R DN 28.05 1175.67 3
1 ETVVJ -14.04 848.5 2
5 ETVVJILSCGPASSGQR 17.88 2036.99 3
2 ETVVK 0.19 718.62 2
1 ETVVK 28.25 746.69 2
1 ETVVK -0.01 718.43 2
0 ETVVK -14.13 704.31 2
1 FQUIEGEMR -28.14 1431.6 3
1 FQYIEGEMR -14.11 1301.52 3
1 FQYIEGEMR 23.27 1338.91 2
1 FQYIEGEMR -14.19 1301.45 3
1 FQYIEGEMR Y->W MR 23.27 1338.91 2
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0 FQYIEGEMR -14.17 1301.46 3
0 FQYIEGEMRTR 0.18 1572.96 3
99 FSVYDVSILIPIIALMVYR -0.06 2355.29 3
1 GRLTTGADVR R->K GR -28.01 1160.66 2
99 HEIPVLPNR -0.04 1217.67 3
99 HEIPVLPNR -0.04 1217.66 3
99 HEIPVLPNR -0.04 1217.66 3
1 ILSCGPASSG
QR 
Q->E PAS 0.7 1319.38 4
1 ILSCGPASSG
QR 
R->K SSG -27.88 1290.8 3
1 ILSCGPASSGQRWMFK -13.76 1897.21 3
1 ILSCGPASSGQRWMFK 0.22 1911.19 4
1 IRUNR -28.09 980.52 2
1 IRYNR -26.02 838.48 2
1 IRYNR -28.02 836.49 2
1 IRYNR -0.02 864.49 2
1 IRYNR I ->V YN -13.96 850.54 2
1 IRYNR -28.02 836.49 2
1 IRYNR -28 836.5 2
1 IRYNR 23.14 887.65 2
1 IRYNR 23.14 887.64 2
99 LEQLAGNLR Q->E EQ 0.93 1157.61 2
99 LEQLAGNLR -0.03 1156.64 2
99 LEQLAGNLR -0.05 1156.63 2
99 LEQLAGNLR -0.05 1156.62 2
1 LTTGADVR R->K TT -27.93 947.63 2
1 LTTGADVR 0.09 975.65 2
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.8 1989.31 2
1 NDGTILNLYS
GLVLDVR 
Y->H LVL -25.94 1979.17 4
1 NGLCVDVR 18.17 1036.7 2
1 NGLCVDVR 13.97 1032.51 2
1 NGLCVDVR 18.07 1036.6 2
1 NGLCVDVR 0.13 1018.67 2
1 NGLCVDVR -27.85 990.69 2
1 NGLCVDVR 18.09 1036.63 2
1 NGLCVDVR 18.11 1036.64 2
1 NGLCVDVRD
GR 
L->M CV 17.88 1364.56 2
99 QIILUPLHGDPNQIWLPLF -0.1 2564.35 3
99 QIILYPLHGDPNQIWLPLF -0.12 2420.22 3
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1 QIILYPLHGDPNQIWLPLF -0.12 2420.23 5
1 RDNTIR 14.16 931.68 2
1 RDNTIR -13.84 903.68 2
1 RDNTIR 14.1 931.62 2
1 RNGSJ -28.05 820.46 2
2 RNGSK -27.94 676.46 2
1 SAPDPSVITLE
NSWGR 
W->Y SA -22.77 1849.19 3
1 SNTDANQLW
TLK 
W->Y QL -22.83 1510.97 2
1 SNTDANQLW
TLK 
W->Y NT -22.81 1510.98 2
1 TRIR -13.81 674.65 2
1 UNRR 0.2 895.72 2
1 UTFAFGGNYDR 23.26 1621.04 2
1 UTFAFGGNYDR 23.24 1621.03 2
99 VGLPINQR -0.05 1039.59 2
99 VGLPINQR -0.05 1039.59 2
99 VGLPINQR -0.07 1039.56 2
3 VGLPINQR -28.05 1011.59 2
1 VGLPINQR 0.91 1040.54 3
1 VGLPINQR 18.07 1057.7 2
93 VGLPINQR -0.01 1039.62 2
98 WMFJ -0.06 898.44 2
1 WMFJ 0.1 898.6 2
1 WMFJ -17.74 880.76 2
1 WMFJ 0.04 898.54 2
1 WMFJ -17.84 880.67 2
1 WMFJ -0.02 898.49 2
1 WMFJ 16.06 914.57 3
1 WMFJ -22.74 875.76 2
1 WMFJ -17.96 880.54 2
1 WMFJ 16.04 914.54 2
1 WMFK 0.14 754.55 2
1 WMFK -22.72 731.69 2
0 WMFK -17.74 736.66 2
1 YNR 23.02 618.35 2
1 YNRR -27.72 723.71 2
1 YNRR 0.22 751.64 2
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Pro Group Report: ricin on 
carpet 48hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 63 92 41.4
>95 (1.3) 1 1 63 92 41.4
>66 (0.47) 1 1 63 92 41.4
As shown: >95 
(1.30) 
1 1 63 92 41.4
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ 14.11 1018.68 2
1 ASDPSLJ 0.21 1004.78 2
1 ASDPSLJ L->M PS 18.13 1022.7 2
1 ASDPSLK 18.11 878.59 2
1 ASDPSLK 0.07 860.54 2
1 ASDPSLK K->R SD 28.09 888.57 2
1 ASDPSLK D->E SL 14.07 874.55 2
1 AVRGR -27.72 673.72 2
1 DNCLTSDSNIR 14.24 1394.89 2
1 DNTIRSNGJ -0.03 1291.68 2
1 DNTIRSNGK K->R SN 27.93 1175.54 3
1 DNTIRSNGK K->R DN 27.95 1175.57 3
1 DNTIRSNGK R->K NT -27.91 1119.7 2
1 ETVVJ -14.04 848.51 2
1 ETVVJ -0.88 861.67 2
1 ETVVJ -14.1 848.45 2
2 ETVVJILSCGPASSGQR 17.86 2036.97 3
0 ETVVK 0.23 718.66 2
0 ETVVK V->I TV 14.19 732.63 2
1 ETVVKILSCGP
ASSGQR 
E->Q TVV -0.8 1874.2 3
1 FHNGNAIQLW
PCJ 
W->Y HN -22.75 1792.21 3
1 FHNGNAIQLW
PCJ 





UI -14.25 1702.65 3
1 FQYIEGEMR 23.27 1338.9 2
  
124
1 FQYIEGEMR -14.15 1301.49 3
99 FSVYDVSILIPIIALMVYR -0.04 2355.3 3
0 GRLTTGADVR 0.05 1188.73 2
99 HEIPVLPNR -0.02 1217.69 3
99 HEIPVLPNR -0.04 1217.67 3
93 HEIPVLPNR -0.04 1217.67 3
1 ILSCGPASSGQRWMFK -0.2 1910.77 4
1 IRYNR I ->V YN -13.96 850.55 2
1 IRYNR -13.94 850.57 2
1 IRYNR -28 836.5 2
1 IRYNR -28.02 836.49 2
1 IRYNR 23.16 887.67 2
1 IRYNR 23.14 887.65 2
1 IRYNR 23.12 887.63 2
1 IRYNR 23.16 887.66 2
1 IRYNR I ->V YN -13.98 850.53 2
1 IRYNR 0 864.5 2
1 IRYNR -26.02 838.49 2
1 IVGRNGLCVDVR 0.07 1443.89 3
1 LEQLAGNLR L->M LAG 17.91 1174.59 2
99 LEQLAGNLR -0.03 1156.65 2
99 LEQLAGNLR -0.05 1156.63 2
99 LEQLAGNLR -0.03 1156.65 2




Q->E QGAFA 0.99 2403.26 3
1 LTTGADVR 0.09 975.65 2
1 LTTGADVR 14.01 989.56 3
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.8 1989.31 2
1 NDGTILNLYSGLVLDVR -26 1979.11 4
1 NGLCVDVR 18.09 1036.63 2
1 NGLCVDVR 18.07 1036.61 2
1 NGLCVDVR 0.13 1018.67 2
1 NGLCVDVR 18.11 1036.64 2
1 NGLCVDVR 18.09 1036.63 2
99 QIILUPLHGDPNQIWLPLF -0.06 2564.39 3
99 QIILYPLHGDPNQIWLPLF -0.06 2420.28 3
1 RDNTIR I ->V RD -13.8 903.73 2
1 RDNTIR 14.18 931.71 2
1 RDNTIR 14.18 931.7 2
1 RDNTIR 14.16 931.69 2
1 RNGSJ -28.05 820.47 2
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1 RNGSJ -27.75 820.76 2





WGR -13.73 1858.23 3
1 SFIICIQMISE
AAR 
Q->E AAR 1.27 1726.18 3
1 SNTDANQLWTLJR 18.15 1852.14 3
1 SNTDANQLWTLJR 0.19 1834.18 3
1 SNTDANQLW
TLK 
W->Y NT -22.81 1510.99 2
1 SNTDANQLW
TLK 
W->Y NT -22.81 1510.99 2
1 TRIR -13.79 674.67 2
82 UNRR 0.14 895.66 2
1 UNRR 0.18 895.7 2
1 UNRR 0.18 895.7 2
1 UNRR 0.16 895.69 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.07 1039.58 2
99 VGLPINQR -0.03 1039.6 2
1 VGLPINQR Q->E VG 0.91 1040.55 3
0 VGLPINQR -28.05 1011.58 3
98 WMFJ -0.04 898.46 2
1 WMFJ -22.78 875.73 2
1 WMFJ 0.04 898.55 2
1 WMFJ 0 898.5 2
1 WMFK 0.16 754.56 2
1 WMFK 0.14 754.55 2
1 YNR 23.02 618.35 2
1 YTFAFGGNUD
R 
Y->W GGN 23.28 1621.07 2
1 YTFAFGGNUDR 14.2 1611.99 3
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Pro Group Report: ricin on 
carpet 72hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 66 85 37.8
>95 (1.3) 2 2 186 225 100
>66 (0.47) 2 2 186 225 100
As shown: >95 
(1.30) 
2 2 186 225 100
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ 14.13 1018.7 2
1 ASDPSLJ 0.01 1004.59 2
1 ASDPSLK 0.07 860.54 2
1 ASDPSLK D->E SL 14.07 874.55 2
1 ASDPSLK K->R SD 28.09 888.57 2
1 DNCLTSDSNI
RETVVK 
R->K SNI -28.14 1908.83 4
1 DNTIR -13.77 747.64 2
1 DNTIRSNGJ I ->V NG -14.29 1277.42 3
1 DNTIRSNGK K->R SN 27.95 1175.57 3





TVV -13.8 2005.3 3
2 ETVVJILSCGPASSGQR 17.88 2036.99 3
1 ETVVK 14.21 732.64 2
1 ETVVK 0.01 718.45 2
0 ETVVK 0.23 718.66 2
1 ETVVKILSCGP
ASSGQR 




D->E FH 14.13 3200.77 4
1 FQYIEGEMR -15.79 1299.85 3
1 FQYIEGEMR -26.23 1289.41 3
1 FQYIEGEMR -14.13 1301.5 3
1 FQYIEGEMRT
R 
M->L YI -17.82 1554.97 3
1 FQYIEGEMRTR -17.76 1555.03 2
1 FQYIEGEMRTR -17.76 1555.02 2
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99 FSVYDVSILIPIIALMVYR -0.02 2355.32 3
1 GRLTTGADVR 0.13 1188.81 2
1 GRLTTGADVR R->K GR -27.99 1160.69 2
99 HEIPVLPNR -0.02 1217.68 3
99 HEIPVLPNR -0.02 1217.68 3
0 HEIPVLPNR -0.88 1216.83 2
1 ILSCGPASSG
QR 
I ->V SCG -13.74 1304.95 2
1 ILSCGPASSG
QR 
Q->E SCG 0.74 1319.42 4
1 IRYNR -27.84 836.66 2
1 IRYNR 23.14 887.65 2
1 IRYNR I ->V YN -13.92 850.58 1
1 IRYNR Y->F YN -15.7 848.8 2
1 IRYNR -26.02 838.49 2
1 IRYNR I ->V YN -13.8 850.71 2
1 IRYNR -28 836.51 2
1 IRYNR -13.96 850.54 2
1 IRYNR -25.94 838.56 2
99 LEQLAGNLR -0.03 1156.64 2
99 LEQLAGNLR -0.07 1156.6 2
1 LEQLAGNLR 0.01 1156.69 2




Q->E QGAFA 0.99 2403.27 3
1 LTTGADVR 0.11 975.66 2
1 LTTGADVR R-> K GA -27.93 947.63 2
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.78 1989.32 2
1 NGLCVDVR 0.15 1018.68 2
9 NGLCVDVR 0.21 1018.74 2
99 QIILUPLHGDPNQIWLPLF -0.06 2564.38 3
99 QIILYPLHGDPNQIWLPLF -0.06 2420.29 3
55 QIILYPLHGDPNQIWLPLF -0.08 2420.27 4
1 RDNTIR 14.2 931.72 2
1 RDNTIR -13.82 903.7 2
1 RDNTIR 14.2 931.73 2
1 RDNTIR 14.18 931.71 2
1 RNGSJ -28.05 820.47 2
1 RNGSK -27.94 676.47 2
1 RNGSK 27.96 732.36 2







WGR -13.75 1858.2 3
1 SNTDANQLWTLJ 13.77 1691.67 5
1 SNTDANQLWTLJR 18.21 1852.21 3
0 SNTDANQLWTLK 17.81 1551.61 4
1 SNTDANQLW
TLK 
W->Y QL -22.83 1510.97 2
1 TRIR -13.79 674.66 2
1 UNRR 0.16 895.68 2
1 UNRR -27.84 867.68 2
1 UTFAFGGNYDR 23.28 1621.07 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.01 1039.62 2
99 VGLPINQR -0.05 1039.59 2
1 VGLPINQR Q->E VG 0.93 1040.56 3
1 VGLPINQR R->K VG -28.01 1011.63 2
98 WMFJ -0.06 898.45 2
85 WMFJ -0.02 898.49 2
1 WMFJ 0.12 898.62 2
1 WMFJ 16.04 914.55 2
1 WMFJ 0 898.5 2
1 WMFJ -22.74 875.76 2
0 WMFJ -17.74 880.77 2
1 WMFK 0.16 754.56 2
1 YNR 23.04 618.36 2
1 YTFAFGGNUD
R 
Y->W GGN 23.3 1621.08 2
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Pro Group Report: ricin on 
carpet 170hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2 













% of Total Spectra 
>99 (2.0) 1 1 72 92 41.1
>95 (1.3) 1 1 72 92 41.1
>66 (0.47) 1 1 72 92 41.1
As shown: >95 
(1.30) 
1 1 72 92 41.1
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ 0.09 1004.66 2
1 ASDPSLJ 18.13 1022.71 2
1 ASDPSLK 0.07 860.55 2
1 ASDPSLK 14.15 874.62 2
1 ASDPSLK D->E SL 14.11 874.58 2
1 ASDPSLK K->R SD 28.09 888.57 2
1 DNCLTSDSNI
R 
D->E IR 14.24 1394.89 2
1 DNTIR -13.77 747.64 2
1 DNTIRSNGJ R->K RS -28.05 1263.66 3
1 DNTIRSNGJ -0.03 1291.68 2
1 DNTIRSNGK R->K NT -27.93 1119.69 2
1 DNTIRSNGK K->R SN 27.95 1175.56 3
1 DNTIRSNGK -14.07 1133.54 3
1 ETVVJ -0.86 861.68 2
1 ETVVK 28.25 746.69 2
1 ETVVK 13.99 732.42 2
0 ETVVK 0.23 718.66 2
1 FHNGNAIQLWPCJ -0.01 1814.94 3
1 FQUIEGEMR F->Y / 
M(Oxidatio
n) 
IE 15.82 1475.57 3
1 FQYIEGEMR Y->W MR 23.29 1338.92 2
1 FQYIEGEMR Y->W MR 23.27 1338.91 2
0 FQYIEGEMR E->D / I-
>V 
GE -14.13 1301.5 3
1 FQYIEGEMRT
R 







ALMV 14.18 2657.72 4
99 FSVYDVSILIPIIALMVYR -0.02 2355.32 3
1 GRLTTGADVR 0.09 1188.77 2
1 GRLTTGADVR 0.13 1188.81 2
1 HEIPVLPNR 17.8 1235.51 3
1 HEIPVLPNR -0.88 1216.82 2
99 HEIPVLPNR -0.02 1217.68 3
99 HEIPVLPNR -0.02 1217.68 3
1 HEIPVLPNRVGLPINQR 0.05 2095.26 4
1 ILSCGPASSGQR -13.78 1304.91 2
1 IRUNR 0.01 1008.63 2
1 IRYNR 23.18 887.69 2
1 IRYNR 23.16 887.66 2
1 IRYNR -27.88 836.62 2
1 IRYNR -26.02 838.49 2
1 IRYNR 23.16 887.67 2
1 IRYNR 0 864.5 2
1 IRYNR -28 836.5 2
0 IVGRNGLCVDVR -28.27 1415.54 4
99 LEQLAGNLR -0.07 1156.6 2
99 LEQLAGNLR -0.03 1156.65 2








R->K ESNQ -28.05 2530.33 4
1 LTTGADVR -27.91 947.64 2
1 LTTGADVR R->K GA -27.91 947.65 2
1 LTTGADVR 0.11 975.66 2
1 LTTGADVR 13.99 989.55 3
1 NDGTILNLYS
GLVLDVR 
Y->F LNL -15.78 1989.33 2
1 NDGTILNLYSGLVLDVR 0.22 2005.33 3
1 NGLCVDVR 0.15 1018.68 2
1 NGLCVDVR 18.07 1036.6 2
1 NGLCVDVR 18.11 1036.64 2
1 NGLCVDVR 18.11 1036.64 2
1 NGLCVDVRDGR 18.26 1364.94 2
1 NGLCVDVRD
GR 
L->M CV 17.94 1364.63 2
99 QIILUPLHGDPNQIWLPLF -0.08 2564.37 3
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99 QIILYPLHGDPNQIWLPLF -0.04 2420.3 3
1 RDNTIR 14.18 931.7 2
1 RDNTIR R->K RD -27.88 889.65 2
1 RDNTIR 14.2 931.72 2
1 RDNTIR -13.8 903.72 2
1 RDNTIR -13.86 903.67 2
1 RNGSJ -27.77 820.75 2
1 RNGSK 27.96 732.36 2
1 RNGSK -28.02 676.38 2
99 SAPDPSVITLENSWGR -0.01 1871.94 3
1 SAPDPSVITLE
NSWGR 
W->Y PDP -22.75 1849.2 3
1 SNGJCLTTUGYSPGVUVMI
UDCNTAATDATR 
UGYSPGV 22.72 4077.73 5
1 SNTDANQLW
TLK 
W->Y NT -22.79 1511 2
1 SNTDANQLW
TLK 
W->Y NT -22.79 1511 2
1 SNTDANQLW
TLKR 
W->Y NT -22.77 1667.13 2
1 TRIR -13.79 674.67 2
1 UNRR 0.18 895.71 2
1 UNRR -27.84 867.68 2
1 UNRR 0.2 895.72 2
99 VGLPINQR -0.03 1039.6 2
1 VGLPINQR 18.07 1057.71 2
1 VGLPINQR Q->E VG 0.91 1040.55 3
98 WMFJ -0.04 898.46 2
43 WMFJ -0.02 898.49 2
1 WMFJ 0.1 898.61 2
1 WMFJ -17.74 880.77 2
1 WMFJ 0 898.5 2
1 WMFJ -22.72 875.79 2
1 WMFK 0.16 754.56 2
1 YNR 23.04 618.36 2
10 YTFAFGGNYD
R 
Y->F FA -15.81 1437.87 3
0 YTFAFGGNYDRLEQLAGNLR -27.97 2420.27 5
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(B) Ricin on parquet over 170 hours  
Pro Group Report:ricin on parquet 0hour 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (61 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 17 41 67.2 
>95 (1.3) 1 1 17 41 67.2 
>66 (0.47) 1 1 17 41 67.2 
 
As shown: 
>95 (1.30) 1 1 17 41 67.2  
    
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ 0.23 1004.8 2
1 ETVVJ -0.22 862.32 2
99 FSVYDVSILIPIIALMVYR -0.02 2355.32 3
99 HEIPVLPNR -0.02 1217.68 3
99 HEIPVLPNR -0.02 1217.68 3
1 IRYNR -0.2 864.3 2
98 LEQLAGNLR -0.03 1156.64 2
1 LEQLAGNLR 0.01 1156.69 2
1 LEQLAGNLR -0.05 1156.62 2
99 LSTAIQESNQGAFASPIQLQR -0.05 2402.22 3
99 LSTAIQESNQGAFASPIQLQR 0.01 2402.28 3
99 LSTAIQESNQGAFASPIQLQR -0.01 2402.26 3
99 LSTAIQESNQGAFASPIQLQR -0.07 2402.21 3
99 NDGTILNLUSGLVLDVR -0.04 2149.17 3
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99 NDGTILNLYSGLVLDVR -0.04 2005.07 3
99 NDGTILNLYSGLVLDVR -0.02 2005.09 3
99 NDGTILNLYSGLVLDVR -0.04 2005.07 3
99 QIILUPLHGDPNQIWLPLF -0.04 2564.41 3
99 QIILYPLHGDPNQIWLPLF -0.02 2420.32 3
99 QIILYPLHGDPNQIWLPLF -0.02 2420.32 3
99 QIILYPLHGDPNQIWLPLF -0.06 2420.29 3
99 SAPDPSVITLENSWGR -0.03 1871.93 3
99 SAPDPSVITLENSWGR -0.03 1871.92 3
99 SAPDPSVITLENSWGR -0.03 1871.93 3
99 SAPDPSVITLENSWGR -0.09 1871.86 2
99 VGLPINQR -0.03 1039.61 2
99 VGLPINQR -0.03 1039.61 2
95 VGLPINQR -0.03 1039.61 2
69 VGLPINQR -0.03 1039.61 2
3 VGLPINQR -0.01 1039.62 2
22 WMFJ -0.04 898.47 2
22 WMFJ -0.06 898.45 2
3 WMFJ -0.02 898.49 2
1 WMFJ -0.02 898.49 2
1 WMFJ -0.02 898.48 2
1 WMFJ -0.02 898.49 2
1 WMFJ -0.12 898.38 2
1 WMFJNDGTILNLYSGLVLDVR -0.14 2741.35 4
1 WMFK 0.16 754.56 2
99 YTFAFGGNYDRLEQLAGNLR -0.05 2448.19 3
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99 YTFAFGGNYDRLEQLAGNLR -0.05 2448.18 3
     
Pro Group Report: ricin on parquet 2hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (48 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 19 41 85.4 
>95 (1.3) 1 1 19 41 85.4 
>66 (0.47) 1 1 19 41 85.4 
As shown: 
>95 (1.30) 1 1 19 41 85.4 
Conf Sequence Mod Zone dMass PrecMW
1 ASDPSLJ 0.23 1004.81
1 ASDPSLK -0.29 860.18
99 FSVYDVSILIPIIALMVYR -0.02 2355.33
1 HEIPVLPNR 0 1217.71
1 IRYNR 0.22 864.73
1 IRYNR 0.12 864.62
99 LEQLAGNLR 0.01 1156.68
99 LEQLAGNLR -0.03 1156.65
99 LEQLAGNLR -0.03 1156.65
99 LEQLAGNLR -0.01 1156.66
99 LEQLAGNLR -0.01 1156.67
99 LSTAIQESNQGAFASPIQLQR -0.01 2402.26
99 LSTAIQESNQGAFASPIQLQR -0.03 2402.25
99 LSTAIQESNQGAFASPIQLQR -0.05 2402.22
1 NDGTILNLUSGLVLDVR -0.06 2149.15
99 NDGTILNLYSGLVLDVR -0.02 2005.09
95 QIILUPLHGDPNQIWLPLF -0.04 2564.4
99 QIILYPLHGDPNQIWLPLF -0.04 2420.3
69 QIILYPLHGDPNQIWLPLF 0 2420.34
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1 QIILYPLHGDPNQIWLPLF -0.04 2420.3
1 RNGSK -0.22 704.19
99 SAPDPSVITLENSWGR -0.01 1871.94
99 SAPDPSVITLENSWGR -0.03 1871.93
99 SAPDPSVITLENSWGR -0.03 1871.93
22 SAPDPSVITLENSWGR -0.01 1871.95
99 UTFAFGGNYDR -0.02 1597.77
99 VGLPINQR -0.03 1039.61
99 VGLPINQR -0.03 1039.61
98 VGLPINQR -0.03 1039.61
95 VGLPINQR -0.03 1039.61
69 VGLPINQR 0.01 1039.64
22 WMFJ -0.02 898.49
9 WMFJ -0.02 898.49
3 WMFJ -0.02 898.49
3 WMFJ -0.02 898.48
1 WMFJ -0.02 898.49
1 WMFJ 0.08 898.58
1 WMFK 0.16 754.56
98 YTFAFGGNYDR -0.03 1453.64
99 YTFAFGGNYDRLEQLAGNLR 0.01 2448.24
99 YTFAFGGNYDRLEQLAGNLR -0.03 2448.2
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Pro Group Report:ricin on parquet 24hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (42 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 13 33 78.6 
>95 (1.3) 1 1 13 33 78.6 
>66 (0.47) 1 1 13 33 78.6 
 
As shown: 
>95 (1.30) 1 1 13 33 78.6  
    
Conf Sequence Mod Zone dMass PrecMW Z 
1 FQYIEGEMRTR 0.02 1572.81 3
99 FSVYDVSILIPIIALMVYR -0.04 2355.3 3
99 LEQLAGNLR -0.03 1156.64 2
22 LEQLAGNLR -0.03 1156.65 2
22 LEQLAGNLR -0.03 1156.64 2
9 LEQLAGNLR -0.03 1156.65 2
1 LEQLAGNLR 0.11 1156.78 2
1 LEQLAGNLR 0.11 1156.78 2
99 LSTAIQESNQGAFASPIQLQR -0.07 2402.2 3
99 LSTAIQESNQGAFASPIQLQR -0.07 2402.21 3
99 LSTAIQESNQGAFASPIQLQR -0.05 2402.23 3
86 LSTAIQESNQGAFASPIQLQR -0.05 2402.23 3
99 NDGTILNLYSGLVLDVR -0.04 2005.07 3
99 NDGTILNLYSGLVLDVR -0.04 2005.07 3
1 QIILUPLHGDPNQIWLPLF -0.04 2564.4 3
99 QIILYPLHGDPNQIWLPLF -0.06 2420.29 3
99 SAPDPSVITLENSWGR -0.05 1871.9 2
98 SAPDPSVITLENSWGR -0.03 1871.92 3
99 UTFAFGGNYDR -0.02 1597.76 3
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99 VGLPINQR -0.05 1039.59 2
69 VGLPINQR -0.01 1039.62 2
45 VGLPINQR -0.03 1039.6 2
1 VGLPINQR -0.03 1039.6 2
1 VGLPINQR -0.03 1039.61 2
1 VGLPINQR -0.03 1039.61 2
1 VGLPINQR -0.05 1039.58 2
22 WMFJ -0.04 898.46 2
9 WMFJ -0.02 898.48 2
1 WMFJ -0.12 898.38 2
1 WMFJ -0.02 898.48 2
1 WMFJ -0.04 898.47 2
1 WMFK 0.14 754.55 2
99 YTFAFGGNYDRLEQLAGNLR -0.03 2448.2 3
     
Pro Group Report: ricin on parquet 48hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (44 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 17 36 81.8 
>95 (1.3) 1 1 17 36 81.8 
>66 (0.47) 1 1 17 36 81.8 
As shown: 
>95 (1.30) 1 1 17 36 81.8 
Conf Sequence Mod Zone dMass PrecMW
9 FQUIEGEMR -0.02 1459.73
99 FSVYDVSILIPIIALMVYR -0.02 2355.33
9 HEIPVLPNR -0.04 1217.66
1 IRYNR -0.2 864.3
1 IRYNR 0.14 864.64
99 LEQLAGNLR -0.05 1156.62
99 LEQLAGNLR -0.03 1156.65
99 LEQLAGNLR -0.01 1156.66
95 LEQLAGNLR -0.01 1156.66
9 LEQLAGNLR -0.01 1156.66
99 LSTAIQESNQGAFASPIQLQR -0.03 2402.24
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99 LSTAIQESNQGAFASPIQLQR -0.03 2402.24
3 LSTAIQESNQGAFASPIQLQR -0.03 2402.24
1 LTTGADVR -0.27 975.28
22 NDGTILNLYSGLVLDVR -0.08 2005.03
99 NDGTILNLYSGLVLDVR -0.06 2005.05
99 QIILUPLHGDPNQIWLPLF -0.04 2564.4
99 QIILYPLHGDPNQIWLPLF -0.04 2420.3
1 QIILYPLHGDPNQIWLPLF -0.04 2420.31
1 RNGSK -0.22 704.18
99 SAPDPSVITLENSWGR -0.03 1871.93
99 UTFAFGGNYDR -0.02 1597.76
99 VGLPINQR -0.05 1039.59
98 VGLPINQR -0.01 1039.62
95 VGLPINQR -0.03 1039.6
1 VGLPINQR -0.05 1039.59
22 WMFJ -0.02 898.48
22 WMFJ -0.04 898.46
3 WMFJ -0.02 898.48
1 WMFJ -0.02 898.48
1 WMFJ 0 898.5
1 WMFJ 0 898.5
99 YTFAFGGNYDR -0.05 1453.63
99 YTFAFGGNYDRLEQLAGNLR -0.03 2448.21
99 YTFAFGGNYDRLEQLAGNLR -0.05 2448.18
45 YTFAFGGNYDRLEQLAGNLR -0.03 2448.2
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Pro Group Report: ricin on parquet 72hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (49 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 16 41 83.7 
>95 (1.3) 1 1 16 41 83.7 
>66 (0.47) 1 1 16 41 83.7 
 
As shown: 
>95 (1.30) 1 1 16 41 83.7  
    
Conf Sequence Mod Zone dMass PrecMW Z 
1 ETVVK 0.21 718.65 2
1 ETVVK 0.25 718.68 2
99 FQUIEGEMR -0.08 1459.66 3
99 FSVYDVSILIPIIALMVYR -0.12 2355.23 3
99 HEIPVLPNR -0.08 1217.63 3
99 HEIPVLPNR -0.06 1217.65 3
1 ILSCGPASSGQRWMFK -0.14 1910.82 4
99 LEQLAGNLR -0.07 1156.6 2
99 LEQLAGNLR -0.07 1156.61 2
99 LSTAIQESNQGAFASPIQLQR -0.09 2402.18 3
99 LSTAIQESNQGAFASPIQLQR -0.11 2402.16 3
99 NDGTILNLYSGLVLDVR -0.12 2004.98 3
99 NDGTILNLYSGLVLDVR -0.1 2005 3
99 NDGTILNLYSGLVLDVR -0.1 2005.01 3
9 NDGTILNLYSGLVLDVR -0.12 2004.99 3
1 NDGTILNLYSGLVLDVR 0.08 2005.18 3
99 QIILUPLHGDPNQIWLPLF -0.12 2564.33 3
95 QIILYPLHGDPNQIWLPLF -0.1 2420.25 3
22 QIILYPLHGDPNQIWLPLF -0.1 2420.24 3
99 SAPDPSVITLENSWGR -0.15 1871.81 2
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99 SAPDPSVITLENSWGR -0.07 1871.89 3
99 SAPDPSVITLENSWGR -0.07 1871.89 3
1 UNRR 0.28 895.8 2
99 VGLPINQR -0.07 1039.56 2
99 VGLPINQR -0.05 1039.58 2
95 VGLPINQR -0.07 1039.57 2
69 VGLPINQR -0.05 1039.59 2
45 VGLPINQR -0.05 1039.59 2
9 VGLPINQR -0.05 1039.58 2
9 VGLPINQR -0.05 1039.58 2
9 VGLPINQR -0.05 1039.58 2
1 VGLPINQR -0.05 1039.58 2
69 WMFJ -0.04 898.46 2
22 WMFJ -0.04 898.46 2
22 WMFJ -0.1 898.41 2
1 WMFJ -0.04 898.47 2
1 WMFJ -0.04 898.47 2
1 WMFJ -0.06 898.45 2
86 WMFJNDGTILNLYSGLVLDVR -0.12 2741.36 3
99 YTFAFGGNYDRLEQLAGNLR -0.13 2448.11 3
99 YTFAFGGNYDRLEQLAGNLR -0.11 2448.13 3
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Pro Group Report: ricin on parquet 170hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins 
within ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (41 total spectra): 
Confidence 
(ProtScore) 











>99 (2.0) 1 1 16 37 90.2 
>95 (1.3) 1 1 16 37 90.2 
>66 (0.47) 1 1 16 37 90.2 
 
As shown: 
>95 (1.30) 1 1 16 37 90.2  
    
Conf Sequence Mod Zone dMass PrecMW Z 
1 ASDPSLJ 0.21 1004.78 2
1 ASDPSLK -0.03 860.45 2
99 FQUIEGEMR -0.06 1459.68 3
99 FQUIEGEMR -0.04 1459.71 3
99 FSVYDVSILIPIIALMVYR -0.12 2355.23 3
99 HEIPVLPNR -0.04 1217.67 3
99 HEIPVLPNR -0.06 1217.65 3
99 LSTAIQESNQGAFASPIQLQR -0.07 2402.21 3
99 LSTAIQESNQGAFASPIQLQR -0.09 2402.18 3
99 LSTAIQESNQGAFASPIQLQR -0.11 2402.17 3
99 LSTAIQESNQGAFASPIQLQR -0.09 2402.19 3
99 NDGTILNLYSGLVLDVR -0.08 2005.02 3
95 NDGTILNLYSGLVLDVR -0.04 2005.07 3
9 NDGTILNLYSGLVLDVR -0.06 2005.05 3
99 QIILUPLHGDPNQIWLPLF -0.1 2564.35 3
99 QIILYPLHGDPNQIWLPLF -0.06 2420.28 3
99 QIILYPLHGDPNQIWLPLF -0.08 2420.26 3
99 QIILYPLHGDPNQIWLPLF -0.08 2420.27 3
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1 RNGSJ -0.11 848.4 2
99 SAPDPSVITLENSWGR -0.07 1871.88 2
99 SAPDPSVITLENSWGR -0.07 1871.89 3
99 SAPDPSVITLENSWGR -0.07 1871.88 3
99 SAPDPSVITLENSWGR -0.05 1871.9 3
1 UNRR 0.26 895.79 2
99 VGLPINQR -0.05 1039.59 2
99 VGLPINQR -0.03 1039.6 2
98 VGLPINQR -0.03 1039.6 2
95 VGLPINQR -0.03 1039.61 2
69 VGLPINQR -0.03 1039.6 2
69 VGLPINQR -0.03 1039.6 2
22 VGLPINQR -0.05 1039.59 2
45 WMFJ -0.04 898.46 2
3 WMFJ -0.02 898.48 2
1 WMFJ -0.04 898.47 2
99 WMFJNDGTILNLYSGLVLDVR -0.1 2741.39 3
99 YTFAFGGNYDRLEQLAGNLR -0.09 2448.15 3
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(C) SEB on carpet over 170 hours   
Pro Group Report: SEB on carpet 0hour 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (184 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 89 162 88 
>95 (1.3) 1 1 89 162 88 
>66 (0.47) 2 2 113 184 100 
As shown: 
>95 (1.30) 1 1 89 162 88 
 
Conf Sequence Mod Zone dMass PrecMW Z
1 DTJ -0.02 650.36 2
99 DVJIEVYLTTJ -0.04 1740.01 3
99 DVJIEVYLTTJ -0.02 1740.03 3
99 DVJIEVYLTTJ -0.06 1739.99 3
99 DVJIEVYLTTJ 0.02 1740.06 3
1 DVJIEVYLTTJ Y->W JIE 22.94 1762.98 4
1 DVJIEVYLTTK 27.86 1623.81 3
1 FDQSJYLMMYNDNJ 
F->Y / 





Phosphoryl) YN 80.01 2164 4










Q(Deamidation) FWYD 1 3328.57 5
76 FIENENSFWYDMMPAPGDJFDQSJ 0 3327.56 4
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Q(Deamidation) FIE 1.02 3328.59 5
99 FIENENSFWYDMMPAPGDJFDQSJ -0.08 3327.49 3
37 FTGLMENMJ -0.02 1357.69 3
7 FTGLMENMJ 0 1357.71 3
1 FTGLMENMJ -0.84 1356.87 2
1 FTGLMENMJ 0 1357.7 3
1 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ -0.02 1357.69 3
99 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ N(Deamidation) ME 1.02 1358.72 3
99 FTGLMENMJ 0 1357.71 3
99 FTGLMENMJ -0.02 1357.69 3
99 FTGLMENMJ -0.02 1357.69 3
99 FTGLMENMJ -0.08 1357.62 2
99 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ -0.02 1357.69 3
99 FTGLMENMJ 0 1357.7 3
93 FTGLMENMJ 0.02 1357.72 3
82 FTGLMENMJ -0.02 1357.69 3
82 FTGLMENMJ 0 1357.7 3
37 FTGLMENMJ 0 1357.7 3
99 HULVJ -0.05 1090.65 2
1 HULVJ 0.01 1090.7 3
1 HULVKNJ 18.04 1350.86 2
99 HYLVJ 0 946.59 3
99 HYLVJ -0.04 946.54 3
99 HYLVJ 0 946.59 3
21 HYLVJ -0.12 946.46 2
1 HYLVJNJ Y->H YL -26.02 1306.81 2
1 HYLVJNK 80.08 1268.81 2
1 HYLVJNK 80.06 1268.78 2
1 HYLVKNJ 14.04 1202.77 2
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.08 1124.7 2
1 HYLVKNK 13.9 1058.52 2
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.08 1124.7 2
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.02 1124.65 2
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99 IEVYLTTJ -0.03 1253.73 2
98 IEVYLTTJ -0.01 1253.74 3
98 IEVYLTTJ -0.01 1253.75 3
85 IEVYLTTJ 0.01 1253.77 3
1 IEVYLTTKJ -0.28 1381.57 3
1 JLUEFNNSPYETGYIJ 1.02 2542.39 5
1 JLYEFNNSPUETGYIK Y->F EFN -15.72 2381.55 4
99 JVTAQELDYLTR -0.03 1723.94 3
99 JVTAQELDYLTR 0.01 1723.98 3
98 JVTAQELDYLTR E->Q EL -1.03 1722.94 3
1 JVTAQELDYLTR -0.05 1723.93 3
1 KVTAQELDULTR E->Q VTA -0.97 1723 3
1 LGNUDNVR N(Deamidation) VR 1.19 1238.86 2
1 LGNUDNVR N(Deamidation) VR 1.17 1238.85 2
1 LGNUDNVRVEFK 0.18 1741.13 3
1 LGNUDNVRVEFK 18.2 1759.14 3
1 LGNYDNVRVEFJ 0 1740.95 4
99 LGNYDNVRVEFJ 0.02 1740.97 4
2 LGNYDNVRVEFJ 0.02 1740.96 3
99 LGNYDNVRVEFJ -0.12 1740.83 2
1 LUEFNNSPYETGYIK -0.04 2125.03 3
1 LUEFNNSPYETGYIK 28.3 2153.36 3
99 LYEFNNSPUETGYIJ -0.14 2269.03 3
10 LYEFNNSPUETGYIK -0.08 2124.98 3
95 LYEFNNSPYETGYIJ -0.02 2125.05 3
48 LYEFNNSPYETGYIJ 0 2125.06 3
1 LYEFNNSPYETGYIJ 0 2125.06 3
1 MUJ -0.1 872.42 2
1 MUJ 16.12 888.65 2
1 MUJ 0.04 872.57 2
1 MUKR 16.13 900.64 2
1 MVDSJ 0.08 866.57 2
1 MVDSJDVK K->R VK 28.21 1236.88 2
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1 MVDSK 28.23 750.61 2
1 MVDSKDVJ M(Oxidation) DV 16.17 1224.84 2
1 MVDSKDVJ 0.11 1208.78 2
1 MVDSKDVK 14.17 1078.75 2
1 MVDSKDVK 28.21 1092.78 2
1 MYK 16.17 600.49 2
1 MYKR -18.01 722.41 2
1 NJDLADK 0.06 1090.68 3
1 NKDLADK N(Deamidation) DL 1.1 947.63 2
99 NLLSFDVQTNJ -0.07 1565.81 2
1 NLLSFDVQTNK 1 1422.77 3
1 NLLSFDVQTNKJ 28.08 1722.04 4
1 SIDQFLUFDLIYSIKDTJ L->M DTJ 18.08 2658.53 4
1 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1.06 2641.5 4
1 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1 2641.44 4
88 SIDQFLUFDLIYSIKDTJ 0.04 2640.48 4
1 SIDQFLUFDLIYSIKDTJ L->M SI 18.06 2658.51 5
3 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1.1 2641.54 4
4 SIDQFLUFDLIYSIKDTJ 0.02 2640.46 4
99 SIDQFLUFDLIYSIKDTJ 0 2640.44 4
24 SIDQFLUFDLIYSIKDTJ 0.02 2640.46 4
99 SIDQFLYFDLIUSIJ -0.07 2296.21 3
1 SIDQFLYFDLIUSIK L->M FDL 18.23 2170.41 3
99 SIDQFLYFDLIUSIKDTJ 0 2640.44 4
98 SIDQFLYFDLIUSIKDTJ -0.04 2640.41 4
95 SIDQFLYFDLIUSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1 2641.44 4
24 SIDQFLYFDLIUSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 0.98 2641.43 4
4 SIDQFLYFDLIUSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1 2641.44 4
99 SIDQFLYFDLIYSIJ 0.01 2152.18 3
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99 SIDQFLYFDLIYSIJ 0.01 2152.18 3
99 SIDQFLYFDLIYSIJ -0.09 2152.08 2
99 SIDQFLYFDLIYSIJ 0.03 2152.2 3
99 SIDQFLYFDLIYSIJ -0.01 2152.16 3
99 SIDQFLYFDLIYSIJ 0.05 2152.23 3
99 SIDQFLYFDLIYSIJ 0.03 2152.21 3
99 SIDQFLYFDLIYSIJ 0.03 2152.21 3
99 SIDQFLYFDLIYSIJ 0.03 2152.21 3
99 SIDQFLYFDLIYSIJ 0.01 2152.19 3
97 SIDQFLYFDLIYSIJ 0.03 2152.2 3
1 SIDQFLYFDLIYSIJ F->Y IJ 16.23 2168.41 3
48 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1 2641.44 4
99 SIDQFLYFDLIYSIJDTJ 0 2640.44 4
95 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.02 2641.46 4
99 SIDQFLYFDLIYSIJDTJ 0.02 2640.46 4
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) YFD 1.02 2641.47 4
99 SIDQFLYFDLIYSIJDTJ 0.04 2640.49 4
99 SIDQFLYFDLIYSIJDTJ -0.02 2640.43 3
1 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.02 2641.47 4
3 SIDQFLYFDLIYSIK Y->H FL -26.29 1981.78 3
1 SITVR 79.97 798.42 2
1 SSKFTGLMENMJ M->L EN -18.18 1641.68 3
1 TCMUGGVTEHNGNQLDKYR M->L TC -18.25 2454.92 3





Q(Deamidation) IN 1.26 1573.05 2
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1 TNDINSHQTDKR 1.04 1572.82 3
1 UJDJ 0.06 1128.77 2
1 UKDJ -0.12 984.49 3
1 ULMMUNDNK M(Oxidation) LM 16.26 1639.08 3





Q(Deamidation) FSJ 0.87 2850.31 3
99 VFEDGJNLLSFDVQTNJ -0.05 2385.25 3
1 VFEDGK F->Y DG 15.75 853.18 2
1 VFEDGK -14.13 823.31 2
1 VFEDGK -0.93 836.5 2
99 VLUDDNHVSAINVJ N(Deamidation) AIN 0.98 2019.11 4
17 VLUDDNHVSAINVJ 1 2019.13 4
1 VLUDDNHVSAINVJ N(Deamidation) AIN 1 2019.13 4
1 VLUDDNHVSAINVJ 1.16 2019.28 3
1 VLUDDNHVSAINVJ 0 2018.13 4
99 VLYDDNHVSAINVJ 0.21 1874.23 3
97 VLYDDNHVSAINVJ 0.01 1874.03 3
1 VTAQELDULTRHYLVK 0.19 2236.45 3
1 YJDJ -16.06 968.55 3
1 YJDJ 80.1 1064.71 2
1 YKDJ D->E KD 13.99 854.49 2
1 YLMMUNDNK 0.01 1478.72 3
96 YLMMYNDNJ 0.01 1478.72 3
1 YLMMYNDNJ 0.03 1478.74 3
99 YLMMYNDNJ -0.13 1478.59 2
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Pro Group Report: SEB on carpet 2hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (129 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 74 109 84.5 
>95 (1.3) 1 1 74 109 84.5 
>66 (0.47) 1 1 74 109 84.5 
 
As shown: 
>95 (1.30) 1 1 74 109 84.5  
    





Q(Deamidation) DK 0.95 2517.11 4
1 DLADJUK 17.72 1301.47 3
1 DLADK 18.02 722.41 2
1 DTKLGNYDNVR -16.27 1421.47 3
1 DTKLGNYDNVR L->M KLG 17.83 1455.56 4
99 DVJIEVYLTTJ 0 1740.05 3
99 DVJIEVYLTTJ -0.06 1739.99 3
99 DVJIEVYLTTJ 0 1740.04 3





Phosphoryl) MM 80.05 2164.04 4
9 FIENENSFWYDMMPAPGDJ M->L ENE -17.85 2560.33 3










Q(Deamidation) FIE 1.04 3328.61 5
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99 FTGLMENMJ N(Deamidation) ME 1 1358.71 3
99 FTGLMENMJ 0 1357.7 3
1 FTGLMENMJ 0 1357.71 3
1 FTGLMENMJ 0.02 1357.72 3
1 FTGLMENMJ 18.04 1375.74 3
1 FTGLMENMJ 15.98 1373.68 3
99 FTGLMENMJ -0.08 1357.63 3
99 FTGLMENMJ 0.02 1357.73 3
99 HULVJ -0.01 1090.68 3
1 HULVJ 25.87 1116.56 2
99 HYLVJ 0 946.59 3
1 HYLVJ 26.02 972.6 3
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.06 1124.69 2
1 IEVULTTJ -0.05 1397.8 3
99 IEVYLTTJ -0.05 1253.7 2
1 IEVYLTTKJ 13.72 1395.56 3
1 IEVYLTTKK Y->H IE -26.3 1211.44 3
99 JLYEFNNSPYETGYIJ -0.1 2397.17 3
5 JVTAQELDULTR -0.03 1868.05 3
99 JVTAQELDYLTR -0.01 1723.97 4
99 JVTAQELDYLTR 0.01 1723.99 3
99 JVTAQELDYLTR 0.03 1724 3
99 JVTAQELDYLTR -0.05 1723.93 3
12 JVTAQELDYLTR 0.01 1723.99 3
1 JVTAQELDYLTR 0.03 1724 3
3 KVTAQELDYLTR 80.23 1660.1 3
1 LGNUDNVRVEFJ 1 1886.05 4
1 LGNUDNVRVEFK K->R UD 28.28 1769.22 2
55 LGNYDNVRVEFJ 0 1740.95 4
1 LGNYDNVRVEFJ 0 1740.95 3
99 LGNYDNVRVEFJ -0.06 1740.89 2
77 LGNYDNVRVEFJ 0.12 1741.06 4
1 LUEFNNSPYETGYIJ -0.02 2269.14 4
99 LYEFNNSPUETGYIJ -0.06 2269.1 3
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99 LYEFNNSPYETGYIJ -0.1 2124.97 3
10 LYEFNNSPYETGYIJ -0.02 2125.05 3
99 LYEFNNSPYETGYIJ 0 2125.07 3
1 MVDSJDVJ M(Oxidation) DV 16.15 1368.93 2
1 MVDSJDVJ M(Oxidation) DV 16.19 1368.96 2
1 MVDSJDVK 0.05 1208.73 2
1 MVDSKDVJ 28.21 1236.88 3
1 MVDSKDVJ -0.07 1208.61 3
1 MVDSKDVJ K->R KD 28.17 1236.84 2
1 MVDSKDVK 13.97 1078.55 2
1 MVDSKDVK 14.19 1078.76 2
1 MYK 80.09 664.41 2





Q(Deamidation) SF 0.99 1566.87 3
1 NLLSFDVQTNJ 0.05 1565.93 3
99 NLLSFDVQTNJ -0.03 1565.84 3
99 NLLSFDVQTNJJ -0.08 1837.99 3
53 NLLSFDVQTNJJ 0.02 1838.08 4
1 SIDQFLUFDLIUSIJ 
S(O-
Phosphoryl) SI 79.75 2520.13 4
99 SIDQFLUFDLIYSIJ 0.01 2296.28 3
24 SIDQFLUFDLIYSIJDTK 
Q->E / 
Q(Deamidation) DQFL 1.04 2641.48 4
48 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1.04 2641.48 4
24 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1 2641.44 4
1 SIDQFLUFDLIYSIKDTJ L->M SI 18.08 2658.52 4
1 SIDQFLUFDLIYSIKDTJ L->M YSIK 18.08 2658.53 5
99 SIDQFLYFDLIUSIJ 
Q->E / 
Q(Deamidation) LY 1.01 2297.28 4
68 SIDQFLYFDLIUSIJDTJ 
Q->E / 
Q(Deamidation) QFL 1.02 2785.57 5
0 SIDQFLYFDLIUSIKDTK Y->W DQF 22.74 2519.09 3
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99 SIDQFLYFDLIYSIJ 0.01 2152.19 3
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.02 2641.47 4
99 SIDQFLYFDLIYSIJDTJ 0 2640.45 3
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.04 2641.48 4
1 SITVRVFEDGK -0.71 1393.06 2





Q(Deamidation) TN 1.18 1416.87 3
1 UKDK 13.99 854.49 2
1 ULMMYNDNKMVDSJ Y->H ULM -25.92 2157.17 4
1 ULMMYNDNKMVDSK L->M KMV 18.22 2057.2 5
0 ULMMYNDNKMVDSK L->M KMV 18.2 2057.18 5
1 URSITVR -0.21 1181.51 3
85 VFEDGJNLLSFDVQTNJ 0.03 2385.32 4
99 VLUDDNHVSAINVJ -0.1 2018.03 3
96 VLUDDNHVSAINVJ -0.02 2018.11 4
3 VLUDDNHVSAINVJ 1.02 2019.15 4
3 VLUDDNHVSAINVJ 1 2019.12 4
1 VLUDDNHVSAINVJ N(Deamidation) AIN 1.02 2019.14 4
99 VLYDDNHVSAINVJ -0.05 1873.97 3
62 VLYDDNHVSAINVJ 0.03 1874.05 4
62 VLYDDNHVSAINVJ 0.01 1874.02 3
7 VLYDDNHVSAINVJ 0.03 1874.05 3
1 VLYDDNHVSAINVJ Y->W LY 23.25 1897.26 3
99 VTAQELDULTR -0.08 1595.81 3
1 YLMMUNDNJ -15.74 1607.08 2
1 YLMMUNDNK 0.01 1478.72 3
1 YLMMUNDNK -25.79 1452.93 2
99 YLMMYNDNJ -0.07 1478.64 2
1 YLMMYNDNJ 0.01 1478.73 3
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1 YLMMYNDNKMVDSJ 18.22 2057.21 3
1 YLMMYNDNKMVDSK -15.69 1879.18 3
1 YVDVFGANYYUQCUFSJ Y->H YV -25.93 2679.41 5
1 YVDVFGANYYUQCUFSJ Y->H YV -25.91 2679.43 5
Pro Group Report: SEB on carpet 27hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (169 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 89 143 84.6 
>95 (1.3) 1 1 89 143 84.6 
>66 (0.47) 2 2 119 169 100 
 
As shown: 
>95 (1.30) 1 1 89 143 84.6  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADJYJ 23.08 1306.83 2
1 DLADJYJ 23.1 1306.84 2
1 DLADK 18.02 722.41 2
1 DLADKYK 23.14 1018.69 2
1 DTKLGNYDNVR N(Deamidation) VR 1.17 1438.91 2
1 DTKLGNYDNVR N(Deamidation) VR 1.17 1438.91 2
99 DVJIEVYLTTJ -0.1 1739.95 2
99 DVJIEVYLTTJ -0.02 1740.03 4
99 DVJIEVYLTTJ 0 1740.04 3
99 DVJIEVYLTTJ 0 1740.05 3
99 DVJIEVYLTTJ 0 1740.04 3
1 DVKIEVYLTTJ E->Q LTT -0.86 1595.08 3
1 FDQSJULMMYNDNK 
F->Y / 
M(Oxidation) ULM 16.26 2244.37 4
1 FDQSJYLMMYNDNK 79.99 2163.98 4





































Q(Deamidation) FIE 1.04 3328.61 4
99 FIENENSFWYDMMPAPGDJFDQSJ -0.06 3327.5 3
99 FIENENSFWYDMMPAPGDJFDQSJ 0.04 3327.6 5
62 FTGLMENMJ -0.06 1357.65 3
82 FTGLMENMJ 0.08 1357.78 3
62 FTGLMENMJ 0 1357.71 3
1 FTGLMENMJ 0 1357.7 3
1 FTGLMENMJ 0.02 1357.72 3
99 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ 0 1357.7 3
99 FTGLMENMJ -0.02 1357.69 3
1 FTGLMENMJ -1.06 1356.64 3
99 FTGLMENMJ -0.1 1357.61 3
99 FTGLMENMJ 0 1357.7 3
97 FTGLMENMJ -0.02 1357.68 3
97 FTGLMENMJ -0.02 1357.69 3
93 FTGLMENMJ 0 1357.71 3
1 HULVJ -0.01 1090.68 3
1 HULVJNK 18.06 1350.88 2
1 HULVK 26 972.58 2
1 HULVKNJ L->M KN 18.04 1350.86 2
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99 HYLVJ 0.02 946.6 3
99 HYLVJ 0.02 946.6 3
99 HYLVJ -0.06 946.53 2
43 HYLVJ 0 946.59 3
9 HYLVJNK 80.14 1268.88 2
1 HYLVJNK 0.1 1188.82 2
1 HYLVJNK 80.12 1268.85 2
1 HYLVJNK 
Y(O-
Phosphoryl) YL 80.18 1268.9 2
1 HYLVK -15.96 786.52 2
1 HYLVKNK 14.08 1058.71 2
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.08 1124.71 2
99 IEVYLTTJ -0.03 1253.73 2
1 IEVYLTTJ 23.07 1276.83 2
1 IEVYLTTJJ 23.02 1548.97 3
1 IEVYLTTJK 13.8 1395.65 3
99 JLUEFNNSPYETGYIK N(Deamidation) UEF 1 2398.26 4
99 JLYEFNNSPYETGYIJ -0.1 2397.17 3
17 JVTAQELDULTR 
Q->E / 
Q(Deamidation) AQ 1.03 1869.1 4
68 JVTAQELDYLTR E->Q EL -0.99 1722.98 3
99 JVTAQELDYLTR -0.01 1723.97 3
99 JVTAQELDYLTR 0.01 1723.99 3
99 JVTAQELDYLTR -0.07 1723.91 3
1 JVTAQELDYLTR E->Q EL -0.87 1723.11 3
1 LGNUDNVR N(Deamidation) VR 1.15 1238.82 2
1 LGNUDNVR N(Deamidation) VR 1.15 1238.82 2
1 LGNUDNVR N(Deamidation) VR 1.19 1238.87 2
1 LGNUDNVRVEFJ -0.1 1884.95 3
18 LGNYDNVR 0.92 1094.49 3
1 LGNYDNVR -15.98 1077.59 2
13 LGNYDNVRVEFJ 0 1740.95 3
13 LGNYDNVRVEFJ 0.06 1741.01 4
1 LGNYDNVRVEFJ 0.08 1741.02 4
1 LGNYDNVRVEFK 0.04 1596.89 3
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1 LUEFNNSPYETGYIJ 0 2269.17 4
99 LYEFNNSPUETGYIJ -0.12 2269.05 3
99 LYEFNNSPYETGYIJ -0.02 2125.05 3
99 LYEFNNSPYETGYIJ 0 2125.06 3
0 MUJ 16.1 888.63 2
1 MUJ 16.08 888.6 2
1 MUKR 16.11 900.63 2
2 MVDSJ -18.02 848.47 2
1 MVDSJ M(Oxidation) DS 16.08 882.56 2
1 MVDSJ D->E / V->I DS 14.1 880.59 2
1 MVDSJDVK M(Oxidation) JD 16.15 1224.82 2
1 MVDSJDVK K->R VK 28.19 1236.86 2
1 MVDSK 28.05 750.43 2
1 MVDSKDVJ 0.09 1208.76 2
1 MVDSKDVJ M(Oxidation) DV 16.13 1224.81 2
1 MVDSKDVJ 0.11 1208.78 2
2 MVDSKDVK 80.17 1144.74 2
76 MVDSKDVK 80.21 1144.79 2
1 MVDSKDVK 28.17 1092.74 2
1 MVDSKDVK 28.15 1092.73 2
1 MVDSKDVK 16.13 1080.7 2
1 NJDLADJ 18.16 1252.88 2
1 NKDLADJ 0.06 1090.68 3
1 NKJ 1.21 677.67 2
99 NLLSFDVQTNJ -0.07 1565.8 2
2 NLLSFDVQTNJ -0.01 1565.86 3





Q(Deamidation) QT 1.18 1422.94 2
1 SIDQFLUFDLIUSIJ 
S(O-
Phosphoryl) SI 79.79 2520.17 4
1 SIDQFLUFDLIUSIJ 
S(O-
Phosphoryl) LU 79.81 2520.18 5
10 SIDQFLUFDLIYSIKDTJ 0.02 2640.46 4




Q-> E / 
Q(Deamidation) QFL 0.98 2785.52 5
1 SIDQFLYFDLIUSIKDTJ L->M USIK 18.06 2658.51 5
99 SIDQFLYFDLIYSIJ 0.03 2152.2 3
99 SIDQFLYFDLIYSIJ 0.05 2152.23 3
99 SIDQFLYFDLIYSIJ -0.01 2152.17 3
99 SIDQFLYFDLIYSIJ 0.01 2152.19 3
99 SIDQFLYFDLIYSIJ -0.01 2152.17 3
1 SIDQFLYFDLIYSIJ 
Q->E / 
Q(Deamidation) IYS 0.93 2153.11 4
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) YFD 1.02 2641.46 4
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.08 2641.52 4
99 SIDQFLYFDLIYSIJDTJ -0.18 2640.27 4





Phosphoryl) ED 80.23 1474 2
1 TNDINSHQTDKR 1.2 1572.98 3
1 ULMMYNDNKMVDSJ 79.82 2262.9 5
1 UVDVFGANUUYQCYFSJ 0.89 2850.32 3
1 UVDVFGANUYYQCYFSJ Y->H UY -25.95 2679.38 5
1 VEFK 28.21 693.61 2
1 VFEDGJ 14.04 995.58 3
1 VFEDGJNLLSFDVQTNJ 0.03 2385.33 4
99 VFEDGJNLLSFDVQTNJ -0.05 2385.24 3
1 VFEDGK -14.11 823.33 2
99 VLUDDNHVSAINVJ -0.1 2018.02 3
7 VLUDDNHVSAINVJ N(Deamidation) AIN 1 2019.13 4
1 VLUDDNHVSAINVJ N(Deamidation) AIN 1.02 2019.15 4
1 VLYDDNHVSAINVJ -15.77 1858.24 3
99 VTAQELDULTR -0.04 1595.85 3
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1 VTAQELDYLTRHYLVJ E->Q VT -1.09 2235.17 4
1 YJDJ 14.04 998.64 2
1 YKDJ D->E KD 13.99 854.49 2
1 YKDJ 14.13 854.62 2
1 YLMMUNDNJ -0.06 1622.77 3
99 YLMMYNDNJ -0.07 1478.64 2
29 YLMMYNDNJ 0.01 1478.72 3
1 YLMMYNDNK 0.27 1334.89 2
Pro Group Report: SEB on carpet 50hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (170 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 103 137 80.6 
>95 (1.3) 1 1 103 137 80.6 
>66 (0.47) 1 1 103 137 80.6 
As shown: 
>95 (1.30) 1 1 103 137 80.6 
 
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADJUK L->M AD 17.76 1301.5 3
1 DLADK 18.04 722.43 2
1 DTKLGNYDNVR K->R DT 27.75 1465.48 3
99 DVJIEVYLTTJ 0.04 1740.09 3
99 DVJIEVYLTTJ -0.04 1740.01 3
99 DVJIEVYLTTJ 0.06 1740.11 3
1 DVKIEVYLTTJ E->Q LTT -0.86 1595.08 3
1 FDQSJ 16.28 927.78 2
1 FDQSJULMMUNDNK 18.16 2390.37 4
1 FDQSJULMMUNDNK 18.16 2390.37 4
1 FDQSJYLMMYNDNJ 
F-> Y / 
M(Oxidation) DQS 16.26 2244.37 4
99 FIENENSFWYDMMPAPGDJ 0.07 2578.25 3
99 FIENENSFWYDMMPAPGDJFDQSJ 0.02 3327.59 3
99 FTGLMENMJ 0.04 1357.75 3
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37 FTGLMENMJ 0.06 1357.77 3
1 FTGLMENMJ 18.08 1375.79 3
1 FTGLMENMJ 0.06 1357.76 3
1 FTGLMENMJ 0.04 1357.75 3
1 FTGLMENMJ 0.04 1357.74 3
99 FTGLMENMJ -0.04 1357.66 3
1 FTGLMENMK K->R MK 27.78 1241.38 2
1 HULVJ 0.03 1090.73 3
99 HULVJ 0.01 1090.7 2
0 HULVKNK 13.84 1202.56 3
99 HYLVJ 0.02 946.61 3
99 HYLVJ 0 946.58 3
1 HYLVJNJ Y->F JN -16.06 1316.77 4
1 HYLVJNJ 80.14 1412.96 2
1 HYLVJNK 80.14 1268.86 2
1 HYLVJNK Y->W YL 22.76 1211.49 3
1 HYLVJNK 80.18 1268.91 2
1 HYLVK 14.3 816.78 2
1 HYLVK 26.04 828.52 2
1 HYLVKNK 18.18 1062.81 2
1 HYLVKNK 18.16 1062.78 2
1 HYLVKNK 0.16 1044.8 2
1 HYLVKNK 26.22 1070.84 2
1 HYLVKNK -25.86 1018.77 2
1 HYLVKNK 18.16 1062.79 2
99 IEVULTTJ -0.03 1397.82 3
1 IEVULTTJ 0.13 1397.98 3
1 IEVULTTKJ 80.02 1605.97 3
99 IEVYLTTJ 0.03 1253.79 3
99 IEVYLTTJ 0.01 1253.77 2
98 IEVYLTTJ 0.03 1253.79 2
1 IEVYLTTKJ 13.88 1395.73 3
1 IEVYLTTKJ 13.78 1395.63 3
1 IEVYLTTKJ 23.04 1404.88 3
1 IEVYLTTKK E->D / I->V YL -13.96 1223.78 2
1 IEVYLTTKK -0.92 1236.82 3
1 IEVYLTTKK 23.22 1260.97 3
99 JLYEFNNSPYETGYIJ -0.04 2397.22 3
1 JTCMYGGVTEHNGNQLDK L->M TEH 18.18 2300.29 5
1 JTNDINSHQTDK D->E ND 13.93 1701.81 3
1 JVTAQELDULTR 
Q->E / 
Q(Deamidation) AQ 1.09 1869.17 4





Q(Deamidation) EL 1.05 1725.02 3
99 JVTAQELDYLTR 0.07 1724.05 3
99 JVTAQELDYLTR 0.07 1724.04 3
0 KVTAQELDULTR 18.05 1742.03 3
97 LGNUDNVRVEFJ 0.1 1885.14 4
99 LGNYDNVRVEFJ 0.12 1741.07 4
30 LGNYDNVRVEFJ 0.12 1741.07 4
2 LGNYDNVRVEFJ 0.1 1741.04 4
1 LGNYDNVRVEFJ 0.08 1741.03 3
1 LGNYDNVRVEFK E->Q NV -0.9 1595.95 3
1 LGNYDNVRVEFK 0.08 1596.93 3
24 LUEFNNSPYETGYIJ 0.1 2269.26 4
99 LYEFNNSPUETGYIJ -0.06 2269.11 3
99 LYEFNNSPYETGYIJ 0.06 2125.13 3
99 LYEFNNSPYETGYIJ 0.02 2125.09 3
1 LYEFNNSPYETGYIK -13.72 1967.25 4
1 MUJR -27.84 1000.78 2
1 MVDSJDVJ M(Oxidation) DV 16.17 1368.94 2
1 MVDSJDVK 0.15 1208.82 2
1 MVDSK 28.27 750.64 2
1 MVDSK 28.03 750.4 2
1 MVDSKDVJ M(Oxidation) DV 16.05 1224.72 2
1 MVDSKDVK 28.23 1092.8 2
1 MVDSKDVK 14.21 1078.78 2
1 MYJ 23.21 751.63 2
1 MYJR -27.89 856.63 2
1 MYJR 16.17 900.69 2
1 MYKR -17.69 722.72 2
1 NJDLADJ N(Deamidation) DL 1.04 1235.77 3
1 NKDLADJ 0.1 1090.72 3
1 NKDLADK 14.06 960.58 3
1 NKDLADK D->E DL 13.98 960.51 2
1 NKDLADK 1.12 947.64 2
51 NLLSFDVQTNJ 0.07 1565.94 3
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99 NLLSFDVQTNJ 0.01 1565.88 3





Q(Deamidation) FD 1.1 1839.17 4
99 NLLSFDVQTNJJ 0.06 1838.12 3
99 NLLSFDVQTNJJ 1.1 1839.17 4
1 NLLSFDVQTNK -0.28 1421.48 3
1 NLLSFDVQTNKJ 28.16 1722.12 4
1 SIDQFLUFDLIUSIJ 
S(O-
Phosphoryl) SI 79.91 2520.28 5
1 SIDQFLUFDLIYSIJ Y->F SI -15.99 2280.29 4
1 SIDQFLUFDLIYSIKDTK Y->W SI 22.8 2519.15 3
99 SIDQFLYFDLIUSIJ 
Q->E / 
Q(Deamidation) LY 0.89 2297.17 4
1 SIDQFLYFDLIYSIJ 
Q->E / 
Q(Deamidation) SI 1.09 2153.26 4
99 SIDQFLYFDLIYSIJ 0.07 2152.24 3
99 SIDQFLYFDLIYSIJ 0.09 2152.27 3
99 SIDQFLYFDLIYSIJ 0.01 2152.19 3
99 SIDQFLYFDLIYSIJDTJ -0.02 2640.42 3
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.1 2641.54 4
1 SITVR 80.09 798.54 2
5 SSJFTGLMENMJ N(Deamidation) LM 0.92 1804.88 4
1 SSJFTGLMENMK M->L TGL -18.14 1641.73 3
1 SSK 28.15 492.42 1
1 TCMYGGVTEHNGNQLDK -15.83 1994.08 3
1 TCMYGGVTEHNGNQLDKYR R->K KY -27.73 2301.34 4
1 ULMMUNDNJ 0 1766.93 3
7 ULMMUNDNK 0.06 1622.88 4












Q(Deamidation) YQC 1.25 2706.59 5
1 VEFJNK 1.25 1052.88 2
1 VEFKNK -13.8 893.72 2





Q(Deamidation) VF 1.11 2386.4 4
99 VLUDDNHVSAINVJ -0.04 2018.08 3
1 VLUDDNHVSAINVJ 1.1 2019.23 5
1 VLUDDNHVSAINVJ 1.1 2019.23 5
1 VLUDDNHVSAINVJ N(Deamidation) VJ 1.1 2019.23 4
0 VLUDDNHVSAINVJ 14.28 2032.4 3
93 VLUDDNHVSAINVJ N(Deamidation) AIN 1.06 2019.19 4
99 VLYDDNHVSAINVJ -0.03 1873.99 3
3 VLYDDNHVSAINVJ N(Deamidation) DDN 1.11 1875.13 4
1 VTAQELDULTRHYLVJ E->D ULT -14.23 2366.12 5
1 VTAQELDYLTRHYLVJ H->Y VT 25.71 2261.97 5
1 YKDJ -25.83 814.67 2
1 YKDK -15.77 680.62 2
99 YLMMYNDNJ -0.05 1478.66 2
1 YLMMYNDNJ 0.07 1478.78 3
1 YLMMYNDNKMVDSK 0.71 1895.59 4
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Pro Group Report: SEB on carpet 74hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (130 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 76 107 82.3 
>95 (1.3) 1 1 76 107 82.3 
>66 (0.47) 1 1 76 107 82.3 
 
As shown: 
>95 (1.30) 1 1 76 107 82.3  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADJ L->M AD 18.18 866.66 1
1 DTKLGNYDNVR -16.29 1421.44 3
99 DVJIEVYLTTJ 0.04 1740.08 3
99 DVJIEVYLTTJ 0.02 1740.06 3
17 DVJIEVYLTTJ 0.06 1740.11 3
17 DVKIEVULTTJ 0.08 1740.12 3





Q(Deamidation) FIE 1.1 3328.67 4
99 FIENENSFWYDMMPAPGDJFDQSJ 0.04 3327.6 3
1 FTGLMENMJ -0.82 1356.88 3
1 FTGLMENMJ -0.82 1356.88 3
1 FTGLMENMJ 0.04 1357.75 3
1 FTGLMENMJ -0.84 1356.86 2
1 FTGLMENMJ E->D FT -14.24 1343.47 3
1 FTGLMENMJ 0.04 1357.75 3
1 FTGLMENMJ 18.08 1375.79 3
99 FTGLMENMJ -0.04 1357.66 3
99 FTGLMENMJ N(Deamidation) ME 1.04 1358.75 3
99 FTGLMENMJ 0.04 1357.74 3
99 FTGLMENMJ 0.06 1357.76 3
3 FTGLMENMJ 0.08 1357.78 3
1 FTGLMENMK 27.98 1241.59 3
99 HULVJ -0.01 1090.69 3
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1 HULVJ 25.89 1116.58 2
1 HULVK 14.28 960.86 2
99 HYLVJ -0.02 946.57 2
99 HYLVJ 0.06 946.64 3
1 HYLVJ 26.22 972.81 2
1 HYLVKNK 14.12 1058.74 2
1 HYLVKNK 18.18 1062.81 2
1 HYLVKNK 18.18 1062.81 2
1 HYLVKNK -25.86 1018.76 2
1 HYLVKNK 
Y(O-
Phosphoryl) KN 80.16 1124.78 2
21 IEVULTTJ -0.03 1397.82 3
85 IEVYLTTJ 0.03 1253.78 2
99 IEVYLTTJ -0.03 1253.73 2
1 IEVYLTTKJ V->I VY 13.8 1395.65 3
1 IEVYLTTKJ 13.84 1395.69 3
99 JLUEFNNSPYETGYIK -0.02 2397.25 3
90 JLUEFNNSPYETGYIK -0.1 2397.17 4
1 JLYEFNNSPYETGYIJ 1.1 2398.37 4
99 JVTAQELDYLTR E->Q EL -0.95 1723.02 3
99 JVTAQELDYLTR 0.01 1723.99 4
99 JVTAQELDYLTR 0.03 1724.01 3
99 JVTAQELDYLTR -0.01 1723.97 3
99 JVTAQELDYLTR 0.07 1724.04 3
1 KTNDINSHQTDJ D->E DIN 13.97 1701.85 3
1 KVTAQELDULTR E->Q VTA -0.97 1723 3
1 LGNUDNVR N(Deamidation) VR 1.19 1238.87 2
1 LGNUDNVR N(Deamidation) VR 1.23 1238.91 2
37 LGNUDNVRVEFJ 0.06 1885.1 4
1 LGNYDNVRVEFJ 0.1 1741.04 3
99 LGNYDNVRVEFJ 0.1 1741.04 4
2 LGNYDNVRVEFJ 0.08 1741.02 3
1 LGNYDNVRVEFJ E->Q VE -0.82 1740.12 4
10 LUEFNNSPYETGYIJ N(Deamidation) UE 1.04 2270.21 4
99 LYEFNNSPUETGYIJ -0.02 2269.15 3
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99 LYEFNNSPYETGYIJ 0.06 2125.13 3
99 LYEFNNSPYETGYIJ -0.04 2125.03 3
1 MVDSK 28.27 750.64 2
1 MVDSKDVJ M(Oxidation) DV 16.13 1224.81 2
1 MVDSKDVK 28.25 1092.83 2
1 MVDSKDVK 28.23 1092.8 2
1 MYK 15.97 600.29 2
1 MYK 16.27 600.58 2
1 MYKR -17.81 722.6 2
1 NKDLADJ 0.1 1090.73 3
7 NKDLADJ 0.12 1090.74 3
1 NKDLADK 13.98 960.51 2










Q(Deamidation) FD 1.1 1839.16 4
99 NLLSFDVQTNJJ 0.04 1838.11 4
1 SIDQFLUFDLIUSIJ 
S(O-
Phosphoryl) SI 79.99 2520.37 4
1 SIDQFLUFDLIYSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1.12 2641.56 4
1 SIDQFLUFDLIYSIKDTJ L->M SI 18.1 2658.54 4
99 SIDQFLYFDLIUSIJ 0.03 2296.3 3
1 SIDQFLYFDLIUSIKDTJ F->Y YFD 16.06 2656.5 5
99 SIDQFLYFDLIYSIJ 0.11 2152.29 3
99 SIDQFLYFDLIYSIJ 0.03 2152.21 3
99 SIDQFLYFDLIYSIJ 0.09 2152.26 3
99 SIDQFLYFDLIYSIJDTJ 0.04 2640.49 3
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) YFD 1.1 2641.54 4
0 SITVR 0.25 718.71 2
1 TCMUGGVTEHNGNQLDJYR E->Q GVTE -0.91 2616.37 4
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1 TCMYGGVTEHNGNQLDJ H->Y TC 25.77 2179.78 3
1 TCMYGGVTEHNGNQLDJ Y->W TC 22.77 2176.78 3
1 ULMMUNDNJ -0.02 1766.91 3
99 ULMMYNDNJ 0.12 1622.94 3
1 ULMMYNDNJ 0.06 1622.89 3
1 URSITVR -0.11 1181.6 3





Q(Deamidation) VF 1.11 2386.4 4
0 VFEDGK 27.95 865.38 2
99 VLUDDNHVSAINVJ 0.02 2018.14 4
93 VLUDDNHVSAINVJ N(Deamidation) AIN 1.08 2019.21 4
0 VLUDDNHVSAINVJ N(Deamidation) AIN 1.06 2019.19 4
99 VLYDDNHVSAINVJ -0.05 1873.95 3
97 VLYDDNHVSAINVJ 0.09 1874.1 3
1 VLYDDNHVSAINVJ 23.15 1897.17 4
10 VTAQELDYLTR 1.01 1452.78 2
1 YJDJ 0.28 984.88 2
0 YLMMUNDNKMVDSK -15.8 2023.19 4
99 YLMMYNDNJ -0.01 1478.71 2
76 YLMMYNDNJ 0.05 1478.76 3





Q(Deamidation) NY 0.95 2850.38 3
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Pro Group Report: SEB on parquet 170hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (109 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 74 88 80.7 
>95 (1.3) 1 1 74 88 80.7 
>66 (0.47) 1 1 74 88 80.7 
 
As shown: 
>95 (1.30) 1 1 74 88 80.7  
    





Q(Deamidation) DK 1.21 2661.47 5
1 DLADJYJ -0.22 1283.52 3
1 DLADK 18.04 722.42 2
1 DLADKYK -15.8 979.74 2
1 DLADKYK -25.86 969.69 2
1 DTJ 14.02 664.41 2
99 DVJIEVYLTTJ -0.04 1740 2





Q(Deamidation) DNK 1.1 2229.21 4
99 FIENENSFWYDMMPAPGDJFDQSJ -0.02 3327.54 4
99 FIENENSFWYDMMPAPGDJFDQSJ 0 3327.56 3
99 FTGLMENMJ 0.02 1357.72 3
7 FTGLMENMJ 0.02 1357.72 3
99 FTGLMENMJ -0.08 1357.63 3
1 FTGLMENMK -0.9 1212.71 2
99 HULVJ -0.01 1090.69 2
1 HULVJ 0.03 1090.72 3
1 HULVJ 25.87 1116.57 2
7 HULVJ 0.01 1090.7 3
1 HULVK 13.9 960.48 2
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0 HULVKNK 28.12 1216.85 2
99 HYLVJ 0 946.59 2
1 HYLVJNJ 80.22 1413.04 2
9 HYLVJNK 80.14 1268.87 2
1 HYLVKNK 80.04 1124.66 2
1 HYLVKNK -25.86 1018.76 2
68 IEVULTTJ -0.03 1397.83 3
1 IEVULTTJ -14.17 1383.68 3
0 IEVULTTKK V->I TT 13.74 1395.58 3
99 IEVYLTTJ -0.09 1253.66 2
1 IEVYLTTK V->I LT 13.89 1123.55 2
1 IEVYLTTKK -26.26 1211.48 3
1 JLYEFNNSPYETGYIK 16.1 2269.27 4
1 JVTAQELDULTR 14.21 1882.29 3
3 JVTAQELDULTR 1.05 1869.12 4
99 JVTAQELDYLTR 0.03 1724 3
99 JVTAQELDYLTR E->Q EL -1.01 1722.97 3
99 JVTAQELDYLTR -0.07 1723.92 2
1 LGNUDNVR N(Deamidation) VR 1.23 1238.9 2
1 LGNUDNVR N(Deamidation) VR 1.21 1238.88 2
1 LGNUDNVRVEFJ 0.04 1885.09 4
1 LGNUDNVRVEFK F->Y FK 15.92 1756.87 4
1 LGNYDNVR 1.18 1094.75 2
1 LGNYDNVR -15.96 1077.6 2
1 LGNYDNVRVEFJ 0.12 1741.06 4
99 LUEFNNSPYETGYIJ 0.06 2269.22 4
99 LYEFNNSPUETGYIJ -0.08 2269.09 3
99 LYEFNNSPYETGYIJ 0.04 2125.11 3
99 LYEFNNSPYETGYIJ -0.06 2125.01 3
10 LYEFNNSPYETGYIJ 0.04 2125.11 3
1 MVDSJDVK K->R VK 28.25 1236.92 2
1 MVDSKDVJ M(Oxidation) DV 16.17 1224.85 2
1 MVDSKDVK 13.99 1078.56 2
1 MVDSKDVK 28.21 1092.79 2
1 MYJR 0.09 884.6 2
1 NKDLADK -0.04 946.48 2
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99 NLLSFDVQTNJ -0.05 1565.82 2
96 NLLSFDVQTNJ 0.01 1565.88 3
82 NLLSFDVQTNJJ 1.02 1839.09 4
99 NLLSFDVQTNJJ -0.02 1838.05 2
1 NLLSFDVQTNK -0.26 1421.51 3
1 NLLSFDVQTNKJ 80.24 1774.2 3
1 SIDQFLUFDLIYSIKDTK Y->F KDTK -15.88 2480.47 5
99 SIDQFLYFDLIUSIJ 
Q->E / 
Q(Deamidation) DQF 0.89 2297.17 4
99 SIDQFLYFDLIUSIKDTJ 0.04 2640.49 3
99 SIDQFLYFDLIYSIJ 0.05 2152.22 3
99 SIDQFLYFDLIYSIJ 0.03 2152.2 3
10 SIDQFLYFDLIYSIJDTK Y->W DQF 22.82 2519.16 3
1 SITVRVFEDGK -14.31 1379.46 2
1 TCMYGGVTEHNGNQLDJ E->Q TC -1.27 2152.74 5
1 UKDK 14.01 854.5 2
1 ULMMUNDNJ -0.02 1766.9 3
1 ULMMUNDNKMVDSJ L->M NDN 18.1 2345.29 4
1 VEFJNJ -14.19 1181.55 3
99 VFEDGJNLLSFDVQTNJ -0.07 2385.22 3
1 VFEDGJNLLSFDVQTNJ 0.03 2385.33 4
99 VLUDDNHVSAINVJ -0.06 2018.07 3
99 VLUDDNHVSAINVJ 0 2018.13 4
99 VLUDDNHVSAINVJ N(Deamidation) AIN 1.04 2019.16 4
99 VLYDDNHVSAINVJ -0.07 1873.94 3
99 VTAQELDULTR -0.04 1595.85 3
1 YJDJ 22.98 1007.59 2
1 YKDJ -16.25 824.24 2
1 YKDJ 23.13 863.62 2
1 YLMMUNDNJ M(Oxidation) MM 16.1 1638.93 3
99 YLMMYNDNJ -0.01 1478.71 2
1 YLMMYNDNJ Y->H YL -25.95 1452.77 3
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1 YLMMYNDNKMVDSK -15.69 1879.18 3
(D) SEB on parquet over 170 hours   
Pro Group Report: SEB on parquet 0hour 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (160 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 81 134 83.8 
>95 (1.3) 1 1 81 134 83.8 
>66 (0.47) 2 2 109 160 100 
 
As shown: 
>95 (1.30) 1 1 81 134 83.8  
    





Phosphoryl) DVFGA 79.99 3028.45 5
1 DLADJUK 27.82 1311.57 4
1 DLADJYK 
Y(O-
Phosphoryl) JY 79.94 1219.59 4
1 DTKLGNUDNVR L->M TK 17.69 1599.52 5
99 DVJIEVYLTTJ -0.08 1739.97 4
99 DVJIEVYLTTJ 0.08 1740.12 4
99 DVJIEVYLTTJ 0.14 1740.18 3
99 DVJIEVYLTTJ 0.02 1740.06 3
99 DVJIEVYLTTJ 0.08 1740.12 3
99 DVJIEVYLTTJ 0.12 1740.17 3
99 DVJIEVYLTTJ 0.08 1740.13 3
99 DVJIEVYLTTJ 0.1 1740.15 3
1 DVKIEVULTTK E->Q IE -0.86 1595.08 3







Phosphoryl) DQS 80.21 2164.21 4





Q(Deamidation) MMPAPG 1.12 3328.68 4
29 FIENENSFWYDMMPAPGDJFDQSJ E->Q NENS -1.2 3326.37 4
97 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ N(Deamidation) ME 1.1 1358.81 3
99 FTGLMENMJ 0.04 1357.75 3
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ 0.08 1357.78 2
99 FTGLMENMJ 0.08 1357.79 3
99 FTGLMENMJ -0.02 1357.69 2
99 FTGLMENMJ 0.08 1357.79 3
62 FTGLMENMJ 0.08 1357.79 3
1 FTGLMENMJ -1 1356.71 3
1 FTGLMENMJ E->D NM -14.16 1343.55 4
1 FTGLMENMJ E->Q ME -0.96 1356.74 3
1 FTGLMENMK E->D FT -13.98 1199.62 4
62 HULVJ 0.05 1090.75 3
37 HULVJ 0.01 1090.7 3
3 HULVJ 0.03 1090.72 3
1 HULVJ 0.05 1090.75 3
99 HYLVJ 0.04 946.63 3
85 HYLVJ 0.02 946.6 3
85 HYLVJ 0.06 946.64 3
85 HYLVJ 0.06 946.64 2
43 HYLVJ 0.04 946.62 3
1 HYLVJ -15.86 930.73 2
9 HYLVJ 0.04 946.63 3
99 HYLVJ 0.06 946.65 3
1 HYLVJ -26.28 920.3 2
99 HYLVJ 0.08 946.66 3
1 HYLVJ 22.92 969.5 3
1 HYLVJNJ 22.82 1355.64 3
1 HYLVKNK K->R LV 27.94 1072.57 2
0 IEVULTTKK V->I UL 13.8 1395.65 3
99 IEVYLTTJ -0.03 1253.73 2
99 IEVYLTTJ 0.07 1253.82 2
1 IEVYLTTJJ -26.24 1499.71 5
1 IEVYLTTJJ -16.1 1509.84 5
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1 IEVYLTTKJ Y->H TK -26.22 1355.63 3
1 IEVYLTTKK -26.24 1211.51 3
99 JVTAQELDYLTR 0.13 1724.11 3
99 JVTAQELDYLTR 0.11 1724.08 3
99 JVTAQELDYLTR 0.11 1724.08 3
99 JVTAQELDYLTR 0.03 1724 3
99 JVTAQELDYLTR 0.09 1724.06 3
99 JVTAQELDYLTR 0.11 1724.08 3
1 KTCMYGGVTEHNGNQLDJ D->E / V->I KT 14.28 2296.39 4
1 KTNDINSHQTDK -14.15 1529.63 3
1 KVTAQELDYLTR K->R YL 27.71 1607.58 4
1 KVTAQELDYLTR -0.19 1579.68 3
1 KVTAQELDYLTR K->R KVT 28.21 1608.08 3
1 LGNUDNVRVEFJ 0.12 1885.16 3
1 LGNUDNVRVEFJ 0.22 1885.27 4
2 LGNYDNVRVEFJ 0.04 1740.98 3
1 LGNYDNVRVEFJ 0.18 1741.12 4
1 LGNYDNVRVEFJ 0.18 1741.12 4
1 LGNYDNVRVEFK Y->W VE 22.82 1619.66 4
99 LYEFNNSPUETGYIJ 0.08 2269.25 3
99 LYEFNNSPUETGYIJ 0.14 2269.3 4
99 LYEFNNSPUETGYIK 0.16 2125.22 3
99 LYEFNNSPYETGYIJ 0.12 2125.18 3
99 LYEFNNSPYETGYIJ 0.14 2125.21 3
99 LYEFNNSPYETGYIJ 0.14 2125.2 3
96 LYEFNNSPYETGYIJ N(Deamidation) NNS 1.24 2126.3 3
1 LYEFNNSPYETGYIJ 18.1 2143.17 4
1 MYK 27.99 612.3 2
1 MYKR -25.71 714.7 2
1 NJDLADJ N(Deamidation) AD 0.88 1235.61 3
1 NKDLADJ 0.14 1090.77 3
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1 NLLSFDVQTNJ L->M DV 17.71 1583.58 4
1 NLLSFDVQTNJ D->E / V->I QTN 13.87 1579.74 4
1 NLLSFDVQTNJ L->M DV 17.69 1583.56 4
99 NLLSFDVQTNJJ 0.02 1838.08 3
99 NLLSFDVQTNJJ 0.1 1838.17 3
99 NLLSFDVQTNJJ 0.12 1838.18 4
99 NLLSFDVQTNJJ 0.18 1838.24 3
1 NLLSFDVQTNKK L->M SF 17.78 1567.65 4
1 SIDQFLUFDLIUSIKDTJ I ->V SID -14.1 2770.45 5
1 SIDQFLUFDLIYSIKDTJ L->M SI 18.22 2658.66 5
1 SIDQFLUFDLIYSIKDTJ L->M SI 18.18 2658.63 4
99 SIDQFLYFDLIUSIKDTJ 0.22 2640.66 4
99 SIDQFLYFDLIYSIJ 0.15 2152.33 3
99 SIDQFLYFDLIYSIJ 0.11 2152.28 3
99 SIDQFLYFDLIYSIJ 0.15 2152.33 3
99 SIDQFLYFDLIYSIJ 0.09 2152.26 3
97 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.2 2641.65 4
99 SIDQFLYFDLIYSIJDTJ 0.04 2640.49 4
99 SIDQFLYFDLIYSIJDTJ 0.12 2640.56 3
99 SIDQFLYFDLIYSIJDTJ 0.1 2640.54 3
0 SITVR 80.05 798.51 2
1 SITVRVFEDGK -14.11 1379.66 3
1 SSJ 0.13 608.5 2
1 SSKFTGLMENMK -0.11 1515.64 4





Phosphoryl) HQ 79.78 1639.57 4
1 UKDJ -0.02 984.58 3
99 ULMMYNDNJ 0.1 1622.93 3
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1 ULMMYNDNKMVDSJ 79.88 2262.97 5
1 UVDVFGANYYYQCUFSJ Y->H CU -25.81 2679.52 4
2 VEFJ 0.09 809.58 2
1 VEFJNJ -14.11 1181.62 3
1 VEFJNJ F->Y VE 15.91 1211.64 3
1 VEFKNK 16.2 923.73 2
99 VFEDGJNLLSFDVQTNJ -0.03 2385.27 3
1 VFEDGK 14.29 851.72 2
1 VFEDGK 14.23 851.67 2
99 VLUDDNHVSAINVJ 0.12 2018.24 3
17 VLUDDNHVSAINVJ N(Deamidation) AIN 1.16 2019.29 4
17 VLUDDNHVSAINVJ N(Deamidation) AIN 1.12 2019.24 5
99 VLYDDNHVSAINVJ 0.13 1874.15 3
99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ 0.11 1874.12 3
99 VLYDDNHVSAINVJ 0.03 1874.04 3
1 VLYDDNHVSAINVK N(Deamidation) NVK 0.85 1730.77 4
1 VTAQELDULTR R->K LT -28.3 1567.58 4
99 YLMMYNDNJ 0.05 1478.77 2
96 YLMMYNDNJ 0.11 1478.83 3
1 YLMMYNDNK 1.03 1335.64 4
1 YRSITVR -13.87 1023.74 2
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Pro Group Report: SEB on parquet 2hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (166 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 80 146 88 
>95 (1.3) 1 1 80 146 88 
>66 (0.47) 1 1 80 146 88 
 
As shown: 
>95 (1.30) 1 1 80 146 88  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADJUK 28.02 1311.77 4
1 DLADJUK -0.12 1283.63 3
1 DTJ 14.08 664.47 2
1 DTKLGNUDNVR L->M TK 17.75 1599.58 5
1 DTKLGNYDNVR Y->F DT -16.17 1421.56 3
99 DVJIEVYLTTJ 0.1 1740.15 3
99 DVJIEVYLTTJ 0 1740.05 3
99 DVJIEVYLTTJ 0.1 1740.15 3
99 DVJIEVYLTTJ 0.18 1740.22 3
99 DVJIEVYLTTJ 0.12 1740.16 3















Q(Deamidation) FIE 1.24 3328.8 4
95 FTGLMENMJ N(Deamidation) ME 1.12 1358.83 3
82 FTGLMENMJ 0.1 1357.8 3
5 FTGLMENMJ E->D GL -14.06 1343.65 3
3 FTGLMENMJ E->Q NM -0.96 1356.75 3
1 FTGLMENMJ E->D NM -14.14 1343.56 4
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99 FTGLMENMJ E->Q ME -0.76 1356.95 3
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ -0.02 1357.69 2
1 FTGLMENMJ E->Q FTG -0.94 1356.76 3
99 FTGLMENMJ 0.02 1357.73 3
99 FTGLMENMJ 0.08 1357.79 2
99 FTGLMENMJ 0.12 1357.83 3
97 FTGLMENMJ 0.12 1357.82 3
37 HULVJ 0.07 1090.77 3
7 HULVJ 0.05 1090.75 3
37 HULVJ 0.03 1090.72 3
99 HYLVJ 0.08 946.66 3
99 HYLVJ 0.06 946.65 2
99 HYLVJ 0.06 946.65 3
99 HYLVJ 0.08 946.66 3
94 HYLVJ 0.02 946.61 3
85 HYLVJ 0.06 946.64 3
1 HYLVJNJ Y->W HY 22.86 1355.69 3
1 HYLVJNJ 22.84 1355.67 3
1 HYLVJNJ -15.74 1317.09 3
1 HYLVKNK K->R LV 27.96 1072.58 2
1 IEVULTTJ 0.11 1397.97 3
1 IEVULTTK 17.85 1271.6 3
1 IEVULTTK 17.89 1271.65 3
1 IEVULTTKJ E->D / I->V TTK -14.28 1511.66 4
1 IEVULTTKK E->D / I->V UL -14.2 1367.64 4
0 IEVULTTKK V->I UL 13.8 1395.65 3
1 IEVYLTTJ V->I TT 14.01 1267.77 4
85 IEVYLTTJ -0.07 1253.68 3
94 IEVYLTTJ 0.09 1253.85 3
99 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.09 1253.84 2
99 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.03 1253.78 2
1 I EVYLTTJJ Y->F LTT -16.28 1509.67 5
1 IEVYLTTKK -14.1 1223.65 4
12 JVTAQELDYLTR 
Q->E / 
Q(Deamidation) EL 1.09 1725.07 3
99 JVTAQELDYLTR 0.17 1724.15 3
99 JVTAQELDYLTR 0.15 1724.12 3
99 JVTAQELDYLTR 0.11 1724.09 3
99 JVTAQELDYLTR 0.13 1724.1 3
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99 JVTAQELDYLTR 0.13 1724.1 3
99 JVTAQELDYLTR E->Q EL -0.91 1723.06 3
99 JVTAQELDYLTR 0.01 1723.99 3
99 JVTAQELDYLTR E->Q EL -0.93 1723.05 3
99 JVTAQELDYLTR 0.03 1724.01 3
94 JVTAQELDYLTR E->Q EL -0.87 1723.11 3
1 KTCMUGGVTEHNGNQLDK D->E / V->I KT 14.26 2296.37 4
1 KTNDINSHQTDK -14.17 1529.6 3





Phosphoryl) KTN 79.73 1623.5 4
1 KVTAQELDYLTR K->R KVT 27.71 1607.59 4
1 KVTAQELDYLTR 28.27 1608.14 3
90 LGNYDNVRVEFJ 0.2 1741.15 4
1 LGNYDNVRVEFJ 0.2 1741.15 4
1 LGNYDNVRVEFJ 1.18 1742.13 3
1 LGNYDNVRVEFK 22.72 1619.57 5
10 LUEFNNSPYETGUIK 0.2 2269.36 4
99 LYEFNNSPUETGYIJ 0.16 2269.33 3
48 LYEFNNSPUETGYIJ N(Deamidation) ETGY 1.04 2270.21 4
99 LYEFNNSPYETGUIK 0.2 2125.26 3
99 LYEFNNSPYETGYIJ 0.12 2125.18 3
99 LYEFNNSPYETGYIJ 0.12 2125.18 3
88 LYEFNNSPYETGYIJ 0.2 2125.27 3
0 MVDSJ D->E / V->I DS 14.16 880.64 2
1 MVDSK 28.07 750.44 2
1 MYKR -17.77 722.64 2
1 MYKR -25.71 714.7 2
0 NJDLADJ 0.92 1235.65 3
0 NJDLADJ 1.1 1235.82 3
1 NJDLADK 0.14 1090.76 3
  
178
1 NKDLADK 13.96 960.49 2
1 NKDLADK 13.98 960.51 2
1 NLLSFDVQTNJ 17.71 1583.59 4
99 NLLSFDVQTNJ -0.01 1565.87 2
99 NLLSFDVQTNJ 0.09 1565.97 3
5 NLLSFDVQTNJJ 0.12 1838.19 4
13 NLLSFDVQTNJJ 0.14 1838.21 4
99 NLLSFDVQTNJJ 0.12 1838.19 3
99 NLLSFDVQTNJJ 0.02 1838.09 2





Q(Deamidation) FD 1.08 1839.15 4
1 NLLSFDVQTNKJ 28.18 1722.14 4
1 NLLSFDVQTNKJ 28.3 1722.27 3
1 NLLSFDVQTNKK -0.14 1549.72 5
1 NLLSFDVQTNKK L->M SF 17.72 1567.58 4
1 NLLSFDVQTNKK 17.8 1567.67 4
99 SIDQFLUFDLIYSIJ 0.13 2296.41 3
99 SIDQFLYFDLIUSIJ 0.09 2296.37 3
99 SIDQFLYFDLIYSIJ 0.15 2152.32 3
99 SIDQFLYFDLIYSIJ 0.21 2152.38 3
99 SIDQFLYFDLIYSIJ 0.03 2152.2 3
99 SIDQFLYFDLIYSIJ 0.23 2152.41 3
99 SIDQFLYFDLIYSIJ -0.03 2152.15 2
99 SIDQFLYFDLIYSIJ 0.23 2152.4 3
99 SIDQFLYFDLIYSIJDTJ 0.16 2640.61 3
0 SITVR 80.07 798.53 2
1 SITVRVFEDGK E->D / I->V SIT -14.11 1379.67 3
1 SITVRVFEDGK 27.79 1421.57 3
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1 SITVRVFEDGK 13.87 1407.65 4
1 SSJ 0.21 608.58 2





Phosphoryl) INS 79.82 1639.6 4
1 ULMMUNDNK 17.92 1640.74 4
1 VEFJ -13.73 795.77 2
1 VEFKNK 1.22 908.75 3
1 VFEDGJ 14.12 995.67 3
99 VLUDDNHVSAINVJ 0.02 2018.14 4
99 VLUDDNHVSAINVJ 0.14 2018.27 3
62 VLUDDNHVSAINVJ N(Deamidation) HVS 1.2 2019.32 4
1 VLUDDNHVSAINVJ N(Deamidation) AIN 1.12 2019.24 5
99 VLYDDNHVSAINVJ 0.13 1874.15 3
99 VLYDDNHVSAINVJ 0.17 1874.19 3
99 VLYDDNHVSAINVJ 0.05 1874.06 3
99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ N(Deamidation) HVS 1.15 1875.16 4
99 VLYDDNHVSAINVJ 0.15 1874.16 3
1 VLYDDNHVSAINVK Y->H SAI -25.99 1703.92 3
16 VTAQELDULTR 0.06 1595.95 3
1 YJDJ -26.12 958.49 2
1 YKDJ 
Y(O-
Phosphoryl) YK 79.81 920.31 2
1 YKDK 80.25 776.65 2
1 YLMMUNDNJMVDSJ 17.86 2345.04 3
99 YLMMYNDNJ 0.11 1478.82 2
99 YLMMYNDNJ 0.03 1478.74 2
53 YLMMYNDNJ 0.13 1478.84 3
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Pro Group Report: SEB on parquet 27hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (152 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 80 129 84.9 
>95 (1.3) 1 1 80 129 84.9 
>66 (0.47) 1 1 80 129 84.9 
 
As shown: 
>95 (1.30) 1 1 80 129 84.9  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADJYK 
Y(O-
Phosphoryl) JY 80.04 1219.69 4
1 DLADKYJ 0.06 1139.7 2
1 DLADKYK 18.16 1013.71 3
1 DLADKYK -26.04 969.51 3
1 DTJ 14.1 664.48 2
0 DTJLGNYDNVR 80.13 1661.96 3
99 DVJIEVYLTTJ 0.02 1740.06 3
99 DVJIEVYLTTJ 0.12 1740.16 3
99 DVJIEVYLTTJ 0.14 1740.19 3
99 DVJIEVYLTTJ 0.12 1740.17 4
16 DVKIEVYLTTJ 0.04 1595.99 3










Q(Deamidation) FWYD 1.28 3328.85 4
99 FTGLMENMJ 0.12 1357.82 3
99 FTGLMENMJ 0.12 1357.83 3
99 FTGLMENMJ 0.12 1357.82 3
99 FTGLMENMJ 0.08 1357.78 3
99 FTGLMENMJ 0 1357.71 2
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99 FTGLMENMJ 0.1 1357.8 2
1 FTGLMENMJ 18.02 1375.72 4
72 FTGLMENMJ N(Deamidation) ME 1.12 1358.83 3
62 FTGLMENMJ 0.12 1357.83 3
3 FTGLMENMJ 0.1 1357.8 3
1 FTGLMENMJ M->L ME -17.86 1339.84 4
1 FTGLMENMK 1.2 1214.8 3
1 FTGLMENMK 
F->Y / 
M(Oxidation) FT 16.06 1229.67 3
1 HULVJ 0.09 1090.79 3
7 HULVJ 0.07 1090.76 3
37 HULVJ 0.03 1090.73 3
99 HULVJ 0.07 1090.77 3
1 HULVK 13.96 960.54 2
1 HULVKNJ 13.96 1346.78 2
43 HYLVJ 0.06 946.64 3
1 HYLVJ -26.28 920.31 2
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.06 946.65 2
85 HYLVJ 0.04 946.62 3
1 HYLVJNJ Y->W HY 22.86 1355.69 3
1 HYLVJNJ 22.82 1355.64 3
1 HYLVJNJ 22.9 1355.73 3
1 HYLVKNK 27.98 1072.6 2
1 HYLVKNK 23.14 1067.76 3
1 IEVULTTKJ E->D / I->V TTK -14.26 1511.69 4
1 IEVULTTKK E->Q UL -1.2 1380.64 2
99 IEVYLTTJ 0.03 1253.79 2
99 IEVYLTTJ 0.09 1253.85 3
99 IEVYLTTJ 0.09 1253.84 2
85 IEVYLTTJ 0.11 1253.87 3
1 IEVYLTTJ E->D / I->V TT -13.87 1239.88 4
1 IEVYLTTJ 17.89 1271.65 3
1 IEVYLTTJ L->M YL 17.87 1271.63 3
1 IEVYLTTKK -14.1 1223.65 4





Phosphoryl) NS 79.67 1767.54 4
99 JVTAQELDYLTR 0.15 1724.12 3
99 JVTAQELDYLTR 0.03 1724.01 3
99 JVTAQELDYLTR 0.11 1724.08 3
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99 JVTAQELDYLTR 0.13 1724.11 3
99 JVTAQELDYLTR 0.13 1724.1 3
99 JVTAQELDYLTR 0.13 1724.1 3
99 JVTAQELDYLTR 0.17 1724.14 3
1 KTNDINSHQTDK I ->V KTN -14.19 1529.59 5
1 KTNDINSHQTDK -14.13 1529.64 3
1 LGNUDNVRVEFJ -28.06 1856.99 4
1 LGNYDNVR 14.12 1107.69 2
30 LGNYDNVRVEFJ 0.18 1741.12 3
2 LGNYDNVRVEFJ 0.06 1741.01 3
1 LGNYDNVRVEFK 22.72 1619.56 5
99 LYEFNNSPUETGYIJ 0.12 2269.29 3
24 LYEFNNSPUETGYIJ N(Deamidation) ETGY 1.16 2270.32 4
72 LYEFNNSPUETGYIK 0.2 2125.27 3
99 LYEFNNSPYETGYIJ 0.14 2125.2 3
99 LYEFNNSPYETGYIJ 0.16 2125.22 3
1 MVDSJ D->E / V->I DS 14.16 880.64 2
1 MYJ 15.91 744.32 2
1 MYK 28.01 612.32 2
1 NJDLADJ 1.12 1235.84 3
1 NJDLADK 13.76 1104.39 2
0 NKDLADK 1.18 947.71 2
1 NKDLADK 1.18 947.71 2
1 NLLSFDVQTNJ L->M DV 17.71 1583.58 4
96 NLLSFDVQTNJ 0.09 1565.96 3
99 NLLSFDVQTNJ -0.03 1565.85 2
99 NLLSFDVQTNJ 0.11 1565.99 3
99 NLLSFDVQTNJJ 0.04 1838.11 3
99 NLLSFDVQTNJJ 0.12 1838.19 3







Q(Deamidation) FD 1.14 1839.2 4
1 NLLSFDVQTNKK -0.14 1549.73 5
99 SIDQFLYFDLIYSIJ 0.21 2152.39 3
99 SIDQFLYFDLIYSIJ 0.07 2152.25 3
99 SIDQFLYFDLIYSIJ 0.11 2152.28 3
99 SIDQFLYFDLIYSIJ 0.23 2152.41 3
99 SIDQFLYFDLIYSIJ 0.19 2152.36 3
99 SIDQFLYFDLIYSIJ 0.23 2152.4 3
99 SIDQFLYFDLIYSIJDTJ 0.12 2640.56 3
1 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) IJ 1.24 2641.69 4
99 SIDQFLYFDLIYSIK 0.13 2008.2 2
0 SITVR 80.05 798.51 2
1 SITVRVFEDGJ R->K VF -28.15 1509.72 5
1 SITVRVFEDGK 27.83 1421.6 3
1 SITVRVFEDGK E->D / I->V RV -14.09 1379.68 3
1 SSKFTGLMENMJ M->L EN -18.1 1641.76 3
1 TCMUGGVTEHNGNQLDKYR Y->W QLD 22.81 2495.98 3
1 TCMYGGVTEHNGNQLDJ Y->W GVTE 23.27 2177.29 4
82 ULMMYNDNJ 0.16 1622.98 3
1 ULMMYNDNJ Y->H ND -25.78 1597.05 3
1 ULMMYNDNJ 17.94 1640.77 4
1 ULMMYNDNKMVDSJ 79.92 2263 5
1 UVDVFGANUUYQCYFSK D->E / V->I YFSK 14.09 2719.43 5
1 VEFJ 14.27 823.76 2
1 VEFJNK 16.07 1067.7 3
1 VEFKNK 16.22 923.75 2
99 VLUDDNHVSAINVJ 0.14 2018.27 3
17 VLUDDNHVSAINVJ N(Deamidation) DDN 1.16 2019.29 4
1 VLUDDNHVSAINVJ 0.18 2018.31 4
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99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ 0.15 1874.17 3
97 VLYDDNHVSAINVJ 0.19 1874.2 3
82 VLYDDNHVSAINVJ 0.09 1874.1 3
37 VLYDDNHVSAINVJ 0.15 1874.16 4
1 VLYDDNHVSAINVK Y->H SAI -26.01 1703.91 3
13 VTAQELDULTR 1.12 1597 3
1 VTAQELDYLTRHYLVJ H->Y VT 25.73 2261.98 5
99 YLMMYNDNJ 0.09 1478.81 2
99 YLMMYNDNJ 0.11 1478.82 3
13 YLMMYNDNJ 0.13 1478.85 3
1 YVDVFGANYYYQCYFSKJ Y->H CYF -25.86 2519.37 4
Pro Group Report: SEB on parquet 50hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (120 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 61 98 81.7 
>95 (1.3) 1 1 61 98 81.7 
>66 (0.47) 1 1 61 98 81.7 
 
As shown: 
>95 (1.30) 1 1 61 98 81.7  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DLADKYJ 79.94 1219.58 2
1 DLADKYK 18.18 1013.72 3
1 DTKLGNYDNVR 17.93 1455.67 4
99 DVJIEVYLTTJ 0.08 1740.13 3
99 DVJIEVYLTTJ 0.1 1740.15 3
1 FDQSJ 16.28 927.79 2







Phosphoryl) LMM 80.15 2164.15 4
1 FDQSK 1.21 768.61 2










Q(Deamidation) NENS 1.22 3328.79 4
99 FTGLMENMJ 0.06 1357.77 3
1 FTGLMENMJ M->L FT -18.22 1339.48 3
99 FTGLMENMJ 0.06 1357.77 2
99 FTGLMENMJ 0.1 1357.8 2
99 FTGLMENMJ 0.08 1357.79 3
99 FTGLMENMJ -0.82 1356.88 3
1 FTGLMENMK 0 1213.61 3
1 HULVJ 0.05 1090.75 3
97 HULVJ 0.05 1090.74 3
1 HULVK 25.82 972.41 2
1 HYLVJ -15.9 930.69 2
1 HYLVJ 25.82 972.4 2
1 HYLVJ -15.9 930.68 2
99 HYLVJ 0.06 946.65 3
99 HYLVJ 0.06 946.64 2
43 HYLVJ 0.04 946.63 3
43 HYLVJ 0.06 946.64 3
1 HYLVK -15.88 786.6 2
1 IEVULTTJ E->D / I->V UL -14.21 1383.65 4
1 IEVULTTJJ 0.03 1670.08 4
1 IEVYLTTJ L->M YL 17.83 1271.58 3
99 IEVYLTTJ 0.07 1253.82 3
99 IEVYLTTJ 0.05 1253.81 2
99 IEVYLTTJ 0.07 1253.83 2
1 IEVYLTTJJ -26.24 1499.7 5
1 IEVYLTTJJ -26.22 1499.72 5
99 JVTAQELDYLTR 0.11 1724.09 3
99 JVTAQELDYLTR 0.09 1724.06 3
99 JVTAQELDYLTR E->Q EL -0.91 1723.07 3
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99 JVTAQELDYLTR 0.11 1724.08 3
89 JVTAQELDYLTR 0.07 1724.04 3
1 JVTAQELDYLTR 
Q->E / 
Q(Deamidation) EL 1.09 1725.06 4
1 KLUEFNNSPUETGYIJ 0.16 2541.52 4
1 KLYEFNNSPYETGYIK Y->W FNN 23.31 2132.37 4
1 KTCMYGGVTEHNGNQLDJ D->E / V->I KT 14.26 2296.36 4
1 KTCMYGGVTEHNGNQLDK Y->F NGNQ -16.04 2121.97 4
1 LGNUDNVRVEFJ 0.14 1885.18 3
99 LGNYDNVRVEFJ 0.08 1741.03 3
5 LGNYDNVRVEFJ 0.16 1741.1 4
2 LGNYDNVRVEFJ 0.12 1741.07 3
99 LYEFNNSPUETGYIJ 0.14 2269.3 3
99 LYEFNNSPUETGYIJ 0.16 2269.32 4
99 LYEFNNSPYETGYIJ 0.14 2125.21 3
99 LYEFNNSPYETGYIJ 0.14 2125.21 3
99 LYEFNNSPYETGYIJ 0.12 2125.19 3
1 MVDSJ D->E / V->I DS 14.16 880.64 2
1 MYK 15.99 600.3 2
0 NJDLADJ 1.02 1235.74 3
1 NJDLADJ 0.88 1235.61 3
1 NJDLADK 1.12 1091.74 3
0 NKDLADK 1.18 947.71 2
89 NLLSFDVQTNJ 0.11 1565.98 3
99 NLLSFDVQTNJ 0.09 1565.96 3
99 NLLSFDVQTNJ 0.05 1565.93 2
99 NLLSFDVQTNJJ 0.12 1838.18 3
99 NLLSFDVQTNJJ 0.06 1838.13 3
29 NLLSFDVQTNJJ 0.12 1838.19 4
1 NLLSFDVQTNJJ 1.12 1839.19 4
93 NLLSFDVQTNJJ 0.22 1838.28 3
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99 SIDQFLUFDLIYSIJ 0.15 2296.43 3
99 SIDQFLYFDLIYSIJ 0.13 2152.31 3
99 SIDQFLYFDLIYSIJ 0.11 2152.28 3
99 SIDQFLYFDLIYSIJ 0.17 2152.34 3
99 SIDQFLYFDLIYSIJDTJ 0.16 2640.6 3
1 SITVR 0.27 718.73 2
1 SITVR 0.27 718.72 2
3 ULMMYNDNJ M->L MY -17.92 1604.9 4
1 VEFJ -13.73 795.76 2
1 VEFJ 14.25 823.75 2
1 VEFJ 14.27 823.76 2
1 VEFJNJ -14.19 1181.54 3
1 VEFJNK N(Deamidation) NK 1.27 1052.9 2
1 VEFKNJ -13.91 1037.72 3
1 VEFKNK 0.22 907.74 2
99 VLUDDNHVSAINVJ 0.12 2018.24 3
1 VLUDDNHVSAINVJ N(Deamidation) AIN 1.12 2019.25 4
99 VLYDDNHVSAINVJ 0.13 1874.14 4
99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ 0.11 1874.12 3
1 VLYDDNHVSAINVK -26.01 1703.91 3
1 YKDJ 23.27 863.77 2
1 YKDJ 
Y(O-
Phosphoryl) YK 79.79 920.29 2
99 YLMMYNDNJ 0.09 1478.81 3
99 YLMMYNDNJ 0.09 1478.8 2
76 YLMMYNDNJ 0.11 1478.82 3
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Pro Group Report: SEB on parquet 74hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (275 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 128 226 82.2 
>95 (1.3) 1 1 128 226 82.2 
>66 (0.47) 2 2 188 275 100 
 
As shown: 
>95 (1.30) 1 1 128 226 82.2  
    
Conf Sequence Mod Zone dMass PrecMW Z
0 DLADK K->R LA 28.02 732.4 2
1 DLADKYK -26.02 969.52 3
1 DLADKYK 0.26 995.8 2
99 DVJIEVYLTTJ 0.1 1740.15 3
99 DVJIEVYLTTJ 0.04 1740.08 3
99 DVJIEVYLTTJ 0.14 1740.18 3
1 FDQSKYLMMYNDNK 14.15 1954.04 3
37 FTGLMENMJ 0.12 1357.82 3
7 FTGLMENMJ -1.16 1356.55 2
1 FTGLMENMJ 1.1 1358.8 3
1 FTGLMENMJ 0.1 1357.81 2
1 FTGLMENMJ 1.1 1358.81 3
1 FTGLMENMJ -13.86 1343.85 3
99 FTGLMENMJ 0.08 1357.78 2
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ 0.02 1357.73 2
99 FTGLMENMJ 0.08 1357.79 3
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ 0.1 1357.81 3
97 FTGLMENMJ 0.12 1357.82 3
93 FTGLMENMJ 0.12 1357.82 3
88 FTGLMENMJ N(Deamidation) ME 1.12 1358.83 3
62 FTGLMENMJ -0.22 1357.48 3
62 FTGLMENMJ -0.22 1357.49 3
38 FTGLMENMJ E->Q ME -0.94 1356.76 3





M(Oxidation) FT 16.14 1229.74 3
1 FTGLMENMK E->Q FT -0.76 1212.85 2
1 FTGLMENMK E->Q FT -0.76 1212.85 2
1 FTGLMENMK E->Q GL -1.02 1212.58 2
1 HULVJ 0.07 1090.77 3
93 HULVJ 0.05 1090.75 3
97 HULVJ 0.05 1090.74 2
97 HULVJ 0.05 1090.74 3
1 HULVK 14.18 960.76 2
1 HULVK 0.12 946.7 2
1 HYLVJ 14 960.58 2
99 HYLVJ 0.06 946.65 3
85 HYLVJ 0.04 946.63 3
85 HYLVJ 0.04 946.63 3
94 HYLVJ 0.06 946.65 3
98 HYLVJ 0.06 946.65 3
99 HYLVJ 0.06 946.64 2
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.06 946.65 3
99 HYLVJ 0.08 946.66 3
99 HYLVJ 0.06 946.65 3
99 HYLVJ 0.06 946.65 3
99 HYLVJ 0.06 946.65 3
1 HYLVKNJ H->Y VK 26.06 1214.79 2
1 HYLVKNK K->R LV 27.94 1072.56 2
1 HYLVKNK 18.24 1062.86 2
1 IEVULTTJ E->D / I->V TT -14.15 1383.7 4
1 IEVULTTJ -14.19 1383.67 4
1 IEVULTTJJ 13.77 1683.83 2
97 IEVYLTTJ 0.23 1253.98 3
97 IEVYLTTJ 0.23 1253.98 3
93 IEVYLTTJ 0.23 1253.98 3
1 IEVYLTTJ L->M YL 17.87 1271.62 3
1 IEVYLTTJ V->I TT 14.03 1267.79 4
1 IEVYLTTJ E->D / I->V TT -13.95 1239.8 4
1 IEVYLTTJ 23.23 1276.98 2
3 IEVYLTTJ E->D / I->V YL -13.87 1239.88 3
62 IEVYLTTJ 0.23 1253.98 3
93 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.07 1253.83 2
99 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.09 1253.84 3
99 IEVYLTTJ 0.11 1253.86 2
99 IEVYLTTJ 0.23 1253.98 3
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99 IEVYLTTJ 0.05 1253.8 2
99 IEVYLTTJ 0.23 1253.98 3
1 IEVYLTTJJ -15.98 1509.96 5
1 IEVYLTTJJ -16.02 1509.92 5
1 IEVYLTTK -25.89 1083.77 2
1 IEVYLTTKJ 13.82 1395.67 3
1 IEVYLTTKK K->R TT 28.24 1265.98 3
1 IEVYLTTKK E->D / I->V IE -14.06 1223.68 4
1 JLUEFNNSPUETGYIK -13.76 2527.6 3
1 JTCMYGGVTEHNGNQLDK Y->W NGNQ 22.76 2304.86 5
1 JTNDINSHQTDK H->Y HQ 25.91 1713.78 2
90 JVTAQELDULTR 0.17 1868.24 4
99 JVTAQELDYLTR 0.11 1724.08 3
99 JVTAQELDYLTR 0.13 1724.1 3
99 JVTAQELDYLTR 0.09 1724.06 3
5 JVTAQELDYLTR 
Q->E / 
Q(Deamidation) EL 1.15 1725.13 3
1 JVTAQELDYLTR 0.11 1724.08 3
99 JVTAQELDYLTR E->Q EL -0.85 1723.13 3
99 JVTAQELDYLTR E->Q EL -0.89 1723.08 3
99 JVTAQELDYLTR 0.11 1724.08 3
1 KLUEFNNSPUETGUIK E->D / I->V UETG -13.82 2527.55 3
1 KLYEFNNSPYETGYIK N(Deamidation) ETG 0.91 2109.97 5
1 KLYEFNNSPYETGYIK -0.05 2109 4
1 KTCMUGGVTEHNGNQLDK D->E / V->I KT 14.3 2296.41 4
1 KTNDINSHQTDK 14.19 1557.97 3





Phosphoryl) VTA 80.11 1659.99 4
1 LGNUDNVRVEFJ 0.1 1885.15 3
0 LGNUDNVRVEFK 0.22 1741.16 3
1 LGNYDNVRVEFK 79.7 1676.55 4
  
191
1 LGNYDNVRVEFK E->Q RVE -0.9 1595.95 3
1 LGNYDNVRVEFK Y->W NVR 22.92 1619.77 4
1 LYEFNNSPUETGUIK N(Deamidation) ETG 1.18 2270.34 4
1 LYEFNNSPUETGUIK N(Deamidation) YEF 1.2 2270.36 4
88 LYEFNNSPUETGYIJ N(Deamidation) YEF 1.16 2270.33 4
99 LYEFNNSPUETGYIJ 0.1 2269.26 3
1 LYEFNNSPUETGYIK 0.2 2125.26 3
99 LYEFNNSPYETGUIK 0.18 2125.24 3
99 LYEFNNSPYETGUIK 0.16 2125.22 3
24 LYEFNNSPYETGYIJ 0.18 2125.24 3
99 LYEFNNSPYETGYIJ 0.12 2125.19 3
99 LYEFNNSPYETGYIJ 0.12 2125.18 3
1 LYEFNNSPYETGYIK 17.96 1998.93 3
0 MVDSJ D->E / V->I DS 14.18 880.67 2
0 MVDSJ D->E / V->I DS 14.18 880.66 2
1 MVDSJ -17.8 848.68 2
1 MYJ 15.81 744.22 2
1 MYJ -18.09 710.32 1
1 MYJ 15.81 744.23 2
1 MYJR -15.91 868.6 2
1 MYJR -25.93 858.59 2
1 MYK 28.23 612.54 2
1 MYK 27.99 612.3 2
1 MYK 16.23 600.54 2
1 MYKR -17.79 722.62 2
1 MYKR -25.73 714.69 2
0 NJDLADJ 0.9 1235.62 3
1 NJDLADJ 14.04 1248.77 4
1 NJDLADJ 0.9 1235.63 3
1 NJDLADJ 1.1 1235.82 3
1 NJDLADK 1.14 1091.77 3
1 NJJ -0.23 820.32 2
1 NKDLADK 28.2 974.72 2
0 NKDLADK 1.2 947.72 2
1 NKDLADK 1.2 947.72 2
1 NKJ 0.15 676.61 2
1 NLLSFDVQTNJ 17.81 1583.68 3
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98 NLLSFDVQTNJ 0.13 1566 3
98 NLLSFDVQTNJ 0.13 1566 3
99 NLLSFDVQTNJ 0.09 1565.97 3
99 NLLSFDVQTNJ 0.11 1565.98 3
99 NLLSFDVQTNJ 0.11 1565.99 3
99 NLLSFDVQTNJ 0.01 1565.89 2





Q(Deamidation) LLS 1.14 1839.21 4
99 NLLSFDVQTNJJ 0.1 1838.17 3
99 NLLSFDVQTNJJ 0.12 1838.18 3
99 NLLSFDVQTNJJ 0.3 1838.37 4
29 NLLSFDVQTNJJ 0.1 1838.17 4
1 NLLSFDVQTNK 0.14 1421.91 3
1 SIDQFLUFDLIUSIK 0.17 2296.45 4
99 SIDQFLYFDLIUSIJ 0.11 2296.38 3
5 SIDQFLYFDLIUSIK 
Q->E / 
Q(Deamidation) FLY 1.21 2153.38 3
3 SIDQFLYFDLIUSIK 
Q->E / 
Q(Deamidation) FDL 1.17 2153.35 3
99 SIDQFLYFDLIYSIJ 0.17 2152.35 3
99 SIDQFLYFDLIYSIJ 0.17 2152.34 3
99 SIDQFLYFDLIYSIJ 0.19 2152.36 3
99 SIDQFLYFDLIYSIJ 0.19 2152.36 3
99 SIDQFLYFDLIYSIJ 0.19 2152.36 3
96 SIDQFLYFDLIYSIJ 0.21 2152.38 3
90 SIDQFLYFDLIYSIJ 0.19 2152.37 3
90 SIDQFLYFDLIYSIJ 0.19 2152.37 3
13 SIDQFLYFDLIYSIJ 
Q->E / 
Q(Deamidation) FDL 1.25 2153.42 3
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99 SIDQFLYFDLIYSIJ 0.19 2152.36 3
3 SIDQFLYFDLIYSIJ 
Q->E / 
Q(Deamidation) FLY 1.17 2153.35 3
99 SIDQFLYFDLIYSIJ 0.03 2152.2 3
99 SIDQFLYFDLIYSIJ 0.13 2152.3 3
99 SIDQFLYFDLIYSIJDTJ 
Q->E / 
Q(Deamidation) DQFL 1.16 2641.61 4
99 SIDQFLYFDLIYSIJDTJ 0.14 2640.59 4
99 SIDQFLYFDLIYSIJDTJ 0.14 2640.59 3
1 SIDQFLYFDLIYSIKDTK 
Q->E / 
Q(Deamidation) SI 0.92 2353.17 4
1 SITVR 0.27 718.73 2
1 SITVR 14.25 732.7 2
1 SITVR -27.77 690.69 2
0 SITVR 0.27 718.73 2
1 SITVRVFEDGJ R->K EDG -27.93 1509.94 5
1 SITVRVFEDGK 79.79 1473.57 4
1 SITVRVFEDGK 27.81 1421.59 3
1 SSKFTGLMENMJ M->L EN -18.08 1641.78 3
1 SSKFTGLMENMK 80.09 1595.84 4
1 TCMYGGVTEHNGNQLDJ Y->W MYG 23.27 2177.28 4
1 TCMYGGVTEHNGNQLDJYR Y->W MYGG 22.81 2495.98 3
1 TNDINSHQTDJ 80.14 1639.92 5
1 TNDINSHQTDJ 80 1639.79 5










Q(Deamidation) DIN 0.96 1416.64 2
1 UJDJ -0.02 1128.69 3
1 UKDJ -0.02 984.58 3
1 ULMMUNDNK 17.94 1640.77 4
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1 ULMMUNDNK 17.96 1640.79 4
1 ULMMUNDNK 0.1 1622.93 3
2 ULMMYNDNJ Y->H LM -25.82 1597 3
1 ULMMYNDNJ 17.9 1640.72 4
1 ULMMYNDNK 1.17 1479.88 3
1 ULMMYNDNKMVDSJ -18.02 2165.06 4
1 UVDVFGANYYYQCYFSJK 28.3 2717.63 4
1 VEFJNJ 13.87 1209.61 3
1 VEFJNJ E->D JN -14.11 1181.63 3
1 VFEDGJ 14.22 995.76 3
1 VLUDDNHVSAINVJ 0.1 2018.22 4
99 VLUDDNHVSAINVJ 0.08 2018.21 3
97 VLUDDNHVSAINVJ N(Deamidation) AIN 1.06 2019.19 4
1 VLUDDNHVSAINVJ 0.02 2018.15 4
99 VLYDDNHVSAINVJ 0.15 1874.17 3
99 VLYDDNHVSAINVJ 0.13 1874.14 3
99 VLYDDNHVSAINVJ 0.05 1874.07 3
37 VLYDDNHVSAINVJ N(Deamidation) DDN 1.13 1875.14 4
1 VLYDDNHVSAINVK -26.01 1703.91 3
1 VLYDDNHVSAINVK 18.09 1748.01 4
1 YKDJ -0.25 840.24 2
1 YKDJ 0.07 840.56 2
29 YLMMUNDNK 0.11 1478.82 3
1 YLMMUNDNK N(Deamidation) YL 1.09 1479.81 3
99 YLMMYNDNJ 0.11 1478.83 3
1 YLMMYNDNJ N(Deamidation) MM 1.13 1479.85 3
99 YLMMYNDNJ 0.11 1478.82 3
99 YLMMYNDNJ 0.05 1478.76 2
1 YLMMYNDNJ 0.13 1478.84 3
5 YLMMYNDNJ 0.13 1478.85 3
1 YLMMYNDNKMVDSJ -18.2 2020.78 3
1 YRSITVR I ->V SI -13.89 1023.73 2
1 YVDVFGANUUUQCYFSK F->Y YFSK 15.75 2721.08 5
2 YVDVFGANYYYQCUFSKJ Y->H YV -26.16 2663.17 4
1 YVDVFGANYYYQCYFSJK Y->F YV -15.96 2529.27 4
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Pro Group Report: SEB on parquet 170hours 
Report Parameters: ProtScore threshold: 1.30;  Show competitor proteins within 
ProtScore: 2.00;  Software version: 1.0.2  
Report Statistics (204 total spectra): 
Confidence 
(ProtScore) 










>99 (2.0) 1 1 79 176 86.3 
>95 (1.3) 1 1 79 176 86.3 
>66 (0.47) 1 1 79 176 86.3 
 
As shown: 
>95 (1.30) 1 1 79 176 86.3  
    
Conf Sequence Mod Zone dMass PrecMW Z
1 DKYVDVFGANYYYQCYFSK -0.07 2516.08 3
97 DVJIEVYLTTJ 0.16 1740.21 4
99 DVJIEVYLTTJ 0.16 1740.21 3
99 DVJIEVYLTTJ 0.18 1740.22 3
99 DVJIEVYLTTJ 0.14 1740.18 3
99 DVJIEVYLTTJ 0.16 1740.21 3
99 DVJIEVYLTTJ 0.16 1740.2 3
1 FDQSJULMMUNDNJ M->L FD -18.18 2498.13 3
1 FIENENSFWUDMMPAPGDJFDQSK 
F->Y / 
M(Oxidation) FDQSK 16 3343.56 4





Q(Deamidation) MMPAPG 0.8 3328.37 4
99 FTGLMENMJ 0.06 1357.77 2
97 FTGLMENMJ E->Q FTG -1.1 1356.61 2
97 FTGLMENMJ 0.12 1357.82 3
99 FTGLMENMJ 0.14 1357.84 3
99 FTGLMENMJ 0.12 1357.83 3
99 FTGLMENMJ 0.12 1357.82 3
99 FTGLMENMJ 0.04 1357.75 2
99 FTGLMENMJ -1.12 1356.59 2
99 FTGLMENMJ 0.12 1357.83 3
99 FTGLMENMJ 0.1 1357.81 3
99 FTGLMENMJ 0.12 1357.82 3
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99 FTGLMENMJ 0.14 1357.84 3
1 FTGLMENMK 1.2 1214.8 3
1 FTGLMENMK 
F->Y / 
M(Oxidation) MK 16.08 1229.68 3
1 FTGLMENMK E->Q FT -0.78 1212.82 2
1 HULVJ 0.07 1090.77 3
17 HULVJ 0.09 1090.79 3
82 HULVJ 0.09 1090.79 3
82 HULVJ 0.09 1090.79 3
98 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.66 3
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.66 2
4 HYLVJ -26.3 920.29 2
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.67 3
99 HYLVJ 0.08 946.66 3
43 HYLVJ 0.08 946.67 3
1 HYLVJNJ -15.72 1317.11 3
1 HYLVJNJ 22.88 1355.71 3
1 HYLVKNJ 13.88 1202.61 3
1 HYLVKNK 27.96 1072.58 2
1 HYLVKNK -16.14 1028.48 2
3 IEVULTTJ 0.13 1397.98 3
9 IEVULTTJ 0.07 1397.93 3
1 IEVULTTJJ E->Q EV -0.85 1669.21 4
1 IEVULTTJJ E->Q EV -0.91 1669.15 4
0 IEVULTTKK V->I UL 13.86 1395.7 3
99 IEVYLTTJ 0.11 1253.86 3
1 IEVYLTTJ L->M YL 17.87 1271.63 3
99 IEVYLTTJ 0.11 1253.87 3
99 IEVYLTTJ 0.09 1253.84 2
1 IEVYLTTJ 22.83 1276.58 2
99 IEVYLTTJ 0.11 1253.87 3
43 IEVYLTTJ 0.11 1253.86 3
98 IEVYLTTJ 0.09 1253.85 3
99 IEVYLTTJ 0.23 1253.98 3
99 IEVYLTTJ 0.13 1253.88 2
99 IEVYLTTJ 0.11 1253.87 2
1 IEVYLTTJJ Y->H LTT -26.24 1499.71 5





Phosphoryl) JT 79.71 1767.59 4
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99 JVTAQELDULTR 0.15 1868.23 4
99 JVTAQELDYLTR 0.15 1724.13 3
99 JVTAQELDYLTR 0.17 1724.15 3
99 JVTAQELDYLTR E->Q EL -0.87 1723.09 3
99 JVTAQELDYLTR E->Q EL -0.83 1723.14 3
99 JVTAQELDYLTR 0.17 1724.15 3
99 JVTAQELDYLTR 0.17 1724.14 3
99 JVTAQELDYLTR 0.13 1724.11 3
99 JVTAQELDYLTR 0.17 1724.14 3
99 JVTAQELDYLTR 0.15 1724.12 3
99 JVTAQELDYLTR 0.17 1724.14 3
99 JVTAQELDYLTR 0.15 1724.13 3
99 JVTAQELDYLTR 0.15 1724.12 3
43 JVTAQELDYLTR E->Q TAQ -0.87 1723.11 3
1 KTNDINSHQTDJ 14.31 1702.18 3
1 KTNDINSHQTDJ 25.91 1713.78 2
1 KVTAQELDYLTR K->R YL 28.29 1608.16 3
97 LGNUDNVRVEFJ 0.2 1885.25 4
1 LGNUDNVRVEFK 0.12 1741.07 2
90 LGNYDNVRVEFJ 0.2 1741.14 3
57 LGNYDNVRVEFJ N(Deamidation) YDN 1.18 1742.12 3
2 LGNYDNVRVEFJ 0.26 1741.21 3
99 LUEFNNSPYETGYIK 0.2 2125.26 3
99 LYEFNNSPUETGYIJ 0.14 2269.3 3
10 LYEFNNSPUETGYIJ N(Deamidation) YEF 1.22 2270.39 4
99 LYEFNNSPYETGUIK 0.2 2125.27 3
99 LYEFNNSPYETGUIK 0.2 2125.27 3
99 LYEFNNSPYETGYIJ 0.2 2125.27 3
99 LYEFNNSPYETGYIJ 0.22 2125.28 3
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99 LYEFNNSPYETGYIJ 0.16 2125.23 3
99 LYEFNNSPYETGYIJ 0.22 2125.29 3
95 LYEFNNSPYETGYIJ 0.2 2125.26 3
1 MVDSJ D->E / V->I DS 14.22 880.7 2
1 MVDSK 28.31 750.68 2
1 MVDSK 28.07 750.44 2
1 MVDSK 16.21 738.59 2
1 MVDSKDVK 28.07 1092.64 2
1 MYK 27.99 612.31 2
1 MYK 27.99 612.3 2
1 MYKR -17.79 722.63 2
29 NJDLADJ -0.24 1234.48 3
1 NJDLADJ 1.14 1235.86 3
1 NJDLADJ 0.92 1235.65 3
1 NJDLADJ 1.12 1235.85 3
0 NJDLADJ 1.12 1235.85 3
0 NJDLADJ 1.12 1235.85 3
1 NJDLADK 1.16 1091.78 3
1 NJDLADK 1.16 1091.78 3
1 NKDLADJ 13.76 1104.39 2
99 NLLSFDVQTNJ 0.13 1566.01 3
75 NLLSFDVQTNJ 0.15 1566.02 3
99 NLLSFDVQTNJ 0.11 1565.99 3
99 NLLSFDVQTNJ 0.15 1566.02 3
99 NLLSFDVQTNJ 0.05 1565.92 2
99 NLLSFDVQTNJ 0.15 1566.02 3
99 NLLSFDVQTNJ 0.17 1566.04 3
99 NLLSFDVQTNJ 0.13 1566.01 3
99 NLLSFDVQTNJ 0.15 1566.02 3
99 NLLSFDVQTNJJ 0.12 1838.18 2





Q(Deamidation) LLS 1.2 1839.26 4







Q(Deamidation) FD 1.18 1839.25 4










Q(Deamidation) LLS 1.18 1839.24 4
99 NLLSFDVQTNJJ 0.16 1838.22 4
99 NLLSFDVQTNJJ 0.3 1838.37 4
99 NLLSFDVQTNJJ 0.18 1838.24 3
99 NLLSFDVQTNJJ 0.18 1838.25 3
99 SIDQFLYFDLIUSIJ 0.17 2296.44 3
37 SIDQFLYFDLIUSIKDTJ 
Q->E / 
Q(Deamidation) DQFL 1.28 2641.72 4
99 SIDQFLYFDLIYSIJ 0.21 2152.38 3
99 SIDQFLYFDLIYSIJ 0.21 2152.39 3
99 SIDQFLYFDLIYSIJ 0.21 2152.38 3
99 SIDQFLYFDLIYSIJ 0.15 2152.32 3
99 SIDQFLYFDLIYSIJ 0.21 2152.38 3
99 SIDQFLYFDLIYSIJ 0.21 2152.38 3
99 SIDQFLYFDLIYSIJ 0.23 2152.4 3
99 SIDQFLYFDLIYSIJ 0.01 2152.18 3
99 SIDQFLYFDLIYSIJ 0.17 2152.35 3
99 SIDQFLYFDLIYSIJDTJ 0.22 2640.66 3
99 ULMMYNDNJ 0.16 1622.98 3
1 UVDVFGANUUYQCYFSK D->E / V->I UU 14.11 2719.44 5
1 VEFJNJ 14.23 1209.96 3
1 VEFKNJ 28.11 1079.74 2
1 VFEDGK E->Q DG -1.15 836.28 2
0 VFEDGK K->R DG 27.95 865.38 2
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7 VLUDDNHVSAINVJ N(Deamidation) AIN 1.18 2019.3 4
99 VLUDDNHVSAINVJ 0.2 2018.32 3
99 VLYDDNHVSAINVJ 0.15 1874.17 3
99 VLYDDNHVSAINVJ 0.17 1874.19 3
99 VLYDDNHVSAINVJ 0.15 1874.17 3
99 VLYDDNHVSAINVJ 0.17 1874.19 3
99 VLYDDNHVSAINVJ 0.19 1874.21 3
93 VLYDDNHVSAINVJ N(Deamidation) DDN 1.17 1875.18 4
3 VLYDDNHVSAINVJ N(Deamidation) HVS 1.11 1875.13 3
1 VLYDDNHVSAINVK Y->H SAI -25.95 1703.96 3
2 VTAQELDULTR 0.12 1596.01 3
1 VTAQELDULTR D->E / V->I QEL 13.76 1609.64 5
1 VTAQELDULTRHULVK 
T(O-
Phosphoryl) HU 80.25 2460.6 5
1 YJDK 23.31 863.8 2
1 YKDJ 23.31 863.8 2
1 YKDJ D->E KD 13.83 854.33 2
99 YLMMYNDNJ 0.11 1478.82 2
99 YLMMYNDNJ 0.13 1478.85 3
99 YLMMYNDNJ 0.15 1478.86 3
90 YLMMYNDNJ 0.13 1478.84 3





Q(Deamidation) DVFGA 1.13 2850.56 3
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(E) Determination of carpet’s extraction factor        
2.5ppm      10ppm     25ppm    
standard 1 2 1 2 1 2
RT(T2) 2.84 2.54 2.68 2.84 2.69 2.68
A(T2) 2.59E+08 5.67E+08 6.87E+08 9.27E+08 1.44E+09 1.54E+09
Extract 1 2 3 1 2 3 1 2 3
RT(T2) 2.69 2.69 2.69 2.54 2.69 2.53 2.68 2.69 2.53
A(T2) 1.39E+08 1.87E+08 3.21E+08 6.17E+08 5.68E+08 4.45E+08 9.20E+08 7.12E+08 1.16E+09




SD 9.93 22.36 12.95
Note that the extract 1 & 2 were made reference to standard 1 and extract 3 to standard 2. Where RT=retention time[min], A=peak 
area, SD=standard deviation   
(F) Determination of parquet’s extraction factor     
2.5ppm   10ppm   25ppm  
A(T2) 8.29E+07 9.18E+07 9.23E+07 1.90E+08 2.07E+08 2.35E+08 3.34E+08 3.24E+08 3.22E+08
RT(Ben) 3.72 3.71 3.7 3.69 3.53 3.67 3.82 3.67 3.67
A(Ben) 2.52E+07 3.30E+07 3.69E+07 4.16E+07 3.44E+07 3.88E+07 3.90E+07 3.90E+07 3.48E+07
Extract 1 2 1 2 1 2
RT(T2) 2.69 2.69 2.85 2.69 2.7 2.7
A(T2) 7.71E+07 6.07E+07 1.86E+08 1.38E+08 2.24E+08 2.12E+08
RT(Ben) 3.55 3.71 3.85 3.54 3.53 3.67
A(Ben) 2.42E+07 2.67E+07 2.44E+07 3.25E+07 3.13E+07 2.34E+07
average 101.1 99.9 90.96
SD 9.6 31.4 18.3
 
Where RT= retention time[min], A=peak area, Ben=Benzophenone internal standard, RRT=relative retention time of T-2/Ben, 
RA=relative area of T-2/Ben, SD=standard deviation       
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(G)  Raw data for Carpet’s stability profile   
25ppm T2 std     25ppm T2 std   
RT(T2) 2.83 2.97   RT(T2) 2.83 2.96  
A(T2) 2.18E+09 2.12E+09   A(T2) 2.32E+09 2.21E+09  
ave 2.15E+09    ave 2.27E+09   
   
1day C1 C2 C3 
0hr C1 C2 C3    2.95 2.78 3.11 
2.77 2.92 2.78    1.17E+09 8.98E+08 1.25E+09 
1.47E+09 1.08E+09 1.05E+09  Recovery 51.66 39.65 55.19 
Recovery 68.37 50.23 48.84  Actual 60.95 46.78 65.12 
Actual 80.68 59.27 57.63  Ave 53.87   
Ave 65.86    SD 10.02   
SD 12.86    2 day C1 C2 C3 
4hr C1 C2 C3    2.79 3.06 2.9 
2.62 2.80 2.95    1.41E+08 5.38E+08 5.11E+08 
1.14E+09 1.01E+09 1.46E+09  Recovery 6.23 23.75 22.56 
Recovery 5.30E+01 4.70E+01 6.79E+01  Actual 7.35 28.03 26.62 
Actual 62.57 55.43 80.13  Ave 20.67   
Ave 66.04    SD 11.56   
SD 12.71    25ppm T2 std    
8hr C1 C2 C3  RT(T2) 2.68   
3.11 2.77 2.79  A(T2) 3.19E+09   
1.27E+09 8.13E+08 7.45E+08  3day C1 C2 C3 
Recovery 59.07 37.81 34.65    2.84 2.84 2.67 
Actual 69.70 44.62 40.89    5.43E+08 5.92E+08 6.15E+08 
Ave 51.74    Recovery 17.02 18.56 19.28 
SD 15.67    Actual 20.09 21.90 22.75 
12hrs C1 C2 C3  Ave 21.58   
2.78 2.77 2.78  SD 1.36   
1.28E+09 1.03E+09 1.21E+09  25ppm T2 std    
Recovery 59.53 47.91 56.28  RT(T2) 2.68   
Actual 70.25 56.53 66.41  A(T2) 1.84E+09   
Ave 64.40    7 day C1 C2 C3 
SD 7.08      2.69 2.68 2.67 
  
4.51E+08 3.74E+08 3.37E+08 
Recovery 24.51 20.33 18.32 
Actual 28.92 23.98 21.61 
Ave 24.84   
SD 3.73    
Where RT=retention time[min], A=peak area, Actual=recovery% x filter factor of 1.18, ave=average of the actual, 
SD=standard deviation.         
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(H) Raw data for Parquet’s stability profile  
25ppm T2 std      
RT(T2) 2.69    
A(T2) 1.28E+09    
   
0hr P1 P2 P3  
2.68 2.68 2.69  
1.27E+09 7.68E+08 1.08E+09  
Recovery 99.22 60 84.38  
Actual 117.08 70.80 99.56      
Ave  95.81        
SD 23.37    3 day P1 P2 P3 
  
2.84 2.69 2.86 
25ppm T2 std      1.04E+08 4.37E+08 1.54E+08 
RT(T2) 2.81 2.82   Recovery 3.26 13.70 4.83 
A(T2) 2.14E+09 1.70E+09   Actual 3.85 16.16 5.70 
Ave 1.92E+09    Ave  8.57   
4hr P1 P2 P3  SD 6.64   
2.69 2.83 2.67      
9.69E+08 5.82E+08 7.82E+08  25ppm T2 std   
Recovery 50.47 30.31 40.73  RT(T2) 2.84   
Actual 59.55 35.77 48.06  A(T2) 1.67E+09   
Ave  47.79    7 days P1 P2 P3 
SD 11.89      2.7 2.85 2.84 
8hr P1 P2 P3    2.85E+08 4.16E+08 3.05E+08 
2.85 2.69 2.82  Recovery 17.07 24.91 18.26 
4.95E+08 4.63E+08 7.42E+08  Actual 20.14 29.39 21.55 
Recovery 25.78 24.11 38.65  Ave  23.69   
Actual 30.42 28.46 45.60  SD 4.99   
Ave  34.83        
SD 9.38        
25ppm T2 std        
RT(T2) 2.99 2.68       
A(T2) 1.99E+09 2.10E+09       
Ave 2.05E+09        
12hr P1 P2 P3      
2.85 2.68 2.69      
3.94E+08 5.24E+08 5.75E+08      
Recovery 19.27 25.62 28.12      
Actual 22.73 30.24 33.18      
Ave  28.72        
SD 5.39        
1 day P1 P2 P3      
2.85 2.85 2.7      
1.73E+08 2.65E+08 3.29E+08      
Recovery 8.46 12.96 16.09      
Actual 9.98 15.29 18.98      
Ave  14.75        
SD 4.52        
Where RT=retention time[min], A=peak area, Actual=recovery% x filter 
factor of 1.18, ave=average of the actual, SD=standard deviation.    
  
204
